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ABSTRACT 
0 
Serologically related arenaviruses have been isolated from West 
Africa, Mozambique, Zimbabwe and the Central African Republic. Human 
disease is only associated with the West African isolates. The virulence of 
Mozambique, Zimbabwe and Central African Republic isolates in humans is 
not known. 
This Thesis is an account of work carried out by the author to 
compare the biological characteristics of isolates from West Africa, 
Mozambique and Zimbabwe. It describes the successful isolation and 
identification of the aetiological agents, their physicochemical and 
antigenic characteristics and describes in vivo studies using mice, guinea 
pigs and Rhesus monkeys. 
A direct comparison was made with a patient diagnosed as having 
Lassa fever. The disease in man and monkeys following infection with 
Lassa virus was similar. The Rhesus monkey and guinea pig proved suitable 
experimental models in which to study and compare the pathogenic 
responses and also to evaluate various aspects of protection. These animal 
models when immunised with the viruses from Mozambique and Zimbabwe 
were protected when subsequently challenged with Lassa virus. 
The Mozambique and Zimbabwe isolates proved to have 
morphological and physicochemical characteristics not dissimilar from 
West African Lassa viruses and those members of the arenavirus family 
from South America. Serological and immunochemical investigations 
suggest the existence of both common and unique antigenic determinants 
on the viruses from Mozambique, -Zimbabwe and West Africa. This 
grouping also coincides with the geographic separation of the viruses, i. e. 
Lassa - West Africa and Mopeia -southeast Africa. Similar differences in 
host susceptibility have also been demonstrated. Lassa virus produces a 
fatal haemorrhagic disease while Mopeia isolates produce only an 
asymptomatic infection. The combined data suggests the possibility of two 
virus groups within the 'Old World' arenavirus classification. The 
proposed name, 'Mopeia', forms one group and includes the viruses from 
Mozambique and Zimbabwe. The Lassa strains from West Africa form the 
second group. 
It is suggested that the Mopeia viruses are minor antigenic variants 
of Lassa and should be included within the arenavirus family. 
1. INTRODUCTION AND HISTORICAL BACKGROUND 
The arenavirus taxon takes its name from the sand-sprinkled 
(arenous) appearance when viewed by the electron microscope. They are a 
family (arenaviridae) of pleomorphic, enveloped viruses containing a single- 
stranded RNA genome of molecular weight of about 4x 106 (Ramsingh et 
al. 1980) in two segments of negative polarity. The first recognised 
member of the group, Lymphocytic choriomeningitis (LCM), is considered 
to be the prototype. The group is divided (Fig. I) into the LCM complex 
('Old World') and the Tacaribe complex ('New World') (Fig. 2) on the basis oä 
immunological cross-reactivity as determined by complement fixation or 
immunofluorescent staining. 
Nearly all the 12 members (Figs. I& 2) so far described cause acute 
or persistent infections of rodents. LCM has been implicated in cases of 
as, 
eptic 
meningitis in man since its original description (Armstrong and 
Lillie, 1934) although these have been largely laboratory-acquired 
infections. Three arenaviruses - Junin (Parodi et al., 1958), Machupo 
(Johnson et al., 1965), Lassa (Buckley and Casals, 1970) - cause severe 
haemorrhagic diseases in man in Argentina, Bolivia and West Africa 
respectively. They represent a serious public health problem in these 
countries. Lassa in particular has achieved public notoriety owing to its 
association with severe febrile illness among missionaries and travellers 
returning from rural parts of West Africa. Human infection of man with 
LCM is rarely fatal whereas the mortality rate of the haemorrhagic 
arenaviruses ranges from 10 to 50% in individual outbreaks. 
Two major rodent families (Table 1) are associated with arenaviruses. 
They are Muridae (mice, rats) and Cricetidae (voles, lemmings, gerbils). 
Lassa, LCM and the more recent isolates of Mopeia from Mozambique and 
Zimbabwe are all found in members of the Muridae family. The 'New 
World' viruses are confined to Cricetine rodents whose members frequent 
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open grasslands and forests. The exception is Tacaribe virus, which was 
originally isolated from the fruit bat, Artibeus literatus, in Trinidad in 
1956-1958 and has not been isolated since (Downs et al. 1963). Tamiami 
virus which was isolated in Florida, USA from the cotton rat, Sigmodon 
his idus, completes the so far characterized Tacaribe complex of 
arenaviruses (Calisher et al. 1970). 
TABLE I. PRINCIPAL NATURAL VERTEBRATE HOSTS OF ARENAVIRUSES 
Virus Vertebrate Habitat 
Tacaribe Artibeus lituratus 
Artibeus jamaicensis 
Junin Calomys laucha 
Calomys musculinus 
Akalo azarae 
Machupo Calomys callosus 
Amapari Oryzomys goeldi 
Neucomys guianae. 
Tamiami Sigmodon hispidus 
Pichinde Oryzomys albigularis 
Parana Oryzomys buccinatus 
Latino Calomys callosus 
LCM Mus musculus 
Lassa Mastomys natalensis 
Tropical forest 
11 
Hedgerows, farm fields 
Grassland, forest, farm 
fields, houses 
Tropical wet forest 
if if n 
Grassland, early secondary 
forest 
Tropical cloud forest 
Tropical dry forest 
Grassland, forest edge, 
farm fields, houses 
to it 
If of 
Mopeia it it " 
Flexal Neocomys spp. 
LCM virus remained unclassified until shortly after the morphology 
was established in 1968 (Murphy It al. 1975). The first obvious link 
between LCM and other viruses came in 1964 when it was found that 
infection of neonatal rodents, Calom s species, with Machupo virus 
5 
resulted in life long viraemia in the absence of specific neutralizing 
antibodies (Johnson et al. 1965; Johnson et al. 1975; Webb et al. 1967). 
Since the same response was known to exist with the murine LCM system, 
serological and morphological comparisons followed (Hotchin 1971; 
Lehmann-Grube, 1979) . Machupo and all the viruses with which 
it shared 
complement fixing antigens (Tacaribe complex) were antigenically and 
structurally related to LCM (Murphy 1975; Rowe et al. 1970a). This led to 
the proposal and definition of a new virus group - arenovirus (Rowe et al., 
1970b). To avoid possible confusion with Adenovirus (especially in oral 
conversation) the International Committee on Nomenclature of Viruses 
(ICTV) 1970 chose the name, arenaviruses, to describe the genus. Family 
status (arenaviridae) by the ICTV was confirmed in 1975 (Fenner 1976). 
With the discovery of Arenavirus-like particles (Mopeia) in southern 
Africa, interest was directed towards studying their relationship to Lassa 
fever and establishing the significance of this virus within the African 
continent. Preliminary investigations demonstrated an antigenic link 
between both viruses but also indicated that the viruses differed 
significantly in their expression of virulence for man. These observations 
parallel those found with the Arenaviruses of South America. Lassa fever 
is perhaps the most publicised of all the viral haemorrhagic fevers with a 
case fatality rate of 36-67% among hospitalized patients. Twenty one 
medical workers are known to have been infected, of whom 10 have died. 
Once Lassa has been successfully transmitted from its natural reservoir 
cam` 
host to man, it is capable of adap ion to produce man-to-man transmission. .X 
It is theoretically possible for such an infection to be introduced from its 
country of origin to countries where the natural host does not exist and 
still be capable of successful transmission. Hence the worldwide public 
health concern. 
Lassa virus was first isolated from an American missionary nurse 
(Fig. 3) following the sequential infection of two other nurses in Nigeria 
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Fig. 4 Map of Zimbabwe, showing areas where rodents 
were captured for detection of Arenavirus infection. 
Capital city, Harare, is indicated as a reference 
point. 
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(Frame et al. 1970). The virologist who made the isolation in turn became 
infected. A seasonal outbreak of Lassa fever with a high mortality of 53 
per cent. among 23 patients confined to hospital was reported in Jos, 
Nigeria in 1970 (White 1972). In March 1972 further cases of Lassa fever 
occurred among 4 patients and 7 members of staff in a hospital in the 
Zorzor district of Liberia, and 4 patients died (Monath et al., 1973). The 
fourth major outbreak was not hospital-associated and took place between 
October 1972 and October 1974 in and around Panguma township, Sierra 
Leone. There were 64 cases, most of whom acquired their infection in the 
community. Several family outbreaks occurred. Between January 1969 
and July 1978 there have been 17 reported outbreaks involving 386 cases 
with 105 deaths, an overall case-fatality rate of 27.2% (Galbraith et al., 
1978). Previously estimated fatality rates for Lassa fever were mainly 
based on hospitalized cases; when serological findings are taken into 
account, the case fatality-rate in the community was calculated to be less 
than 5%. Since 1978, Lassa fever has continued to occur in West Africa, 
but usually as sporadic cases. Quite often medical personnel are those who 
manifest the disease, presumably being infected through contact with a 
febrile patient. In an endemic area of Lassa virus activity, it has been 
found that almost half of the patients presenting a febrile illness have had 
a Lassa infection but very few develop severe disease. 
Lassa virus is present in several West African countries although 
outbreaks are confined to Nigeria, Liberia and Sierra Leone. Major studies 
on the epidemiology of the disease have shown Lassa to be a zoonosis 
transmitted to man from a rodent reservoir, known to be Mastomxs 
natalensis, widely distributed throughout Africa (Demartini et al. 1975). 
The disease is endemic in certain areas of West Africa, particularly Sierra 
Leone, Liberia and the Jos plateau of Nigeria, while other areas of Nigeria 
together with Guinea, Senegal, Mali, Central African Republic and Zaire 
have been implicated on historical or serological evidence (Monath I975). 
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The mode of transmission of Lassa virus from rodent to man or from 
man-to-man is not yet known. Similarly the pathogenesis of Lassa virus 
infection in its natural host is still not fully understood. Like other 
arenaviruses, Lassa produces a persistent tolerant infection in its rodent 
reservoir host, with no apparent ill effects. The animals are infected at 
birth and remain infective during their life time, excreting the virus in 
urine and other body fluids. Transmission to man probably occurs when he 
comes in close contact with rodents, and could be either via the respiratory 
or the gastrointestinal route from the consumption of contaminated food or 
water (Monath, 1975). Monath suggested that the low level of sanitation, 
the storage of grain and food within houses and the ease with which rodents 
infect mud and thatch houses enhance the contact between rodents and 
man. The means by which the virus is spread from person-to-person is still 
not clear. Medical attendants or relatives providing direct personal care 
are most likely to contract the infection. Lassa virus has been isolated 
from the blood, pharynx and urine of patients, suggesting that indirect 
airborne spread of the virus as well as mechanical transmission are most 
likely (Buckley and Casals, 1970) . Community infection in the endemic 
areas is dominated by the pattern of rodent-to-man transmission . Fraser 
et at. (1974) suggested that the clustering of sero-positives among people 
who shared the sleeping accommodation of the cases, might be due to 
person-to-person transmission possibly by the respiratory route. This 
possibility cannot be proved or disproved on epidemiological grounds. If it 
does occur then it is considered of little importance in the natural history 
of the disease pattern. 
In the hospital situation the reverse is true. Here rodent-to-man 
transmission may be discounted and the only possible mechanism is person- 
to-person spread. This occurs under three conditions: 1. Direct inoculation 
of the virus through the skin, 2. Nosocomial transmission as a result of 
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close patient contact, 3. Airborne transmission through droplet material 
derived from the respiratory tract of the patient. Each emphasises the 
need for extreme caution within a research programme including Lassa 
viruses. Of the 17 recorded episodes, II were hospital outbreaks involving 
a total of 57 cases with 25 deaths (43.8%). Two were laboratory infections 
and two were prolonged community outbreaks studied over a period of 2-3 
years respectively (Fraser et al., 1974, Keane and Gilles 1977). The 
observed case-fatality case of 43.8% among nosocomial (hospital-acquired) 
infections is a sharp contrast to the rate of 24.3% in community acquired 
infections. 
Information about the ecology of the Lassa infections is far from 
complete. The evidence so far suggests that the natural reservoir of the 
multimammate rat, Masto ys natalensis which has been the only animal 
carrier identified among 26 species tested in Sierra Leone and Nigeria. 
The numbers of animals tested so far have been small and their 
geographical area limited. While there can be no doubt that this species 
acts as a reservoir, some epidemiologists believe there is insufficient 
evidence to identify it positively as the primary reservoir of the virus. 
Whatever may prove to be the primary source, the function of Mastomis as 
a link reservoir and its close association with residential compounds in 
endemic areas, make it the most likely intermediate source of infection for 
the majority of human cases. What is of concern results from the 
ecological threat which could occur from the introduction of the virus into 
a virgin community such as the United Kingdom, Europe and North 
America. 
In contrast, Mopeia virus has been isolated from the same rodent 
species (Mastomys) in Mozambique and Zimbabwe where haemorrhagic 
fever disease like that produced by Lassa virus has not been reported. 
During studies on arbovirus infections in Mopeia, Central Mozambique, five 
virus strains were isolated from the spleens of Mastom s natalensis which 
showed no immunological relationship to any known arbovirus (Wulff et al. 
1977). The agents isolated from this study suggested that they were 
morphologically and immunologically related to Lassa. Four of 19 sera 
from Mastomys captured in the study area had antibodies to both Lassa 
virus and one of the unidentified strains. Although not definite, the 
differences noted in results from complement fixation and indirect 
immunofluorescent tests suggested that the viruses from south east Africa 
were not identical to the West African Lassa virus. In the second study, 
six strains of Mopeia virus were isolated from Zimbabwe, and this was the 
first study to suggest that these agents were more widely distributed than 
previously recognized (Johnson et al., 1981). Rodents were captured from 
four areas in central, eastern and southern Zimbabwe (Fig. 4), Chiredzi; 
Rusape; Enkeldoom and Que Que. Upon capture, rodents were bled by 
heart puncture and liver and spleen tissue removed. The study also 
included the differential identification of rodent species in an attempt to 
determine a relationship between the isolates and specific rodent species. 
Immunofluorescent antibodies to Mopeia were found in II of 55 Mastomis 
natalensis and one of 13 Aethom s chr so hilus rodents captured near Que 
Que and Chiredzi, Zimbabwe. All Mas tomnys having virus or antibodies to 
Mopeia were of the chromosomal form 2N = 32 (M. ramom s natalensis), 
none being found in the other member of the Mastomis group M. coucha 
(chromosomal type 2N = 36). 
In terms of host-parasite relationships, data relating to Mopeia virus 
provide a strong stimulus to answer a variety of questions. As antibody 
had been found in the species A. chrysophilus, their role in the natural 
maintenance of Mopeia virus has to be resolved. A second area of study 
needs to elucidate the specificity of Mopeia to M. natalensis (2N = 32) in 
southern Africa. In order that M. coucha (2N = 36) could be disregarded as 
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a reservoir a large number of rodents must be tested. M. coucha and M. 
natalensis differ in their distribution throughout southern Africa (Gordon, 
1978; Green et al. 1978; Green et al., 1980). Any difference in their 
susceptibility to Lassa and Mopeia could have important implications for 
related human diseases. No evidence as to the extent of Mopeia virus 
infections and antibody levels in the human population is at present known. 
Since Lassa virus appears to be a single-host rodent parasite, and 
because M. natalensis is widely distributed, the presence of Lassa virus or a 
closely related arenavirus in south-east Africa does not represent a 
biological surprise (Isaacson, 1975) . Since Mopeia virus was found more 
than 2,500 miles from the place in which Lassa is endemic, it is of special 
importance to determine whether the new strains are antigenically related, 
pathogenic for man and whether M. natalensis of West Africa and south- 
east Africa are truly identical. 
Since structurally and morphologically the arenaviruses appear to be 
a homogeneous group, extensive studies have been directed at determining 
their molecular biological and physical properties. The major component 
of arenavirus particles (including Lassa) is the nucleocapsid protein with a 
molecular weight ranging from 54,000 - 68,000 (Clegg and Lloyd, 1982; 
Howard and Simpson, 1980; Pederson 1979). Lassa virus also has two 
envelope glycoproteins with molecular weights similar to those found in 
most other members of the family (Howard and Simpson, 1980) although 
Tacaribe and Tamiami viruses are reported to have only a single envelope 
glycoprotein (Gard et al., 1977). Other minor proteins have been found in 
purified arenavirus preparations, but their status as true components of the 
virion is at present unclear. Thus, the molecular biochemical structure 
has demonstrated limited differentiation between the 'Old' and 'New' World 
arenaviruses. 
Alternatively, arenaviruses are known to show varying degrees of 
antigenic relationships using complement fixation and immunofluorescent 
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antibody tests. Cross-reactivity among the arenaviruses using 
complement-fixation tests (CFT) demonstrates a close association between 
Amapari, Junin, Machupo and Tacaribe viruses (Casals et al., 1975). LCM 
antisera was also reported to show a cross-reactivity with other members 
of the family with the exception of Lassa. Evaluation of reciprocal 
antibody titres for at least one representative of each known arenavirus 
serotype, leads to some conclusions concerning their immunofluorescent 
antibody (IFA) inter-relationship. Two groups can clearly be distinguished. 
The first comprises the 'Old' World arenaviruses, i. e. Lassa and LCM, both 
viruses cross-reacting at a very low level with other members of the 
arenavirus group. Although originally isolated in North America, LCM 
virus is considered an 'Old' World agent because its rodent reservoir Mus 
musculus, is believed to have originated in Asia. Antisera obtained from 
man and animals against 'New' World arenaviruses, which forms the basis of 
the second group, showed strong cross-reactions with most antigens except 
Lassa and LCM (Wulff et a!., 1978) 
To date, there has not been any reliable data produced on arenavirus 
cross-neutralization. Difficulties in demonstrating convincing specific 
neutralization of arenaviruses tends to preclude a final judgment on their 
identity. Casals (1977) claimed that members of the Tacaribe complex do 
not cross-react in neutralization assays. The only evidence to date of any 
cross-neutralization between arenaviruses is with Tacaribe-immunized 
guinea pigs which also produce anti-Junin neutralization antibodies 
(Weissenbacher et al., 1976; Coto et call., 1980). 
The foundation of this thesis is a study of the biological 
characteristics of Mopeia viruses and other arenaviridae, particularly 
Lassa virus. This involved comparison of their morphological, physico- 
chemical, molecular biological, antigenic and pathogenic properties using in 
vitro and in vivo models. It is proposed on this basis that Mopeia viruses 
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are minor antigenic variants of Lassa virus and the aim of the thesis is to 
examine this hypothesis critically with a view to their inclusion in the 
arenavirus family. 
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2. METHODS AND MATERIALS 
2.1 CATEGORY A FACILITIES 
2.1.1. Laboratory Suite 
Since Lassa virus is categorized a Category A pathogen, all 
experiments involving this agent were carried out under the most stringent 
precautions to prevent infection of laboratory personnel. All serology and 
tissue culture studies were carried out in the maximum security laboratory 
at the Centre for Applied Microbiology and Research. 
The unit (Fig. 5) consists of a laboratory connected to a changing 
room with shower and an annex housing the clean side of a double-doored 
autoclave. All three rooms operate under a gradient of negative pressure 
and are ventilated by a plenum and exhaust system. The input air is 
filtered to remove coarse particles and the exhaust air is passed through 
High Efficiency Particulate Air (HEPA) filters in the ceiling. Entry to the 
unit is gained through the autoclave annex to the changing room where 
everyday clothing is exchanged for protective clothing. This, briefly, 
consists of underpants, pyjamas, socks, gown and surgical boots. On 
entering the laboratory the staff put on two pairs of gloves, a thin latex 
pair and a pair of white linen ones. 
The laboratory consists of a series of inter-connecting gas tight 
aluminium safety cabinets which operate under negative pressure (Figs. 6- 
11), each cabinet having gauntlet covered portholes for access. The 
negative pressure is provided by two banks of three fans; each fan being 
capable of pulling approximately (510m3/h) of air through the system, 
giving a flow rate of between (60m3/h) of air through each cabinet. Under 
normal operative conditions only a single fan is used from one of the banks. 
The others are mainly back-up fans. If there is a need, the negative 
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pressure in the system can be increased by a second or even a third 
fan 
which would increase the flow rate to approximately (170m3/h). In the 
case of a power supply failure, the Establishment's stand-by generator 
comes into operation in well under a minute. If this too should fail, as 
soon as the negative pressure in the system drops to 0.2 inches of water 
pressure, an automatic pressure switch situated in the trunking switches on 
2 battery operated fans which are capable of maintaining this negative 
pressure for at least 24 hours. 
Air is filtered into and out of each of the cabinets and is again 
filtered before it leaves the trunking at the end of the system. Material 
can be passed into the system through a double-ended autoclave, the 
autoclave acting as an air-lock. There is a safety device to ensure that 
both doors cannot be opened at the same time. Material is then passed 
along from cabinet to cabinet through inter-connecting portholes. 
Within the cabinet system are housed a small centrifuge (MSE Minor), 
built-in +4°C refrigerator and 37°C incubator, 2 water baths, one operating 
at 37°C and the other at 60°C; one inverted microscope (Prior), one 
multipurpose microscope (AO Microstar) predominantly used for 
fluorescence and a Flow 'Titertek' automatic E. L. I. S. A. analyser. 
Specimens are brought out of the system for storage purposes through a 
dunk tank containing 5 per cent. hypochlorite solution, following 
established codes of practice. All material which is discarded within the 
system is placed in autoclavable bags and decontaminated in the autoclave, 
access to which is gained directly from the cabinet system. Each cabinet 
is decontaminated after working with formaldehyde vapour overnight. 
In the laboratory itself, there are -70°C, -20°C and +4°C refrigerator 
units, a 37°C incubator and a store cupboard for everyday laboratory 
equipment. There is a second autoclave leading from the laboratory itself. 
This is mainly used for the sterilization of clothing plus other items that 
require autoclaving from the room. 
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Figs. 6 to 11 show the cabinet layout in the Maximum 
Containment Laboratory at the Centre for Applied 
Microbiology and Research 
Fig. 6. Cabinets housing +4°C refrigerator (J), bench 
centrifuge and double-ended autoclave. 
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Fig. 7. Cabinet housing bench centrifuge. 
Fig. 8. Cabinet containing two 370 C incubators. 
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Fig. 9. Double sided working cabinets. 
Fig. 11. Cabinet containing two 370C incubators and 
inverted light microscope. 
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Fig. 10. Cabinet designed around an immunofluorescent 
microscope. The light source, power packs and main 
body of the microscope are sealed inside the cabinet 
from the eye-piece head and camera which are positioned 
on the outside. 
2.1.2. Animal Laborator 
Animal experiments, ultracentrifugation, growth of large batches of 
virus and biochemical analysis were carried out in a suite of rooms with 
entry and exit through an airlock and shower. Personnel wore protective 
clothing, gloves, rubber boots and full-face biological respirators and hoods 
(Figs. 12 & 13). 
This suite of rooms has a gradient negative pressure from corridor to 
suite. Entry can only be gained through the shower and air-lock. At the 
opposite end of the animal suite a double-ended autoclave is housed. This 
is large enough to use as an airlock for transport of animals and equipment 
into the suite. Animal bedding, waste, post-mortem material are all 
autoclaved before removing to the clean side of the autoclave. 
All effluent from this suite of rooms is sterilised by boiling in special 
collecting tanks and extracted air filtered through double HEPA room 
filters. Before leaving infected animal rooms personnel swab down their 
respirators with 5% hypochlorite solution and discard their gowns and 
hoods. Boots are thoroughly washed down in 5% hypochlorite and rubber 
gloves removed and left to soak in the hypochlorite solution. Having left 
the infected rooms, the remaining clothing is removed in the air lock and 
discarded. Boots and respirators are stored in lockers. Personnel shower 
completely before returning to the clean changing area. 
2.2 VIRUSES 
2.2.1. Lassa strain (LGA 391) 
The origin of this virus was Zaria, Nigeria and it was isolated at 
Porton in November 1977. The patient (G. A. ) was a part-time doctor in a 
paediatric ward at Ulussa Hospital. Her symptoms started on 16 October 
1977 when she was admitted to hospital. Lassa virus was isolated from her 
blood which was taken on 25 October. The isolation was carried out in vero 
cell cultures and confirmatory diagnosis carried out by 
im munofluorescence using known anti-Lassa serum. 
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Fig. 12. Cabinet containing LKB (Ultralab) analyser, 
dilution and analytical data microprocessor for serum 
biochemistry studies. 
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1 
rrr 'j{ 
Fig. 13. This shows the clinical biochemical cabinet 
positioned in a Category A animal room, together with 
the protective clothing used by personnel. Room 
filtration is through double HEPA filter in the 
ceiling (arrow). 
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For the purposes of the studies in this thesis the original LGA 391 
strain was used and had been passed three times in Vero cultures. A stock 
of this pass 3 material was made and stored in 0.2 ml aliquots at -70°. The 
titre of the stock was estimated to be 107.8 tissue culture infectious 
doses50(TCID50)/ml. Later stocks were made using roller bottles the virus 
titre of which was raised to 109 TCID50/ml. 
TABLE 2. LASSA AND MOPEIA VIRUSES STUDIED 
Virus Reference 
LGA39 t Grundy 
H et a1 
1980) 
M20410 Wulff 
et al. 
1977) 
History 
Human case, originated 
in Nigeria, 
hospitalised in UK 
Isolated from Mastomys 
natalensis, Mopeia 
Source Laboratory History 
Serum Isolated in Vero cells, 
CAMR passed x3 
Spleen Mouse brain x4 CDC 
Vero cell passed x3 
CAMR 
MI50 it 
M 152 of 
of 
to 
It 11 
11 ei 
Z478 Johnson Isolated Praeomys Spleen Isolated in Vero 
et al. natalensis, Chiredzi cells CDC passed x2 
9 1) Zimbabwe CAMR 
2.2.2. Mopeia viruses 
Five strains of Mopeia viruses were supplied to me by Dr. M. 
Kiley (Center for Disease Control, Atlanta). Three of these agents were 
derived from an epidemiological study on rodents carried out in Mopeia, 
Central Mozambique and two from Zimbabwe (Wulff et al. 1977; Johnson 
et al. 1981). The five viruses were isolated from pooled liver, spleen and 
kidney homogenates from different Mastom s natalensis. Original 
isolations were made in mice after intracerebral inoculation. They were 
subsequently passed four times I. C. in mice and finally once through Vero 
cells. The Zimbabwe strain was isolated from Vero cells. It was at this 
stage that I received the samples. 
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The viruses were subsequently passed twice in Vero cells and 
stock preparations made. A summary of passage history is recorded 
in 
Table 2. Only pass 3 Vero cell preparations were used in all the studies. 
2.3 ANIMALS 
2.3.1. Mice 
Inbred Balb/c and Porton all purpose mice of outbred stocks of 
both sexes with an age range between 2 days and 10 weeks were used 
during these studies. The mice were obtained from Bantim and Kingman 
Limited, Alderbrough, Yorkshire or from Olac Limited, Bicester, 
Oxfordshire. 
Adult mice were kept in groups of five and suckling mice kept 
with their mother in individual litters. All mice were housed in 
polypropylene boxes with stainless steel wire mesh lids. They were 
allowed a Prepared Mouse Diet (PMD) pelleted (Christopher Hill Group 
Ltd., Poole, Dorset) and tap water ad libitum. The bedding consisted of 
sterilized wood chips. 
(a) Intracerebral inoculation (I. C. ) 
Adult and newborn mice (I -21 days old) were lightly anaesthetised 
in a large jar containing a wad of cotton wool soaked with ether. The 
solution to be inoculated was taken up in a 0.25 ml syringe with 0.01 ml 
calibrations fitted with af inch, 27-gauge needle with a short bevel. The 
mice were secured on a flat surface by holding their head and trunk 
between thumb and index finger. The skull was swabbed with I% 
cetrimide in 70% alcohol. The injection was given by inserting the needle 
into the cranium at a point half way between the eye and the ear, lateral 
to the midline. The volume of the inoculum was 0.02 ml. 
The procedure used for adult mice was essentially the same as for 
the newborn mice. With older mice the skull becomes tougher and 
therefore requires stronger pressure to penetrate. The mice were 
26 
therefore put under deeper ether anaesthesia. The volume of the inoculum 
given was 0.03 ml. 
(b) Intra eritone l inoculation (I. P ) 
Mice were injected intraperitoneally with a 25-gauge hypodermic 
needle in the right hand lower quarter of the abdomen after swabbing the 
area with 1% cetrimide in 70% alcohol. The usual volume, unless 
otherwise stated, was 0. I ml. 
(c) Intravenous iniection 
Intravenous injections were made via one of the lateral tail veins 
with a 25 gauge hypodermic needle after warming the mice for 2-3 minutes 
under a chick incubation lamp (150W infra-red lamp, Phillips Electrical 
Limited, Holland) to dilate the veins. 
(d) Collection of blood 
Blood samples were taken from the retro-orbital plexes of ether- 
anaesthetized mice, using a finely drawn-out Pasteur pipette. Gentle 
suction was maintained with a small rubber teat to encourage blood flow. 
Unless they were to be exsanguinated, approximately 0.2 ml of blood was 
taken. The blood was put into small screw capped polypropylene tubes 
containing heparin (50 units/ml). The sera was separated by centrifuging 
at approximately 300 g on an MSE Minor centrifuge, removed and stored at 
-200C. 
(e) Killing of animals 
At the end of an experiment or for post-mortem studies, mice were 
killed by chloroform inhalation. 
2.3.2. Guinea Pigs 
Dunkin-Hartley strains of guinea pigs weighing between 250-300 
grams were used for guinea pig experiments. The pigs were obtained from 
the Porton animal farm on site. 
The guinea pigs were kept in groups of four in metal cages. They 
were allowed PMD pelleted diet (Christopher Hill Group, Ltd., Poole, 
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Dorset) and tap water ad libitum. Bedding consisted of sterilised wood 
chips and hay. 
(a) Intra eritoneal injections (I. P. ) 
Guinea pigs were injected intraperitoneally with a 25 gauge 
hypodermic needle in the right hand lower quarter of the abdomen after 
swabbing the area with 70% alcohol. The volume inoculated (unless 
otherwise stated) was 0.1 ml. 
(b) Collection of blood 
Guinea pigs were bled under ether anaesthesia by intracardiac 
puncture. Normally 2 ml was removed unless it was the end of the 
experiment when as much blood as possible was removed. The blood was 
either collected into heparin 50 units/m1 or allowed to clot at room 
temperature, the clot then being allowed to contract at +4°C overnight. In 
both cases the heparinised blood or serum aspirated from the clot was 
centrifuged at approximately 300 g for 15 minutes in an MSE Minor 
centrifuge. The serum/plasma, free of erythrocytes, was taken and stored 
at -70°C for subsequent virus isolation or inactivated at 60°C/30 mins for 
storage at -20°C for serology. 
(c) Killing of animals 
At the termination of an experiment or for post mortem studies, 
chloroform inhalation was the method used. 
2.3.3. Monkeys 
The animals used were Rhesus (Macaca mulatta) monkeys. The 
monkeys were held in individual metal cages, measuring 26" x 40" x I8". 
Monkeys were handled only under sedation with intramuscular 
injection of ketamine hydrochloride (Vetalar, Parke Davis) 60 mg. They 
were bled from the femoral vein before inoculation with infective 
material. Monkeys were inoculated intraperitoneally or sub-cutaneously 
with stock virus at various concentrations (see Results). Rectal 
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temperatures were recorded every 2 days. Five millilitres of heparinised 
blood samples were collected aseptically by femoral venepuncture and 
examined virologically, biochemically and immunologically. 
Urine samples were collected aseptically at autopsy by bladder 
aspiration with syringe and needle which was similarly tested for virus. 
Necropsy was carried out on all monkeys shortly after death and 
various tissues were taken for virological studies and histological 
examination. 
2.4 CELLS 
2.4.1. Vero cells 
Vero cells obtained from Flow Laboratories Ltd., Irvine,. Scotland, 
designated African Green Monkey Cells ATCC No. CCL81, were 
maintained by serial passage at weekly intervals in 75 cm2 plastic flasks 
(Nunc). On receipt the level of passage was P133. The growth medium 
was Medium 199 supplemented with 5% foetal calf serum (FCS) and 25 
units/ml of gentamycin. The medium was equilibrated with 5% carbon 
dioxide in air to maintain a pH of approximately 7.2. Subculture of cells to 
plastic roller, 25 cm flasks or microtitre plates was established in Plaisners 
medium (Plaisner et al., 1974) supplemented with 5% F. C. S. and 
crystamycin. Maintenance medium was Plaisners supplemented with 2% 
foetal calf serum and 100 units/ml of penicillin plus 100mg/ml 
streptomycin. 
Confluent monolayers were first washed with Phosphate Buffered 
Saline (PBS) (pH 7.2) and then treated with versene-trypsin solution. After 
draining the cells were incubated at 37°C until they had detached 
(approximately 5 minutes). The detached cells were taken up in 
maintenance media and, after a suitable dilution, were counted in an 
improved Neubauer haemocytometer. The cell concentration was adjusted 
to 2x 105 cells/ml in maintenance media. Nunc sterile 25 cm2 flasks were 
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seeded with 5 mis, flat bottom 96 well microassay plates 
(Sterilin) were 
seeded with 100 p1/well and Lab Tek slides 2 mis/well. The cells were 
allowed to settle out to form a monolayer at 37°C overnight. 
2.4.2. L cells 
L cells were obtained from Flow Laboratories Ltd., Irvine, Scotland, 
Flow designated P569 (mouse areolar adipose tissue). Stocks were 
maintained and serially passaged weekly in 75 cm2 plastic flasks in 
Leibovitz medium (LI5) supplemented with 5% foetal calf serum and 
crystamycin (Leibovitz, 1963). 
Subcultural growth was carried out as outlined under Vero cells. 
2.4.3. CV-1 cells 
The Rhesus monkey kidney cell lines were obtained from Flow, Irvine 
Scotland and designated P318. The CV-1 cells are Green Monkey Kidney 
cell lines originally obtained from Flow and maintained at Porton. The 
CV-1 cells were treated in exactly the same way as Vero cells (2.4.1. ). 
2.5 VIRUS ISOLATION 
Material to determine antigen levels was cultured in in vivo and in 
vitro host systems. 
2.5.1. Pre aration of Inocula 
2.5.1.1. Urine specimens 
The pH of the urine was adjusted to 7.0-7.4 with NaHCO3 if 
necessary. Urine was concentrated by centrifuging at 2,500 r. p. m. for 20 
minutes, and the sediment resuspended in one-tenth of the original volume 
of supernatant urine. A portion of this concentrate was treated with 
penicillin (10,000 units) and streptomycin (50,000 pg/ml). A portion of the 
concentrate was mixed with an equal volume of 70% sorbitol and stored at 
-70°C. The sample was diluted in Plaisners medium supplemented with 2% 
heat treated FCS and inoculated into 25 cm2 flasks and microassay plates. 
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2.5.1.2. Tissue sus ensions 
Tissues taken at autopsy were homogenised into a suspension for 
inoculation into cell cultures or in mice. 
A representative sample of the tissue was weighed and transferred to 
a mortar and ground into a suspension with Plaisners medium containing 1% 
FCS. The suspension was then centrifuged at 2,500 r. p. m. for 10 minutes at 
+4°C. The supernatant fluid was removed and treated with antibiotics, i. e. 
to each millilitre of clarified tissue suspension is added 0.1 ml of a solution 
containing 10,000 units penicillin/ml and 50,000 pg streptomycin/ml. The 
samples were stored at -70°C. 
Samples from cell culture were titrated by 10 fold amounts in 25 cm2 
flasks and microassay plates and incubated at 370 C. A 0.1 ml volume was 
inoculated I. C. into adult mice or I. P. into guinea pigs. 
2.5.1.3. Serum 
Serum collected as in Section 2.3 was diluted I0-fold in 2% Plaisners 
medium and 0.1 ml amounts inoculated into 25 cm2 flasks and/or 
microassay plates. 
2.5.2. Titration of Virus in Monola er Cell Culture (TCID5n) Endpoints 
Determination of TCID50 (tissue culture infectious dose) endpoints in 
all virus suspensions were carried out using logarithmic dilutions prepared 
in maintenance medium. Each dilution was added in volumes of 0.5 ml/25 
cm2 flask on 100 pl/well of a microassay plate. Each dilution placed in 
flasks was completed in duplicate and microassay plates in quadruplicate. 
The inoculated cultures were incubated at 37°C and observed daily over a7 
day period for specific viral cytopathic effect. Confirmation of endpoint 
was made using immunofluorescence. The TCID50 endpoint was calculated 
by the method of Reed and Muench (1938). 
2.5.3. Titration of virus after. chemical inactivation 
After treatment, the level of infective virus was estimated by 
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a modification of the virucide floating technique (Fig. 14, van der Groen et 
al., 1980). A 2% agarose block 0 cm2) was mounted on the edge of a glass 
0 
slide. A known quantity of virus suspension was put on the surface of the 
agarose, and allowed to diffuse and evaporate until the surface was 
completely dry (approximately 10 minutes). Two drops of 0.5% (w/v) 
formvar (BDH) dissolved in 1,2-dichloroethane (Merck) were addded and 
left for a few seconds. Excess formvar was then removed with blotting 
paper. When the film was dry the edges of the block were cut with a 
scalpel. By placing the block into the inactivant solution a film containing 
the virus was released: this moment of virus-inactivant contact was noted. 
After a known time the film was removed with a sealed glass Pasteur 
pipette. 
Excess inactivant still present was removed by gently bonding the 
film against the side wall of a tube. The film was transferred into I ml 
tissue culture medium, disrupted with a sealed Pasteur pipette and soni- 
cat'd to release residual virus into suspension. The suspension was then 
inoculated into tissue culture in order to determine residual infectious 
virus. 
Control experiments were included where the inactivant was replaced 
by tissue culture medium. 
2.6. SEROLOGICAL AND IMMUNOCHEMICAL PROCEDURES 
2.6.1. Serum neutralization assay 
Serum obtained from both animals and human sources were tested for 
neutralization antibodies by the microneutralization test. 
Tests were carried out in sterile microtitre plates (Sterilin Ltd., 
Teddington, Middlesex). Serum and virus dilutions were prepared in 
Plaisners medium, containing 2% FCS (heat treated at 56°C for 30 
minutes). Immune and pre-immune sera for test were treated at 56°C for 
30 minutes. Neutralization tests were performed by mixing 0.5 ml of a 1/5 
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Fig. 14. 'Virucide floating technique' (Van der Groen, 1980) 
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serum dilution (containing 1/ 10 guinea pig complement C') with 0.5 ml of 
two 10-fold serial dilutions of virus. After incubation at 37°C for 60 
minutes 100 Ul volumes of the mixture was distributed into 10 wells of a 
micro-assay plate containing a monolayer of Vero cells. After I hr 
incubation at 37°C 100 pi of media was added. The plates were incubated 
at 37°C and examined daily for development of cytopathic effect (CPE). 
Final readings were made on the 10 day following incubation, and the 50% 
end-point calculated by the Reed-Muench method. 
Neutralizing antibody was expressed as a log 10 neutralizing index 
(LNI) which represents the difference between the titre of the virus in the 
presence of normal control serum and the titre of the virus in the presence 
of the test (immune) serum. 
LNI = log 10 
(TCID50 in control) - (TCID50 in test serum) 
2.6.2. Immunofluorescent test 
The indirect immunofluorescent test was to measure antibody levels 
in studies involving mice, guinea pigs, monkey and human serum. The 
technique was also used to identify isolations of viruses from body fluids 
and tissues. 
2.6.2.1. Anti en slides for Antibody determination 
Antigen-containing cell preparations were prepared on Teflon-coated 
slides with 15 circular areas or spots (Flow, Irvine, Scotland). L cell 
cultures under fluid medium were infected with any of the required viruses 
under study at a multiplicity of infection (M. O. I. ) of 0.1. Three or four 
days later, regardless of the presence or absence of CPE, the infected 
cultures were harvested; the cells were dispersed with 0.25% 
Trypsin/Versene, washed x3 with PBS (pH 7.2) and resuspended in a volume 
of 0.01% Bovine Serum Albumin (BSA)/PBS, giving a final concentration of 
approximately 106 cells/mi. The suspension was mixed and a drop placed 
on each spot of the slide (103 cells approximately). The slides were held at 
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room temperature for 15 minutes until dry, then fixed in acetone at +4°C 
for 10 minutes, dried in air, stored in plastic slide boxes and screw capped 
tins at -700C until used. 
2.6.2.2. Antigen detection 
Slides, microassay plates and flasks used for isolation and 
confirmatory IFA testing were prepared by the following technique. Cell 
monolayers under fluid media were grown on chambers slides (Lab Tek) 
plates or flasks. Each chamber of the Lab Tek slides was seeded with 2x 
105 cells in a volume of 0.8 ml growth medium. Flasks and microtitre 
plates were prepared as described in Section 2.4.1. After 24 hours they 
were infected with tissue homogenates or sera from experimental animals 
with a range of dilutions (10-1 - 10-8). Between 4-7 days the chambers 
were removed, slides thoroughly rinsed with PBS, fixed in Acetone at +4°C 
for 10 mins. dried in air and stained or stored at -70°C. The microassay 
plates were fixed with pre-coated methanol and tested immediately by the 
IFA. Cells from flasks were prepared as outlined in 2.6.2.1. 
2.6.2.3. IFA procedures 
The serum for antibody determination was diluted in PBS pH 7.2 and 
overlayed on infected cells or Lab Tek slide chambers (see Section 2.1) for 
30-40 mins. at room temperature. Slides were then washed x3 in changes 
of PBS for a total of 5 minutes. The material was reacted with an optimal 
dilution of fluorescein isothiocyanate conjugate prepared against the 
species of immunoglobulin in which the viral antisera was prepared. The 
conjugates used were obtained from Miles Research Products (Slough, 
England). The reaction times were 30-40 minutes. Slides were washed 
three times in PBS (10 minutes), twice in distilled water (3 minutes), dried 
and read immediately. 
Microassay plates and slide chambers received the same treatment 
with one exception. After the final wash in PBS, one drop of 50% glycerol 
in PBS was added to each well and a coverslip applied. 
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The fluorescence was observed using a Reichert A0 fluorostar 
microscope (Buffalo, New York 14215) at a magnification of x 160 for 
screening and x 400 for end-point determination with incident illumination 
provided by a 50W mercury vapour lamp. The filtration system utilized a 
fluorocluster 2072 which contained a BG I2 + KV418 exciter, OG 515 
barrier and dichroic beam splitter reflecting all the desirable short wave 
excited light down through the objective to the specimen (500 mm). 
2.6.3. Immunochemical studies on virus structural proteins using the 
"Western blot" technique 
2.6.3.1. Viral rowth and purification 
Confluent monolayers of cells in 1750 cm2 plastic roller bottles 
(Falcon, Beckton-Dickinson, Ltd. ) were infected at a multiplicity of 0.1 in 
a volume of 10 ml of Plaisners Modified Eagles Medium supplemented with 
2% FCS and antibiotics. After 60 minutes adsorption 150 ml maintenance 
medium was added and incubation continued at 37°C. Medium was 
harvested and replaced on day 2 post-infection and finally harvested on day 
3. Virus was purified by a method similar to that of Kiley It al., (1981). 
The pooled medium was centrifuged at 12,000 xg for 10 minutes at 4°C to 
remove cells and debris and the supernatant brought to 5% NaCI and 7% 
polyethylene glycol 6000 (BDH, Ltd. ) by addition of solids with gentle 
stirring at 4°C. The pellets were then resuspended in 1/100th the original 
volume of 200 mM glycine, 100 mM NaCl, I mM EDTA, 50 mM Tris-HCI, 
pH 7.5 (GTNE) and clarified by centrifugation at 10,000 xg for 10 minutes 
at 4°C. The supernatant was layered on 30 ml glycerol-tartrate gradients 
(Obijeski et al., 1974) in heat-sealable tubes for the Beckman 60 Ti rotor 
and centrifuged at 44,000 xg for 16-18 hours at 4°C using the slow 
acceleration and deceleration facilities of a Sorvall OTD 65 
ultracentrifuge. The visible virus band about half way down the tube was 
recovered, diluted in GTNE and pelleted by centrifugation at 27,000 xg for 
90 minutes at +4°C.. The pellets were resuspended in a small volume of 
GTNE, and stored at -70°C. 
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2.6.3.2. Infected cell 1 sates 
Confluent monolayers of Vero or CV-1 cells were infected at a 
multiplicity of 0.1 with virus diluted in maintenance medium. For direct 
lysis in SDS the cells were dissolved in electrophoresis sample buffer (ESB) 
(1% SDS, 1% 2-mercaptoethanol, 15% glycerol, 0.01% bromophenol blue, 50 
mM Tris-HCI, pH 6.8) and heated at 60°C for 2 hrs to denature the proteins 
and inactivate the virus. For lysis under denaturing conditions the cell 
monolayer was exposed to PBS containing 1% Triton X-100 and 1% SDS for 
5 minutes at room temperature. 
2.6.3.3. P ol acr ! amide gel electrophoresis 
Samples were treated with 1% SDS, 1% 2-mercaptoethanol, 100 mM 
Tris-HCI, pH 6.8,15% glycerol, 0.01% bromophenol blue and heated at 
100°C for 2 minutes prior to analysing or 8-15% polyacrylamide concave 
exponential gradient gels using the buffer system of Laemmli (1970). The 
gels were run at 75 mA for 1.5 mm thick gels or 40 mA for 0.75 mm gels. 
The stain Kenacid blue R (BDH, Ltd. ) in 25% isopropanol, 10% acetic acid 
was used for protein identification. Restaining was achieved with 10% 
isopropanol and 10% acetic acid. Molecular weights were estimated by 
comparison of electrophoretic mobilities with those mixtures of standard 
protein markers, either unlabelled (Sigma) or 
14C-methylated (Amersham 
International). 
The proteins separated on gels were transferred to nitrocellulose 
sheets (BA85, Schleicher and Schull) as described by Towbin et al. (1979) 
except the transfer buffer was 96 mM glycine, 12.5 mM Tris, 20% 
isopropanol and current was passed at 200-300 mA for 14-16 hours. 
Monitoring of the transfer to nitrocellulose sheets was made by staining 
with Amido black (Towbin et al., 1979) and destaining in 10% acetic acid, 
109 isopropanol. 
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2.6.3.4. Gl co rotein detection 
Nitrocellulose transfers were incubated for I hour in PBS, 0.5% 
Triton X-I00 containing 50uM Mg2+, Mn2+ and Ca2+ ions (GS buffer) and 
IOUg concanavalin A (Pharmacia) per ml with constant agitation. The 
transfers were washed 5 times in GS buffer and incubated in GS containing 
horseradish peroxidase (Sigma 50 pg/ml) for I hour before repeating the 
washing cycle. The positions of the glycoprotein bands were revealed by 
incubation with aminoethlycarbazole (200 pg/ml), H202 (0.03%) in 50 mM 
sodium acetate buffer pH 5.0 (Clegg, 1982). 
2.6.3.5. Immunological detection of proteins using nitrocellulose transfers 
Nitrocellulose transfers were incubated at room temperature with 
constant agitation in PBS containing 2.5% BSA, 5% FCS 1% Triton X-100 
and 0.1% SDS (AB buffer) in which antisera or monoclonal antibodies had 
been suitably diluted. After 2.4 hours the transfers were washed 3 times in 
PBS containing 0.05% Triton X-I00 and incubated in AB buffer containing a 
1/1000 dilution of horseradish peroxidase conjugated anti-globulin of the 
appropriate species (Miles) for I hour and washed. Antibody-binding bands 
were revealed by incubation with aminoethylcarbazole as for the 
glycoprotein detection method. 
2.7 ELECTRON MICROSCOPY 
2.7.1. Negative_ sta 
(a) Infective Blood 
Blood appeared to be one of the richest sources of virus in body 
fluids, with titres of approximately 106.5 TCID50/ml at the height of 
viraemia with Lassa virus (Buckley and Casals, 1970). Serum obtained 
from guinea pigs, mice and monkeys was mixed with 3% gluteraldehyde in 
cacodylate buffer and held at room temperature for 24 hours. The sample 
encased in Beckman sealed tubes, was pelleted at 18,000g for 2 hours in a 
Beckman L8 refrigerated centrifuge using a 40 fixed angle rotor. A small 
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amount of distilled water was used to resuspend the pellet. A 
drop of the 
specimen was placed on to copper specimen grids coated with Formvar. 
The excess was removed with filter paper after 2-3 minutes. Drops of 
P. T. A. (pH 6.4-7.2) were placed on the grids, the excess being removed 
with filter paper. The grids were then stabilised with a film of evaporated 
carbon and examined in a Phillips EM 400T electron microscope. 
(b) Tissue Culture Su ernatant 
Monolayers of cells in Nunc 25 cm2 flasks were infected with Lassa 
and Mopeia viruses. At various points during the infection, cell culture 
fluids were mixed with an equal volume of 3% glutaraldehydelcacody late 
buffer at room temperature for 24 hours and then treated as for plasma 
(Section 2.7.1. (a). 
2.7.2. Tissue for Electron Microscopy 
During pathogenesis studies with guinea pigs, mice and monkeys 
infected with Lassa and Mopeia viruses, tissue was removed at post- 
mortem for electron microscopy. The tissues of main interest were: 
liver, spleen, kidney, lymph nodes, pancreas, heart, lungs, small and large 
intestine. 
2.3 mm cubes were prepared from the organs and placed in 3% 
glutaraldehyde in cacodylate buffer in sealed containers. Forty-eight 
hours later, I mm cubes were cut from these and placed in fresh phosphate 
buffered glutaraldehyde. These were later washed in repeated changes of 
sucrose/cacodylate buffer (pH 7.4) for 18 hours. The washed specimens 
were then post fixed in L% osmium tetroxide in cacodylate buffer and 
distilled water for 2 hours, then washed for a similar period of time in 
distilled water. Dehydration was carried out in graded methanol, 
specimens then spending 30 minutes in 3% uranyl acetate in 30% methanol. 
Final embedding was carried out in Durcupan (EM Scope), via graded 
propylene oxide mixtures. After 48 hours polymerization at 60°C, sections 
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were cut on a Reichert (OMU 2) or a Cambridge Huxley Ultramicrotome, 
and stained with lead nitrate before viewing with a Phillips EM 400T at 
CAMR or a 3EOL 100 CX at the London School of Hygiene and Tropical 
Medicine. 
2.7.3. Tissue cells for E. M. 
To study developmental growth kinetics, cells were infected with a 
multiplicity of infection (MOI) of 0.1 of Lassa and Mopeia viruses. 
Infected cells were mixed with 5 ml of 3% glutaraldehyde in 0.1 M 
cacodylate buffer, pH 7.4, and held for 24 hours. During this time both 
cells and container were exposed to formalin vapour before being taken 
from the Maximum Containment Laboratory. 
The cell pellet produced by the first centrifugation at 500g for 15 
minutes was washed overnight in 0.1M cacodylate/0.2M sucrose buffer, pH 
7.4. After several washings the cells were spun at 500g for 5 minutes to 
produce a pellet, which was post fixed in 1% osmium tetroxide for 2 hours. 
The cells were then washed in buffer and pelleted in 2% agar (Oxoid No. 1) 
and further processed as outlined in 2.7.1(a). 
2.8. HISTOLOGICAL EXAMINATION 
Mice and guinea pigs were killed with ether, monkeys with 
intravenous nembutal. Whether natural or induced death, organs were 
removed immediately, and portions of the following tissue were removed: - 
myocardium, duodenum, ileum, caecum, colon, pancreas, salivary glands, 
lung, liver, spleen, kidney, adrenal glands, testes, and lymph nodes. Since 
Lassa is so readily transmitted to man via skin wounds with very serious 
consequences, the brain and spinal cord were not removed because of the 
risk of piercing a glove on spikules. 
Tissues were fixed in 10% buffered neutral formalin and embedded in 
paraffin wax. Sections were cut at 5 i. t and stained by haematoxylin and 
eosin (H and E). 
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2.9 REAGENT PREPARATION 
2.9.1. Immune serum and ascitic fluids 
2.9.1.1. Mice. 
Arenavirus-infected newborn mouse brain tissue suspensions were 
freshly prepared in physiological saline (pH 7.2) to a final concentration of 
10%. Alternatively, tissue culture derived virus was used. On day 0,0.3 
ml of virus (106 TCID50/ml or 10 
5 LD50/ml) was inoculated i. p. into 4-5 
mice. On day 20-25, a second similar injection of fully active virus was 
given and a test bleed was carried out 7 days later. 
A third injection of virus similar to the second was given at this point 
followed 2 days later by an i. p. injection of 0.1-0.2 ml of ascites from a 
mouse bearing sarcoma 180 cells. Sarcoma fluid was removed by 
parencentesis 7-9 days after the administration of sarcoma 180 cells. The 
ascites were pooled and allowed to clot at room temperature, centrifuged 
at 3200 xg for 30 minutes. The clear fluid was collected and stored at - 
20°C until used. 
2.9.1.2. Guinea g. 
An LGA 391 inoculum of 105 log lo virus-infective tissue culture 
results in a 75% mortality; the survivors were bled 28-30 days after 
infection yielding serum with a workable CF and IF antibody. The serum 
obtained after 60 days contained neutralizing antibodies which were used 
as a standard reagent. No advantage was gained by repeated inoculation. 
Serum was placed in 0.2 ml aliquots, serologically standarized and stored at 
-70°C or lyophilized and stored at -20°C until used. 
2.9.2. Monoclonal antibodies. 
The technique for preparing monoclonal antibodies by fusion of spleen 
cells derived from immunized mice and murine myeloma cells was based on 
the work of Kohler and Milstein (1975). Hybridoma cell lines were 
generated by the fusion of spleen cells from immunised Balb/c mice with 
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Fig. 15 Basic Steps in the Production of 
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SP2 mouse myeloma cells (Schulman et al., 1978) in Roswell 
Park Memorial 
Institute (RPMI) 1640 (Moore 1967) containing hypoxanthine-aminopterin- 
thymidine (HAT) medium (Littlefield 1964). An outline of the basic steps 
in the production of monoclonal antibodies is shown in Fig. 15. 
The protocol for immunization involved priming Balb/c mice i. p. with 
0.1 ml tissue culture supernate containing 6 log 10 TCID50 of virus. 
Four 
weeks later, 0.1 ml booster doses of antigen (6 109 10 TCID50) were 
administered over three consecutive days, i. e. Day I i. p., Day 2 i. p., day 3 
i. p. and i. v. Twenty four hours after the final boost of antigen, the animals 
were killed and the spleens removed aseptically. The spleen cells were 
manually separated, washed, counted and adjusted to 108/ml in RPMI 1640 
without any serum. 
Peritoneal macrophages were obtained from adult mice by injecting 
approximately 6 ml of an 0.34 M-sucrose solution peritoneally and, after 
gentle massaging of the abdomen, withdrawing the fluid. The sucrose- 
containing macrophages were collected in plastic universals and after 
centrifugation the cell concentration was adjusted to 5x 105 cells/ml in 
RPMI 1640 + HAT. 
The SP2/0 AG 14 myeloma cells were grown in stationary cultures (75 
cm2 flasks) in RPMI 1640 media containing 20 mM Hepes, 15% FCS and 
glutamine, usually allowing a cell density of around 10 
5/ml. In preparation 
for fusion, the cells are harvested and washed twice in RPMI 1640 without 
FCS and adjusted to 10 
7 
cells/ml. 
For fusion, the technique described by Frazekus de St. Groth and 
Scheidegger (1980) was used as a guide. In general, spleen and myeloma 
cells were mixed together in serum free RPMI 1640 at a ratio of 10 :I 
(spleen : myeloma). The combined cell suspension was centrifuged (400 xg 
for 5-10 min) and supernatent removed. Fusion was initiated by slowly 
adding I ml 50% polyethylene glycol (PEG) 4000 (Serva) in saline, gently 
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stirring over I minute and transferring the centrifuge tube to a 
37°C water 
bath for 90 seconds (Galfre and Milstein, 1981). The solution was 
gradually diluted to 10 ml, by gently stirring over several minutes with 
serum free RPMI 1640. The cells were then pelleted (200 g, 10 minutes) 
washed and resuspended in 12 ml RPMI 1640 medium containing HAT 
medium (0.1 mM-hypoxanthine (H), 0.4 pM aminopterin (A) and 16 JIM 
thymidine (T), 20% heat inactivated foetal calf serum and antibiotics). 
Fifty ul amounts were then distributed into the wells of a 96 well plastic 
culture tray (Linbro), which had previously been seeded with 50 Ill HAT 
medium containing peritoneal macrophages at a concentration of 5x 105 
cells/mi. The cultures were then inspected 7 to 10 days later and those 
wells which showed growth of cells were fed with fresh HAT medium, in 
some cases by removal and replacement of medium. At this stage, the 
culture supernates were screened for the secretion of antibodies by IFA. 
Those cultures showing positives were cloned by limiting dilution in 
further 96-well plates previously seeded with peritoneal macrophages. This 
process was repeated twice. The cells derived from wells showing growth 
of single colonies were transferred to 24-well plastic trays (Linbro) and 
then 6-well trays (Linbro) and were again screened by IFA. Those clones 
which still retained their ability to produce specific antibodies were 
further amplified before storing in liquid nitrogen or producing mouse 
ascites. Ascitic fluids were made in Balb/c mice by inoculating 106 cells 
i. p., and withdrawing fluid and/or tumour 10-I5 days later. 
Monoclonal antibodies to LCM were kindly donated to me by Dr M 
Buchmeier at the Scripps Clinic and Research Foundation. Monoclonals 
derived from Pichinde, Junin and Tacaribe were obtained from Dr CR 
Howard and Dr AC Chanas, London School of Hygiene and Tropical 
Medicine. 
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2.9.3. Human Sera 
All sera used were derived from patients with proven Lassa infection. 
2.9.4. Com lement-fixin anti ens 
Brains from 2-5 day old suckling mice inoculated i. c. with Lassa or 
Mopeia viruses, were harvested and pooled. The brains were homogenized 
in chilled 8.5% sucrose in IM Tris (hydroxymethyl) methylamine buffer pH 9 
containing 1% i-propiolactone (BPL) puriss grade (Fluka AG, Glossop, 
Derbyshire) using a glass homogenator, followed by sonication using a soni- 
probe (Dawe Instruments Ltd., London). This was kept at +4°C for 18 
hours. The sucrose buffer was removed and added dropwise with 
mechanical stirring to 20 volumes of chilled acetone (analytical grade). 
The mixture was centrifuged at 500 xg for 5 minutes. The supernatant 
fluid was removed and discarded. A volume of acetone equal to that first 
used was added to the sediment, and centrifuged at 500 xg for 5 minutes, 
the sediment subsequently being dried under oil-pump vacuum. After 3-4 
hours 0.9% NaCl equal to 40% of the volume or the original homogenate 
was added to the dry sediment. This solution was held at +4°C overnight, 
centrifuged for I hour at 12,800 x g. The supernatant fluid constituted the 
antigen and was stored in 0.5 ml or 1.0 ml amounts at -20°C. 
Alternatively an infected cell culture CF antigen was made. Roller 
bottles or 75 cm2 tissue culture flasks were infected with 0.1 ml MOI, the 
cells and fluid being harvested between 6-8 days. One volume of IM Tris 
buffer pH 9 containing 1% beta-propiolactone was added to 9 volumes of 
culture fluid. After 18 hours at +4°C the material was centrifuged at 500 
xg for 15 minutes to sediment the cellular debris. The supernatant fluid 
constitutes the antigen. 
2.10 CLINICAL BIOCHEMISTRY 
Evaluation of changes in animal serum components were determined 
using test kits (Boehringer Ingelheim Ltd., Southern Industrial Estate, 
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Bracknell, Berkshire). The activities of enzyme and substrates in sera 
studied are listed below: 
alkaline phosphatase (AP) 
glutamine oxaloacetate transaminase (GOT) 
glutamine pyruvate transaminase (GPT) 
lactate dehydrogenase (LDH) 
a-hydroxybutyrate dehydrogenase (a -HBDH) 
creatine kinase (CK) 
y-glutamyl transpeptidase ((-GT) 
creatinine 
urea 
total protein 
triglycerides 
cholesterol 
All the above analyses were carried out in an LKB Kinetic Analysis 
System (Ultralab) according to the LKB method guide (LKB Booklet 1975). 
2.11. PHYSICOCHEMICAL STUDIES 
2.1 1.1. Thermal stability 
Stock Lassa and Mopela viruses were added to human sera, guinea pig 
sera or phosphate buffered saline containing different percentages of 
foetal calf serum. A water bath in which the water is circulated and the 
temperature controlled to within IOC was used. A sterile glass tube of 10 
ml capacity was placed in the water bath set at a selected temperature. 
When the temperature of 5 mis of support medium + virus reached that of 
the water bath, it was considered zero time and 0.5 ml samples for virus 
assay were removed at predetermined time intervals and placed in an ice- 
water bath until they were used. 
2.1 I. 2. Ultra violet light inactivation 
Stock tissue culture derived Lassa and Mopeia viruses were diluted in 
phosphate buffered saline pH 7.3 which contained varying levels of human 
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or guinea pig sera. The final concentration of viruses was adjusted to 106 
TCID50/ml for easy comparison. 
Each solution was dispensed into plastic petri dishes having a 
diameter of 50 mm. The depth of this fluid was approximately 3-3.5 mm. 
The dishes were placed on a rocking shelf with a rocking cycle of 20 
complete cycles per minute, and at a distance of 15 mm from a 15 watt 
Phillips germicidal tube giving an intensity of 600 microwatts/cm3. 
Exposure times ranged from 0 to 10 minutes, samples being removed and 
assayed for virus at intervals. 
2.1 1.3. RH sensitivity 
Infectious tissue culture fluid was adjusted to the desired pH level by 
the addition of I molar HCl or I molar NaOH. To facilitate rapid 
manipulation, the amounts of these reagents required to adjust a given 
volume of infectious tissue culture fluid were determined in advance. In 
the inactivation experiments the predetermined amounts of the reagents 
were added to the measured volume of infectious tissue culture fluid under 
gentle agitation whereupon the final pH was determined and the 
temperature noted. Samples for virus assay were removed at 
predetermined time intervals and re-adjusted to pH 7.3. Adjustment and 
re-adjustment of the pH required approximately 1-, ' -2 minutes. 
2. I 1.4. Sensitivity to solvents 
The effects of solvents on viral infectivity were tested at 37°C by 
adding equal amounts to stock infectious tissue culture fluid. The samples 
were continually mixed at +37°C by a magnetic stirrer for I hour and 
titrated in tissue culture. A list of solvents and their source is shown in 
Table 3. 
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TABLE 3. LIST OF SOLVENTS USED 
Solvents 
Ether 
Chloroform 
Sodium desoxycholate 
Acetone 
Alcohol 
Final concentration 
509b 
l0% 
0.5% 
50% 
50% 
Source 
BDH Poole, Dorset 
of 
It 
11 
J Burrough Ltd., London 
2.1 1.5. Glutaraldeh de and Formaldehyde inactivation 
Glutaraldehyde 25% solution in water (Taab, 52 Kidmore End Road, 
Emmer Green, Reading) and formaldehyde 40% w/v (Fisons Scientific, 
Loughborough, Leics. ) were used as stock solutions. 
The effect of glutaraldehyde and formaldehyde on Lassa and Mopeia 
was studied by following the rate of inactivation at pH 7.4 at temperatures 
of 4°C, 25°C, and 37°C . For each temperature combination, a series of 
experiments using different concentrations of formaldehyde and 
glutaraldehyde in the range 0.2% - 10% was used. The control experiments 
excluded the use of formaldehyde or glutaraldehyde. Each concentration 
employed a mixture using tap water or 10% foetal calf serum in Plaisner's 
medium as a diluent for the stock suspension of virus. Residual amounts 
of infective virus were measured at intervals after the initial exposure. 
Their treatment and titration followed the procedure found in 2.11.4. 
2.1 I. 6. ro iolactone inactivation (BPL) 
An aqueous solution of BPL (Fluka AG, Glossop, Derbyshire) (puriss 
grade), usually 10% v/v, was first made with distilled water at 4°C, the 
solution being kept in an ice bath to reduce the rate of BPL hydrolysis. 
The inactivation of LGA 391 and Mopela viruses with various final 
concentrations of BPL (0.025 - 0.3%) was determined at 4°C2 22°C and 
37° C. 
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The effect of BPL with various combinations of concentrations and 
temperatures was determined in blood, sera, mouse brain and tissue culture 
fluid. 
The rate of BPL hydrolysis was based on the absorbance of BPL in the 
infra-red spectrum, which showed a characteristic peak of 5.511 in a 
solution of carbon tetrachloride (CCl4). The size of this peak was used to 
measure the amounts of BPL extracted by CCl4" Hydracrylic acid, the 
hydrolXsis product of BPL in an aqueous solution, showed no peak at this 
wavelength. AI ml sample of test material was added to 2g of anhydrous 
sodium sulphate (Na2SO4) and 3 ml CCl41 in a mortar, previously cooled to 
4°C. The crystalline (hydrated sodium salt) product of the mixture was 
ground with a pestle. The solution was coarse-filtered through a sintered 
glass funnel, gentle suction being applied to pull through the maximum 
amounts of CCl4 containing the BPL. The mortar was washed three more 
times with 2 ml CCl4, each washing being poured over the Na2SO4 and 
through the filter. The final filtrate was made up to 10 ml with CCl4 and 
mixed. Samples of CC14 extract were placed in an infra-red 
spectrophotometer (Hilger-Watts 'Infragraph' 1-11200) and peaks at 5.511 
were measured. 
In this study the amount of BPL remaining during the course of 
hydrolysis at different temperatures (4°C, 22°C and 37°C) in various 
solutions (phosphate buffered saline, tissue culture fluid, serum or blood) 
was measured with the method described. 
2.11.7. Nucleic-Acid Determinations 
5-bromodeoxyuridine (BUDR), obtained from the California 
Corporation for Biochemical Research, was stored frozen (-20°C) as a 10-$ 
molar (M) solution in distilled H20. The BUDR solution was diluted in 
Plaisners tissue culture fluid to give varying dilutions 10-6 - 10-2 M. 
Plaisners medium supplemented with 2% inactivated foetal calf serum 
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0.02M glutamine and BUDR was placed on the cells previously adsorbed 
with virus. Samples of fluid were periodically sampled for viral 
infectivity. 
LGA 391, Mopeia and Vaccinia viruses were titrated in Vero cells in 
the presence of Plaisners medium containing 100 jig of 5-BUDR and 
samples taken over 6 days. 
2.1 I. S. Effect of Actinom cin D 
Vero cells were infected with virus at a multiplicity of 0.1. After 2 
hours adsorption at 37°C the monolayers were washed and treated with 
doses of actinomycin D ranging from 0.01 - 0.5 jig/ml. After 60 hours' 
incubation, yields of extracellular virus were assayed by titration in 
microassay plates. A second set of culture was treated in the same way 
by actinomycin D added simultaneously with the virus. 
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2.12. Sources and make-u of reagents used 
2.12.1. MEM (Eagle) - Plaisner Modified (Plaisner et al. 1974) 
mg/litre 
L-arginine HCI 126.4 
L-cystine 24.02 
L-Histidine HCIH2O 41.9 
L-isoleucine 52.5 
L-leucine 52.5 
L-lysine HCl 73.06 
L-methionine 14.9 
L-phenylalanine 33.02 
L-tyreonine 47.64 
L-tryptophan 10.2 
L-tyrosine 36.22 
L-valine 46.9 
D-Ga pantothanate 1.0 
Choline bitartrate 1.8 
Folic acid 1.0 
1-inositol )( 2.0 
Nicotinamide 1.0 
Pyriboxal HCl 1.0 
Riboflavin 0.1 
Thiamin HCI 1.0 
CaCl2 2H2O 200.0 
Galactose 800.0 
Sodium pyruvate 200.0 
MgSO4 7H2O 98.0 
KCl 4 0 .0 0 
NaCl 6800.0 
NaH2PO-H20 140.0 
Phenol Red 10.0 
Sodium succinate 1000.0 
Succinic acid x 750.0 
pH 7.4 with 6% NaOH 
Sterilize by filtration 
Replace used medium with Plaisners after 5 days' incubation 
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2.12.2. L-15 (Gibco Biocult Cat. No. 430-1300) (Leibovitz, 1963) 
Com onents ME/litre 
Ivor anic salts 
CaCI2(anhyd) 140.000 
KCl 400.000 
KH2PO4 60.000 
MgCl2 (anhyd) 93.800 
MgSO4 (anhyd) 97.670 
NaCI 8000.000 
Na2HPO4 (anhyd) 190.123 
Other com onents 
D(+) Galactose 900.000 
Phenol Red 10.000 
Sodium pyruvate 550.000 
Amino acids 
DL Alanine 450.000 
L-Arginine (free base) 500.000 
L-Asparagine 250.000 
L-Cysteine (free base) 120.000 
L-Glutamine 300.000 
Glycine 200.000 
L-Histidine (free base) 250.000 
DL-isoleucine 250.000 
L-Leucine 125.000 
L-Lysine (free base) 75.000 
DL-Methionine 150.000 
DL-Phenylalanine 250.000 
L-Serine 200.000 
DL-Threonine 600.000 
L-Tryptophan 20.000 
L-Tyrosine 300.000 
DL-Valine 200.000 
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Vitamins 
............. 
DL-Ca pantophenate 1.000 
Choline chloride 1.000 
Folic acid 1.000 
Inositol 2.000 
Nicotinamide 1.000 
Pyridoxine HCI 1.000 
Riboflavin-51-phosphate sodium 0. I00 
Thiamine monophosphate 1.000 
2.12.3. Foetal calf serum 
Virus and mycoplasma screened in 500 ml amounts obtained from: 
Gibco Biocult Ltd, 3 Washington Road, 
Paisley, PA3 4EP, Scotland. 
2.12.4. Phosphate buffered saline (Dulbecco A) PBS 
Na Cl 8. Og 
K Cl 0.20g 
Na HPO4 I. 15g 
KH2 PO4 0.20g 
Phenol red (2% solution) O. I Og 
H2O to 1000 ml 
pH 7.4 
Sterilized by autoclaving 
2.12.5 Versene-tr sin solution (0.05% versene 0.2% tr sin) 
Versene (5% solution) 1.0 ml 
Trypsin (2% solution) 10.0 ml 
NaHCO3 (5.5% solution) 2.5 ml 
PBS 86.5 ml 
pH 7.6 
Sterilized solutions were mixed aseptically. 
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* Versene (5% solution) 
Ethylenediaminetetraacetic acid (disodium salt) 50g 
H2O to 1000 ml 
Sterilize by filtration 
** Trypsin (2% solution) 
Trypsin 1: 250 (Difco, Michigan, USA) 20g 
PBS to 1000 ml 
Sterilize by filtration 
2.12.6 Cr stom cin (Gibco) 
Penicillin - Streptomycin 
Lyophilized. Prepared in normal saline 
Pencillin (Base) 5,000 units/ml 
Streptomycin (Base) 5,000 mcg/ml 
(Gibco Biocult Ltd., 3 Washington Road, 
Paisley PA3 4EP, Scotland) 
2.12.7. Neutral formol saline for histo atholo 
10% solution: - 
* 22.75 gm Sodium dihydrogen phosphate (NaH2PO4) 
(anhydrous) 
** Formaldehyde 40% 500 ml 
Dist. H2O 4,500 ml 
* BDH Chemicals Ltd, Poole 
** Formaldehyde solution 37/40% w/v 
Fisons Scientific Apparatus, Loughborough, Leics. 
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2.12.8.3% Glutaraldeh de for E. M. fixation 
15 ml cacodylate buffer 
5 ml stock 25% glutaraldehyde 
0.5 ml I% calcium chloride 
2.12.9 1% Osmium tetroxide 
13.4 mis dist. H2O 
6.6 mis 0.2m cacodylate buffer 
0.2 mis 1% calcium chloride 
0.2 gms osmium tetroxide (Agar Aids, 66a Cambridge Road, 
Stanstead, Essex CM24 8DA). 
2.12.10 * Methanols (James Burrough Ltd., Fine Alcohols Division, 
60 Montford Place, London SE lI). 
100% direct from bottle 
90% 90 mis Methanol + 10 mis dist. H2O 
70% 70 mis Methanol + 30 mis dist. H 20 
60% 60 mis Methanol + 40 mis dist. H2O 
30% 30 mis Methanol + 70 mis dist. H2O 
* Must be A. R. Quality Methyl Alcohol CH3OH 
2.12.11. Cacod late buffer (0.2m) 
21.4 gms sodium cacodylate Na(CH3)2AsO2 3H2O (Taab Laboratories) 
3.45 ml N. HCI 
Made up to 500 ml with dist. H 20 
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2.12.12 Pro lene oxide 
1,2 Epoxypropane obtained from Taab Laboratories, 52, Kidmore 
End Road, Emmer Green, Reading. 
2.12.13. Durco an 
Solution B-Hardene 100 mis 
Solution A. M. Resin 80 mis 
Solution D Plastissier 2 mis 
Stir for 20 mins. 
Solution C Accelerator 4 mis 
Degas for 15 mins 
Obtained from EMScope, Kingsnorth Industrial Estate, Wotton 
Road, Ashford, Kent TN23 2LN 
2.12.14 PTA (Agar Aids, Stanstead, Essex CM24 8DD) 
3% aqueous solution to pH 6.5 - 7.0 with 1N potassium hydroxide 
2.12.15 Conjugates 
Issued freeze dried in bottles each containing the residue from 1 
millilitre of sterile conjugate in phosphate buffered saline containing 1% 
glucose and 0.1% sodium azide as preservative. Each bottle contains 
approximately 10 mg of protein with a minimum of I mg of specific Ab. 
prepared from hyperimmune antisera raised in rabbits or sheep against the 
appropriate purified IgG. 
Supplied by: Wellcome Reagents Ltd., Wellcome Research Laboratories, 
Beckenham, Kent BR3 3BS. 
2.12.16 R. P. M. I. 1640 Medium (Moore et al., 1967) 
Imperial Laboratories, Ashley Road, Salisbury, Wiltshire 
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2.12.17 H. A. T. Medium (for monoclonal production) 
Materials 
H-Hypoxanthine (6-hydroxypurin M. wt. 136.1) 10 x 10-2 
(B. D. H. Chemicals Ltd., Poole, England) 
A-Aminopterin (4-amino-folic acid; 4-aminopteroyl glutamic acid). 
(M. wt. 440.4) 4.0 x 10-5M. 
(Sigma (London) Chemical Co. Ltd., Fancy Road, Poole, England). 
T-Thymidine (M-wt. 242.2) 1.6 x 10-3M 
(B. D. H. Chemicals Ltd., Poole, England) 
Procedure: 100 fold stock solution of h oxanthine and th midine 
I. Dissolve 136.1 mg hypoxanthine and 38.8 mg thymidine 100 ml of 
distilled water. 
2. Warm to 45-50°C to dissolve powdered reagents. 
3. Sterilize by membrane filtration and store at -20°C in 2 ml aliquots. 
100 fold concentrated stock solution of amino terin 
1. Add 1.76 mg aminopterin to 90ml distilled water. 
2. Add IM NaOH dropwise until aminopterin dissolves and titrate to 
neutrality with IM HCl. 
3. Adjust final volume to 100 ml with distilled water. 
4. Sterilize by membrane filtration, dispense into 2 ml aliquots and 
store at -20°C. 
H. A. T. medium 
20 ml foetal bovine serum (inactivated 56°C for 30 minutes) 
ml stock hypoxanthine/thymidine 
I ml stock aminopterin 
I ml glutamine (given final concentration 2 mM) 
I ml penicillin/streptomycin (final concentration 100 mg/ 100 iu) 
76 ml R. P. M. I. 1640 
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2.12.18 ß-PPropiolactone (BPL) (Fluka AG, Glossop, Derbyshire) 
Stock stored at -20°C until required, made up in distilled water at 
+40C and used immediately. 
2.12.19 Actinoomycin D (Aldrich Chemical Co. Ltd., Gillingham, Dorset) 
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3. RESULTS 
3.1. TISSUE CULTURE STUDIES WITH LGA 391 AND MOPEIA VIRUSES 
3.1.1. Susceptibility of different cell lines 
Different cell lines known to support arenavirus growth were infected 
with Lassa amd Mopeia viruses at a multiplicity of infection (M. O. I. 
) of 0.1. 
The preliminary study was tb determine the ability of each cell line to 
support growth, the level of viral production, and to assess cytopathic 
effect and plaquing ability. 
All the viruses produced a CPE in Vero and CV-1 cells, commencing 
at the 5th day p. i. when inoculated with LGA 391 and M 152. The other 
Mopeia viruses did not show a CPE until 6-8 days p. i. (Table 4). In both 
cell lines onset of a cytopathic effect was demonstrated by small foci of 
necrotic cells progressing to extensive cellular degeneration resulting in 
total destruction. The 'L' cell exhibited no CPE with any of the viruses. 
In the case of BHK the CPE was difficult to assess, since these cells 
showed some variation in their ability to grow and be maintained in P. M. E. 
In both Vero and CV-1 cells LGA 391 virus particles were detected by 
EM 2-3 days p. i. Mopeia particles were detected between 4-5 days p. i. 
Detection by EM of virus in L cells and BHK ranged from 3-5 days p. i. In 
all cell lines, viruses were detected by EM before the appearance of CPE. 
LGA 391 was demonstrated by IFA on day I p. i. in Vero and CV-1 cells 
while in L cells and BHK it was day 2 p. i. Detection of the Mopela viruses 
by IFA in all cell lines tested ranged between 2-3 days p. i. (Table 4). 
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TABLE 4. EARLIEST DETECTION OF AFRICAN ARENAVIRUSES 
IN VARIOUS STATIONARY CELL LINES 
Virus strain Detection by Vero 'L' cell BHK CV 
LGA 391 IFA DI D2 D2 D 
CPE D5 -ve +/- D5 
EM D3 D3 D4 D2 
20410 IFA D2 D2 D3 D2 
CPE D7 -ve +/- D5 
EM D3 D3 D5 D3 
148 IFA D3 D3 D3 D2 
CPE D6 -ve +/- D5 
EM D5 D3 D4- D4 
i 
150 IFA D3 D3 D3 D3 
CPE D6 -ve +/- D5 
EM D4 D4 D4 D5 
152 IFA D2 D2 D2 D2 
CPE D5 -ve +/- D5 
EM D4 D3 D4 D4 
Z478 IFA D3 D3 D3 D2 
CPE D8 -ve +/- D5 
EM D5 D5 D5 D4 
D= days post infection 
As the cells used in the high containment suite were grown in a 
closed system with no facility for incubating in a CO2 atmosphere, all the 
cultures had to be grown in medium with a high buffering capacity. The 
most suitable medium found was L15 or PME. The latter was found to 
maintain cells for longer periods. Therefore all cells were grown in PME 
for consistency. In each cell line tested LGA 391 grew faster than all the 
Mopeia strains, peak titres being reached on day 3 p. i. in CV-1 and Vero 
cells; day 4 p. i. in L cells and day 6 p. i. in BHK. Mopeia viruses reached 
peak titres between days 4-6 p. i. in all the cell lines and were at least 10- 
fold lower than LGA 391 levels. Each of the viruses took longer to become 
established in BHK cells (Table 5). 
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TABLE 5. MEAN PEAK LEVELS OF EXTRACELLULAR VIRUS OBTAINED IN STATIONAR`: 
CELL CULTURES INFECTED WITH AFRICAN ARENAVIRUSES AT M. O. I. 0.1 
Vero L cell BHK CV-1 
e 
LGA 391 8.0 D4 7.5 D5 8.0 D6 8.2 D3 
M 20410 5.2 D4 6.5 D5 7.2 D8 7.0 D4 
M 148 6.3 D5 7.0 D5 7.0 D5 6.8 D4 
M 150 6.8 D4 7.0 D4 7.1 D6 6.8 D4 
M 152 7.4 D5 8.0 D5 7.9 D6 7.0 D3 
Z478 5.5 D4 7.5 D5 7.9 D8 7.2 D5 
Expressed as log 10 TCID50/ml 
D= days post infection 
N. B. Each value represents the mean of 5 experiments 
In roller bottles all the arenaviruses reached their peak levels in a 
shorter time and it. was found that using L- 15 gave marginally better levels 
of extracellular virus (Table 6). 
TABLE 6. MEAN PEAK LEVELS OF EXTRACELLULAR VIRUS OBTAINED FROM CELLS 
OR WN IN ROLLER BOTTLES IN L-15 MEDIUM INFECTED WITH AN M. O. I. 0.1 
Vero BHK L cell CV-1 
LGA 391 8.2 D2 8.0 D6 9.7 D3 8.9 D2 
M 20410 7.0 D3 N. D. 8.2 D4 7.0 D4 
M 148 7.3 D4 N. D. N. D. N. D. 
M 150 7.4 D3 N. D. 8.0 D3 8.2 D4 
M 152 7.8 D2 8.0 D6 8.8 D4 8.5 D2 
Z 478 7.5 D3 7.8 D4 8.5 D4 7.5 D4 
Expressed as Log, 0 TOD 50 
/ml 
D= days post infection 
N. B. Each value represents the mean of 5 exp eriments 
59 
As a result of the preliminary data it was decided to use Vero cells 
for assay studies as they gave a consistent CPE and plaque appearance. A 
TCID50 assay according to Reed-Muench was possible in microassay plates, 
which enabled a large number of assays to be carried out in limited and 
restricted laboratory conditions. Although the plaque assay was possible 
the logistics proved impossible to implement owing to the number of assays 
required. Vero cells were also chosen since the original pools were 
obtained from Vero cultures and it was thought that to stray from the 
original cell line would be unwise before basic characterisation was 
completed. 
The L cells and CV-1 proved to be the most productive in roller 
bottles. As future biochemical studies required large quantities of virus, it 
was considered appropriate to use these cells as the base for viral 
purification. However, it was discovered that the L cell population used 
contained a latent virus considered to be an Orbivirus, hence it was 
discarded. Therefore the purification procedure proceeded with Vero or 
CV-1 cells. 
3.1.2. Effects of concentration and purification on the viruses 
Table 7 summarises the levels of virus after concentration and 
purification. 
TABLE 7. INFECTIVITY DATA AT DIFFERENT STAGES DURING PURIFICATION 
Vero L cell CV-1 
Stages in purification 
Clarified tissue 
culture fluid 
Polyethylene glycol 
Glycerol-tartrate 
bands 
Glycerol-tartrate 
pellets 
LGA M 150 LGA M 150 LGA M 150 
8.7 8.2 8.7 7.0 8.0 ND 
10.5 9.8 10.5 7.7 9.6 ND 
11.0 10.1 11.0 9.7 10.0 ND 
1 1.3 10.7 11.0 9.8 1 1.3 ND 
Expressed as Log 10 TCID50/ml 
ND - Not done 
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3.1.3. Growth kinetics of Lassa and Mo eia in Vero cells 
3.1.3.1. Rate of Virus Adsorption 
Vero cell monolayers in drained 25 cm2 flasks were inoculated with 
approximately 100 plaque forming units (pfu) of virus in 0.2 ml aliquots. 
These were incubated at 37°C with intermittent rocking of the flasks to 
prevent drying of the cells and to improve distribution of virus seed. At 
various intervals bottles were removed from the incubator, washed and 
overlaid with 2% agarose in PME. 
In all cases between 30-40% of the virus was absorbed within 30 
minutes maximum adsorption being achieved within 120 minutes at 37°C. 
3.1.3.2. Effect of different multi licities of infection 
Flasks (25 cm2) containing Vero cell monolayers were inoculated at 
different MOIs. They were adsorbed for 2 hours at 37°C, washed, and 5 
mis of PME containing 2% FCS added. Incubation was carried out at 
37°C. Aliquots of 0.4 mis were removed daily, centrifuged at 1000 rpm to 
remove debris and titrated in microtitre plates containing Vero cell 
monolayers. 
Figure 16 demonstrates the growth kinetics of LGA 391 and M20410 
at different multiplicities of infection. A similar pattern was observed 
with the other Mopeia strains. It was evident that high multiplicities of 
infection (10 - 0.1) gave rise to low levels of extracellular virus production 
(103 - 104 TCID50/ml). Low multiplicities of infection as demonstrated in 
Figures 16 and 17 provide the highest rates of growth during the first two 
to three days, maximum viral titre being achieved between 3-5 days. 
There was increased evidence of prozoning as measured by CPE. This was 
particularly evident in cultures containing high concentrations of virus over 
3 days post infection and was a phenomenon common to all the strains 
studied. The degree of prozoning increased as the age of the cultures 
advanced. 
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Fig. 16 Growth kinetics of (a) LGA 391 and 
(b) M20410 in Vero cells at different 
multiplicities of infection in PATE 
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3.1.3. Growth kinetics of Lassa and Mo eia in Vero cells 
3.1.3.1. Rate of Virus Adsor tion 
Vero cell monolayers in drained 25 cm2 flasks were inoculated with 
approximately 100 plaque forming units (pfu) of virus in 0.2 ml aliquots. 
These were incubated at 37°C with intermittent rocking of the flasks to 
prevent drying of the cells and to improve distribution of virus seed. At 
various intervals bottles were removed from the incubator, washed and 
overlaid with 2% agarose in PME. 
In all cases between 30-40% of the virus was absorbed within 30 
minutes maximum adsorption being achieved within 120 minutes at 37°C. 
3.1.3.2. Effect of different multi licities of infection 
Flasks (25 cm2) containing Vero cell monolayers were inoculated at 
different MOIs. They were adsorbed for 2 hours at 37°C, washed, and 5 
mis of PME containing 2% FCS added. Incubation was carried out at 
37°C. Aliquots of 0.4 mis were removed daily, centrifuged at 1000 rpm to 
remove debris and titrated in microtitre plates containing Vero cell 
monolayers. 
Figure 16 demonstrates the growth kinetics of LGA 391 and M20410 
at different multiplicities of infection. A similar pattern was observed 
with the other Mopeia viruses. It was evident that high multiplicities of 
infection (10 - 0.1) gave rise to low levels of extracellular virus production 
(IO 3- 104 TCID50/ml). Low multiplicities of infection as demonstrated in 
Figures 16 and 17 provide the highest rates of growth during the first two 
to three days, maximum viral titre being achieved between 3-5 days. 
There was increased evidence of prozoning as measured by CPE. This was 
particularly evident in cultures containing high concentrations of virus over 
3 days post infection and was a phenomenon common to all the strains 
studied. The degree of prozoning increased as the age of the cultures 
advanced. 
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a 
Fig. 18 A photograph of LGA391 
showing (a) early fine 
inclusions and (b) the 
cytoplasmic inclusions 
cytoplasmic membrane. 
fluorescence in vero cells 
granular cytoplasmic 
latter stages of large 
in close proximity to the 
(x400). 
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Examination by IFA of fixed and unfixed Vero cell cultures infected 
with Lassa or Mopela viruses using guinea pig anti-arenavirus hyperimmune 
sera or Lassa and Mopeia monoclonal antibodies revealed similar cellular 
changes during infection. An identical pattern of events occurred with 
each virus studied as outlined below. 
Following infection of cells with MOI's of 0.1 or 0.01, detection of 
LGA 391 and Mopeia viruses by IFA ranged from day I to day 3 dependent 
on the reagents used. The presence of virus was observed by day 1-2, 
which was earlier than observable CPE (Table 4). Fluorescence in the early 
stages of infection was denoted by a fine granular cytoplasm which 
progressed during the latter stages to display large cytoplasm inclusions in 
close proximity to the cytoplasmic membrane (Fig. 18). No observable 
nuclear involvement was noted. Experience using monoclonal antibodies 
has demonstrated how valuable these reagents are in detecting viral 
antigens earlier than the hyperimmune sera by virtue of the fact that less 
non-specific responses are likely to occur. 
3.1.4. Growth kinetics of Lassa and Mo eia viruses in L cells 
Maximum adsorption for all the viruses in stationary and roller 
bottles was achieved within 120 minutes at 37°C by the method outlined 
for Vero cells (Section 3.1.3.1. ). 
The maximum production of extracellular virus in stationary or roller 
bottles was dependent on the multiplicity of infection. Figure 19 
demonstrated the growth kinetics of LGA391 with varying M. O. I. s. Similar 
results were achieved with all the strains of Mopeia viruses. High M. O. I. s 
ranging between I to ßl0 resulted in lower levels of virus production (2-5 
log10 TCID50/ml) and were accompanied by the demonstration of 
prozoning in micro-assay tissue culture titrations. Samples had to be 
diluted 10-3 to eliminate the prozoning in culture. Low M. O. Ls were 
found to be necessary for the production of high extracellular virus with 
either Lassa or Mopeia viruses. 
66 
_S 
c6A` `A 
Hsö ýo -O`o 
ýýk 
o ýo 0 to 4A 
0 
+4 
Y"1 
2 
1ý 
1234567 
Days post infection 
M. O. I. 0.01 
M. O. I. 0.1 
M. O. I. 1.0 
Fig. 19 Growth kinetics of LGA 391 in 'L' cells 
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The growth kinetics of LGA391 and Mopeia viruses in 'L' cells at 
M. O. Is of 0.1 or 0.01 are shown in Fig. 20a and b. Maximum yields of 
viruses occurred between 3-5 days p. i.; thereafter a gradual reduction was 
noted. A more rapid growth of Lassa and Mopeia strains was observed 
with an M. O. I. of 0.1. L cells inoculated with LGA391 and M152 viruses 
produced the highest levels of virus at both 0.1 and 0.01 M. O. I. The other 
strains of Mopeia virus produced maximum yields within the same time 
(day 3-5) but always 101 -102 TCID50/ml below that achieved with LGA 
391 and M 152. 
None of the Lassa or Mopeia viruses initiated a C. P. E. in 'L' cells, 
although it was noted that during viral growth the cells were easily 
detached from the surface of the flasks. 
Examination of the cells histologically or by IFA demonstrated a 
similar developmental pattern as found in Vero cells. 
3.1.5. Growth kinetics of Lassa and Mo eia viruses in CV-1 cells 
Maximum adsorption for all the viruses in stationary and roller 
bottles was achieved within 120 minutes at 37°C by the method outlined 
for Vero cells (Section 3.1.3.1. ). 
The production of extracellular virus to peak levels is less dependent 
on the level of M. O. I. Figure 21 demonstrates the growth kinetics of 
LGA39I with varying M. O. I. s. Similar results were achieved with all the 
strains of Mopeia viruses. With M. O. I. s of between 0.01 and 1.0 maximum 
yields of virus were achieved by day 2. 
With an M. O. I of 0.1 or 0.01 a consistent pattern of growth kinetics 
was observed with Lassa and Mopeia viruses. Peak levels of extracellular 
virus were observed by day 2 with LGA 391, M 152, M 150 and Z478 and by 
day 3 with M20410 and Z478 (Figs. 21 and 22). There were no major 
differences in the levels of virus production between the two M. O. Ls 
except that the initial growth phase was one day longer when using a M. O. I. 
of 0.01. As with Vero and L cells LGA 391, M 150 and Z478 were the most 
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--r- 
productive achieving between IO 
1- 102 TCID50/0.1 ml higher levels than 
the other strains (Fig. 22). Prozoning was observed in low dilutions (10-1) 
from samples tested after day 1. 
The cytopathic effect was evident with all the viruses on day 5. It 
appeared more rapidly than in Vero cells. There was no early rounding of 
the cells with the accompanying granulation. The CPE was rapid and 
uniform extending over the whole culture, resulting in extensive 
detachments of the affected cells. 
Examination by cellular histology or by IFA demonstrated a similar 
developmental pattern as found in Vero cells. 
3.2. ELECTRON MICROSCOPIC STUDIES OF TISSUE CULTURE MATERIAL 
3.2.1. lli"9 r holo of virus particles 
The morphological details of the Mopeia viruses were identical with 
that of Lassa. Identification on sub-grouping of the individual viruses was 
not possible on morphological grounds. The morphological structure of the 
virus particles and their development in cell culture or animal tissue are 
similar so the following general description applies to all the viruses 
studied even though only limited examples are shown (Figs. 23-42). 
In ultra-thin sections Lassa and Mopeia virus particles appeared round 
or oval with varying degrees of pleomorphism. The mean diameters of the 
particles showed minor differences (Table 8). 
TABLE 8. MEASUREMENT OF AFRICAN ARENAVIRUSES 
Virus Mean Diameter (nm) Individual variation (nm) 
M 20410 140 130-150 
M 148 170 80-300 
M ISO 120 100-150 
M 152 120 100-240 
Z 478 160 120-230 
Z 481 200 150-220 
LGA 391 160 80-250 
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Fig. 23 
M150 virus particle which 
has not been completely 
penetrated by negative 
contrast medium revealing 
membrane nature of its 
envelope (arrow). 
Surface projections more 
widely spaced than other 
Mopeia particles. 
-- 
Fig. 24 
M20410 virus particle 
showing typical arenavirus 
morphology. 
x 200,000 
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Fig. 25 
178 virus particle 
!; bowing typical arenavirus 
i, orphology. Also 
demonstrates a membranous 
bleb (arrow). 
x 200,000 
, _ ý. 
Fig. 27 
M148 virus particle 
showing typical 
granular appearance. 
Delicate membranous 
bleb (arrow) was 
considered to result 
from osmotical sensitive 
envelope membrane. 
Surface projections 
separated more widely. 
x 200,000 
! Sý 
Fig. 26 
LGA 391 virus particle 
in negative-contrast, 
showing typical granular 
appearance and closely 
spaced surface projections. 
x 176,000 
Fig. 28 
M152 indistinguishable 
from other arenavirus 
particles. Uniform 
granular appearance 
with closely spaced 
surface projections. 
x 200,000 
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The morphology of LGA 39 and Mopela viruses differs little from the 
standard arenavirus particle. All the viruses demonstrated surface 
projections forming an outer layer having a regular configuration, 
reflecting the shape and spacing of the individual projections. The viral 
envelopes were formed from the basic trilayer of the plasma membrane of 
the host cell, which were modified by a significant increase in the width of 
both membrane leaflets and by an increase in the width and uniformity of 
the electron dense intermediary zone. This envelope layer may take on a 
more complex form. The internal structure of all the viruses has been 
shown to contain varying numbers of 20-30 nm electron dense particles, 
which were easily distinguishable from glycogen granules, but were 
morphologically indistinguishable from ribosomes (Figs. 29-42). The 
distribution of these particles appeared to be random although there were 
indications that there are linear structures connecting the ribosomes. 
Negative contrast microscopy of the viruses demonstrated the 
friability of the unit membrane envelope of the particles giving rise to 
bizarre shapes. In addition the staining and drying conditions often caused 
osmotic blebbing of the membrane. It was also noted- that to prevent 
complete distortion of these particles there was a critical pH range for the 
staining of each particle (Table 9). It must also be noted that the 
procedure for removal of the particles out of a High Containment 
Laboratory may also have some bearing on the quality of these studies, a 
factor beyond the control of the author. 
TABLE 9. PH TOLERANCE DURING NEGATIVE STAINING 
Virus pH range 
LGA 391 6.8-7.0 
N1 20410 6.2 - 6.5 
M 148 6.2 - 6.6 
M 150 6.2 - 6.4 
M 152 6.2 - 6.5 
Z 479 6.2 - 6.4 
Z 481 6.2 - 6.4 
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The surface projections have been shown to be closely arranged on all 
the viruses, but osmotic swelling can have an effect on these special 
arrangements. The individual projections do have a degree of variation in 
their size (Table 14) even though they conform to the recognizable club 
shape appearance. 
TABLE 10. COMPARATIVE SIZES OF PROJECTIONS ON THE 
SURFACE FOR AFRICAN ARENAVIRUSES 
Viruses Mean size range (nm) 
LGA 391 15-21 
M 20410 8-10 
M 148 10-15 
M 150 8-10 
M 152 15-20 
Z 478 8-13 
Z 481 8-12 
3.2.2. Viral mor ho enesis and infected cell characteristics 
All the Mopela and Lassa viruses grown in Vero, CV-1, LLC-Mk2, 
BHK and L-cells mature by budding from the plasma membrane (Figs. 29- 
42). During the early part of the infection the host cell membrane changes 
at bud sites which indicates the onset of viral envelope construction (Figs. 
29,32,34,37,40). Late in infection areas of the plasma membrane 
became more dense, and had observable surface projections (Figs. 30,33- 
35,37,39). Distinctive intracytoplasmic inclusion bodies were found (Figs. 
34,38,41). The inclusions consisted of an electron dense, smooth matrix 
in which the dense particles were identical with those found in the virus 
particles. As illustrated the granules were homogeneous in size and were 
indistinguishable from host-cell ribosomes. In all cases the inclusions 
varied in their degree of condensation, were not confined within structural 
margins and varied widely in shape and size. Infection of Vero, LLC-Mk2, 
CV-1 and BHK cells with all the African arenaviruses studied causes 
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Fig. 29. LGA 391 virus infected Vero cell (day 2 p. i. ) with particles 
budding from plasma membrane (arrows). Envelope structure 
more distinct than normal plasma membrane at sites of 
particle budding. (x 50,000) 
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Fig. 30. LGA 391 virus particles in final stages of budding from 
Vero cell surface (day 5 p. 1. ). (x 50,000) 
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Fig. 31. LGA 391 virus particles in extracellular space (day 5 p. i. ) 
at the periphery of Vero cells. Particles consist of heavy 
membrane envelope containing various amounts of 20 to 25 nm 
dense granules (arrows). (x 200,000) 
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Fig. 32. M148 virus infected Vero cell (day 4 p. i. ) with particles 
budding from plasma membrane and free in extracellular 
space. Envelope structure more distinct than normal 
plasma membrane at sites of potential particle budding. 
(x 40,000) 
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Fig. 33. M148 virus infected Vero cell (day 5 p. 1. ) showing distinct 
unit-membrane envelopes especially at sites of particle 
budding. Surface projections on budding particles are also 
visible. The cell also shows a high concentration of dense 
granules within the cytoplasm beneath the altered plasma 
membrane. (x 115,000) 
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Fig. 34. M150 virus infected Vero cell (day 2 p. i. ) showing a distinct 
thickening of the plasma membrane along the whole length of 
the cell with one particle budding. Surface projections on 
the budding particle are also visible. (x 150,000) 
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Fig. 35. M150 virus particles in extracellular space at 6 days p. i. 
from Vero cells. (50,000) 
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Fig. 36. M150 virus particles at final stages of budding from Vero 
cells (day 5 p. i. ). Particles demonstrate surface 
projections on unit-membrane envelopes. (x 200,000) 
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Fig. 37. M152 virus infected Vero cell (day 3 p. i. ) demonstrating 
characteristic arenavirus distinct unit-membrane envelope 
at site of particle budding. Even at early stages of 
budding, surface projections are visible. Cytoplasmic 
dense granules also in evidence below thickened cellular 
membrane. (x 150,000) 
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Fig. 38. M152 virus infected Vero cell (day 5 p. i. ) showing final 
stages of typical arenavirus budding from cell surface. 
Each particle containing 20-25 nm dense granules. (x 115,000). 
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Fig. 39. M152 virus infected cells (day 6 p. i. ) demonstrating 
virus particles in extracellular space. A varying 
number of dense particles, double membrane and surface 
projections are visible. Budding is also in progress 
at other sites on the cell surface (arrows), (x 150,000) 
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Fig. 40. Z478 virus infected Vero cells (day 5 p. i. ) showing various 
stages of typical arenavirus development. (x 150,000). 
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Fig. 41. Z478 virus inclusion at a stage of infection preceding 
cytopathic changes. An increase in packing occurred late 
in infection, making inclusions appear very dense. 
(x 80,000) 
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Fig. 42. Z478 virus particles budding from plasma membrane over an 
extensive portion of Vero cell surface (arrows)(day 4 p. i. ). 
The entire surface of some cells was involved in virus 
production. (x 52,000) 
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cytopathic changes that include rarefaction, condensation and lysis as 
stages in the common terminal necrotic pathway. 
3.3. PHYSICOCHEMICAL STUDIES 
The work outlined in this section was . aimed at. 
determining the 
physicochemical characteristics of Mopela virus compared with LGA 391 
and relating the findings to the arenavirus family. It was also aimed at 
. using 
the data to comment on various clinical and work practices. 
3.3.1. Thermal inactivation 
The rate of inactivation of Lassa and Mopeia viruses was measured in 
the temperature range 28-60°G Survival curves were constructed by 
plotting the reduction of. infectivity at different times (Figs. 43-47). When 
a virus is inactivated according to. a first order, reaction the rate, constant 
is given by. the formula: 
K' = (in Vt/V0)t 
where V. is the original concentration of infectious virus and Vt the 
concentration of surviving virus at a given time. 
An exponential decrease in infectivity of all viruses, without an 
initial shoulder, could be observed between 28-60°C. Thus the 
inactivation proceeded as a first-order reaction implying that the virus 
preparations were homogeneous. At the higher temperatures "(50°C and 
60°C) a two. component curve was observed, a finding which has been 
occasionally recognised with some other RNA viruses (Ginoza, W., 1968). 
Reference to Table II indicates the rate of their inactivation, the 
time taken to-achieve a 50% reduction in infectivity (half-life t) and. total 
time taken to reduce infectivity to undetectable limits. 
The different velocity constants were plotted against temperature 
according to an Arrhenius diagram. As shown in Fig. 48, the plot is 
composed of two straight lines which intercept at about 45°C. The slope 
of the curves, which are related to the enthalpy change, were not 
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TABLE 11. EFFECT OF VARIOUS TEMPERATURES ON LASSA AND MOPEIA VIRUSE 
Virus 
Temp 
0C 
Half-life 
to 
Total inactivation 
Time 
Velocity constant 
K' (min-1) 
LGA391 60 2.0 mins 18 mins 0.84 
56 3.0 " 55 " 0.63 
50 7.5 " ISO +* mins 0.076 
37 1 hour 64 + hours 0.004 
28 18 hours 108 +11 0.002 
M 152 60 0.6 mins 15 mins 1.03 
56 1.0 " 45 " 0.53 
50 2.5 " 120 + mins 0.23 
37 1 hour 64 + hours 0.004 
28 12 hours 108 " 0.002 
M 150 60 0.5 mins 10 mins 1.68 
56 1.0 " 30 " 0.76 
50 2.5 " 150 + mins 0.07 
37 1 hour 64 hours 0.004 
28 12 hours 108 " 0.002 
N120410 60 2.0 mins 22 mins 0.83 
56 2.5 80" 0.57 
50 3.5 150 + mies 0.19 
37 I hour 64 + hours 0.004 
28 24 hours 108+11 0.002 
Z478 60 0.6 mins 22 mins 0.92 
56 2.5 " 60 " 0.46 
50 4.0 " 105 Of 0.13 
37 1 hour 64 + hours 0.004 
28 24 hours 108+11 0.002 
+. experiment terminated before complete inactivation 
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Fig-48 Arrhenius plots for thermal inactivation of Lassa 
and Mopeia viruses. Logarithms of rate constant were 
plotted against reciprocal of absolute temperature. 
The K' values were derived from fast components of 
Figs. 03 47 by the formula: 
Vo 2.3 
K=- 
Vt t 
where V0 = original virus concentration 
V= virus concentration at time t r 
t= exposure time (minutes) 
1= reciprocal of absolute temperature 
T 
Dotted line represents the trend for each virus. 
" LGA 391. O M20410 Q Z478 * 1.1152 A L1150 
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significantly different when the data for each virus was plotted. From 
each component it was possible to obtain the thermodynamic constants for 
the overall process of inactivation which they described (Table 12). These 
were the energy of inactivation (tH) and the entropy of activation (6S) and 
were calculated from inactivation velocity constants according to Ginoza 
(1968). 
TABLE 12. THERMODYNAMIC PARAMETERS FOR THE INACTIVATION OF 
LASSA AND MOPEIA VIRUSES 
Virus Temp. tG AH AS 
0C (Kcal/mol) (Kcal/mol) (cal. mol/°C) 
LFGA391 50 - 60 1]. &- 17.8 100 265 
28 - 45 24.3 -25.5 22.10 -9.3 
M 152 50 -'60 11.1 - 15.0 64.02 155 
28 - 45 24.9-25.1 20.78 -13.8 
M 150 50 - 60 9.9- 18.1 131.78 360 
28 - 45 24.5 - 25.3 22.19 -9.2 
M20410 50 - 60 11.9- 15.4 59.24 139 
28 - 45 24.8-25.4 19.95 -16.8 
Z478 50 - 60 11.5- 16.1 76.45 191 
28 - 45 24.8-25.7 22.44 -9.4 
The AH and AS values are consistent with those reported for RNA 
containing viruses (Ginoza, 1968) and suggest the existence of two 
different inactivation reactions at temperatures below and above 400- 
45°G The results also demonstrate a consistency in reaction by Lassa and 
Mopeia viruses to thermal inactivation. 
3.3.2. Effect of ultraviolet HEM 
Ultraviolet flight reduced the infectivity titre from 10 
7 to 101 
TCID50/ml in 15-20 seconds. This reduced further after 30 seconds to a 
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Fig. 49 Inactivation rate of Lassa and Mopeia 
viruses irradiated with UV light. Each 
point represents the mean of 5 separate 
experiments. 
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level where only the undiluted tissue culture fluid (PMB) was positive. No 
detectable virus was made beyond 40 seconds. All arenaviruses reacted 
the same way as demonstrated in Fig. 49. 
3.3.3. pH sensitivity 
Infectivity reductions at various pH levels for Lassa and Mopeia 
viruses are depicted in Fig. 50. Of the Mopeia strains, M 152 remains stable 
between pH 6.6 - pH 8.0. Lassa GA 391 has a pH stability range between 
pH 6-8.5. Less than one log 10 'reduction in titre occurred at pH' 8.0 and 
above for LF GA 391 and M 152. A larger reduction in infectivity (I01-102 
log 10) was observed with 
M204 10, M 150 and Z478 at pH 8.0 and above. 
In all cases complete inactivation was observed at pH 5.0 and below . 
Table 51 shows the elfects at different pH levels on suspensions of 
Lassa and Mopela viruses maintained for 6 hours and 18 hours at +4°C. The 
decrease of infectivity was not significant between pH 6.5 and 9.5 after 6 
hours at +40C or between pH 6.5 and 9.0 after 18 hours. Complete 
inactivation was achieved at below pH 5.5. This applied to all the viruses 
studied. 
TABLE 13. EFFECT OF pH ON LGA 391 AND MOPEIA VIRUSES 
pH Time of incubation % Inactivation 
(hours) 
LF M 152 M150 M20410 Z478 
4.5 6 99.9 99.9 99.9 99.9 99.9 
5.5 11 Is it 11 if it 
6.5 0 00 0 0 
7.5 0 00 0 0 
8.5" It 5 6 10 6 7 
9.5 It 8 78 9 l0 
4.0 18 99.9 99.9 99.9 99.9 99.9 
4.5 11 11 11 It it of 
5.5 I' of of of II is 
6.5 10 10 17 . 15 20 
7.5 21 12 14 15 24 
8.5 18 12 15 14 l8 
9.5 35 40 42 38 43 
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3.3.4. Effects of solvents 
Ether and chloroform reduced the infectivity titre of Mopeia and 
LGA 391 viruses. These-viruses were therefore- considered to be ether 
sensitive but not completely inactivated under the conditions of the test. 
After acetone and alcohol treatment both Lassa and Mopela virus was 
recovered at the end of the test period. No recovery of any of the viruses 
resulted from -sodium desoxycholate treatment (Table 14). 
TABLE 14. EFFECT OF ETHER, CHLOROFORM, ALCOHOL, ACETONE 
AND SODIUM DESOXYCHOLATE 
Titre of virus 
Virus Ether Chloroform Alcohol Acetone Sodium Control 
desoxycholate 
LGA391 
. '. 
1.5 1.0 5.0 2.8 <0.5 7.0 
M20410 
, <0.5 
<0.5 5.5 3.3 " 6.5 
M 150 <0.5 <0.5 5.6 2.4 6.8 
M 152 1.0 <0.5 6.1 3.4 7.2 
Z478 <0.5 1.0 5.0 2.4 5.8 
Expressed as TCIDS0/ml 
je and " lutaraldeh de 3.3.5. Effect of formaldehy 
The effect of formaldehyde. and. glutaraldehyde on LGA 391 and 
Mopeia. viruses was observed to be similar irrespective of the temperature 
being used (4°C, 28°C, 37OC): The concentrations of main interest were 
10%, 3-4%, and 0.02% for the following reasons. The 10% concentration 
has long been used as a requirement.. for decontamination under high 
containment (CAMR Code of Practice); 3-4% are the levels used for EM 
preparation and 0.02% for the inactivation of material used in 
immunisation protocols. 
The results of the LGA 391 and Mopela virus inactivation studies with 
formaldehyde and glutaraldehyde were very similar irrespective of the 
concentration and the temperature conditions used (Figs. 51 and 52). At 
100 
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[]-ý Untreated control 
Fig. 51 Effect of various concentrations of formaldehyde on 
LGA 391 at Room Temperature 
A-A 0.02% 0-0 3% "-O 10% 
Q-Q Untreated control 
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Fig. 51 Effect of various concentrations of glutaraldehyde 
on WA 391 at Room Temperature. 
109 both formaldehyde and glutaraldehyde inactivated both LGA 391 and 
the Mopeia viruses (6 log1OTCID50) to undetectable levels within 5-10 
minutes. Glutaraldehyde at a concentration of 3% inactivated 90% of 
Lassa and Mopeia virus populations within 15 minutes, the residual 10% 
being eliminated after 2 hours incubation. Formaldehyde at a 
concentration of 4% inactivated all viruses within tI hours to undetectable 
limits. The 0.02% levels of formaldehyde and glutaraldehyde did not 
inactivate the viruses until 5 days incubation had been completed but it 
was noted that the pH of the support medium changed from pH 6.5 to pH 3 
which in itself has an inactivating effect. The EM studies carried out on 
the samples prepared in 3% glutaraldehyde were found to be suitable for 
-structural studies even when the- preparation was kept for 24 hours. 
Formaldehyde at a concentration, of 4% appeared to structurally alter the 
virus particles upon EM study. 
3.3.6. Effect of BPL concentrations 
The aim of these studies was to establish the most appropriate 
working concentration for BPL to inactivate Lassa and Mopela virus , 
-strains The effect of 
different temperatures, time and type of media on 
BPL inactivation was considered. 
In the case of Lassa infected sera (Table 15) a 0.1% solution of BPL 
used at 4°C reduced all virus titres to 101.0-100'5 TCID50 /ml within 18 
hours, and at 37°C the reduction was to between 102'3-101.5 TCID50/ml 
within 30 minutes. To obtain undetectable levels of virus it was found 
necessary to double the BPL concentration to 0.25% . In a human acute 
phase serum containing 105.0 TCID50/ml, 0.2% BPL reduced viral 
infectivity to undectable levels within 18 hours at 4°C and 30 minutes at 
37°C. Similar data was observed using Guinea Pig and Monkey infected 
sera. 
102 
TABLE 15. INACTIVATION OF LGA 391 AND MOPEIA VIRUSES 
IN HUMAN SERA BY BPL 
Cone of 
Recovery of Virus (log 10 TCID50/ml) 
BPL% ab 
LGA391 20410 478 150 152 LGA391 20410 478 150 152 
0.3 -ve - -ve -ve -ve -ve - -ve -ve ve 
0.2 -ve - -ve -ve -ve -ve - -ve -ve ve 
0.1 <0.5 <0.5 1.0 <0.5 <0.5 2.3 1.2 1.5 2.0 . 
1.8 
0.05 2.0 2.6 3.1 2.9 3.5 4.8 3.6 2.8 4.2 3.8 
0.025 5.2 4.8 6.5 6.0 6.8 6.5 5.8 6.8 6.0 6.8 
Control 7.5 6.8 7.0.6.8 7.2 7.5 6.8 7.0 6.8 7.2 
a. 4°C for 18 hours 
b. 37°C for 30 minutes 
In the case of tissue culture fluid containing between 106'8-107.5 
TCID50/ml 0.1% BPL proved to be adequate in inactivating virus to 
undetectable levels (Table 16). 
TABLE 16. INACTIVATION OF LGA 391 AND MOPEIA VIRUSES 
IN TISSUE CULTURE FLUID BY BPL 
Conk of 
Recovery of Virus (log10 TCID 50/ml) 
BPL % ab 
LGA391 20410 478 150 152 LGA391 20410 478 150 152 
0.3 -ve -ve --ve -ve -ve -ve -ve -ve -ve ve 
0.2 -ve -ve -ve -ve -ve -ve -ve -ve -ve ve 
0.1 -ve -ve -ve -ve -ve -ve -ve -ve -ve ve 
0.05 6.8 5.0 6.8 6.0 6.5 5.5 4.5 6.0 5.8 6.5 
0.025 7.5 6.8 7.0 6.5 7.2 7.0 6.7 7.0 6.8 7.2 
Control 7.5 6.8 7.0 6.6 7.2 7.5 6.8 7.0 6.8 7.2 
a. 4° C for 18 hours; 
b. 37 °C for 30 minutes 
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No Lassa or Mopeia viruses could be recovered from susceptible 
guinea pigs or mice after inoculation of BPL treated tissue culture 
material. Purified LGA 391 and M 150 virus when treated with 0.2% BPL 
for 18 hours at +4°C, also proved successful in that no detectable virus was 
recovered from in vitro or in vivo assays. 
3.3.6.1. Kinetic rate of 0.2% BPL hydrolysis in various media 
The kinetic rate of 0.2% BPL hydrolysis in relation to the rate of 
virus inactivation by BPL (Section 3.3.4) is demonstrated by Figs. 53 and 54 
with LGA 391. At either temperature LGA 391 was inactivated before 
the half-life points of the drug. This also applies to all the Mopeia virus. 
Hydrolysis of BPL in human, guinea pig and monkey sera has shown that the 
half-life at 37°C was between 24-30 minutes and at 4°C 15-20 hours. 
Complete inactivation of LGA 391 and Mopeia virus was achieved within 30 
minutes at 37°C and within 18 hours at +4°C. Total hydrolysis of BPL was 
completed within 3-4 hours at 37°C and within 3-4 days at +4°C. 
IIYULuiyata 
+4 PBS 36-40 hours 7.2-6.6 5-6 days 
of TCF 34-38 hours 7.4 - 6.2 5-6 days 
Human sera 15-20 hours 8-6.5 3-4 days 
of Guinea pig 15-20 hours 7.8-6.4 3-4 days 
sera 
It Monkey sera 15-20 hours 7.8-6.3 3-4 days 
37°C PBS 60-65 minutes 7.2 -6.5 5 hours 
TCF 55-60 minutes 7.4 - 6.6 41 hours 
Human sera 24-30 minutes 8.0-6.3 2+ -3 hours 
Guinea Pig 24-30 minutes 7.8-6.0 21 -3 hours 
sera 
" Monkey sera 24-30 minutes 8.0 - 6.3 2+ -3 hours 
TABLE 17. RATE OF HYDROLYSIS OF 0.2% BPL IN DIFFERENT MEDIA 
AT DIFFERENT TEMPERATURES 
°C Media Half-life pH change 
Complete Temp 
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53 Rate of LGA 391 inactivation and BPL hydrolysis 
in human sera at 370C 
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In both PBS and tissue culture fluid containing 2% FCS the hydrolysis 
of BPL was very much slower at both 37°C and 4°C when compared to sera 
(Table 17). Inactivation of all viruses was completed well within the half- 
life of 0.2% BPL. Total hydrolysis was extended at +4°C by 1-2 days and 
at 37°C for 1-2 hours. 
Measurements of the pH change during hydrolysis in both serum, PBS 
and TCF showed a marked reduction which also aided inactivation of the 
viruses. 
3.3.6.2. BPL inactivation of infected Vero cells 
The aim of this section was to determine the ability of BPL to 
inactivate intracellular viruses without affecting the cells ability to react 
to hyperimmune antisera in diagnostic-immunofluoresence assays. 
Infected Vero cells. washed. in PBS were resuspended in freshly 
prepared BPL solution (0.1% or 0.2%) in Plaisners medium pH 8.0 and kept 
at the times and temperatures shown in Tables 18 and 19. At the end of 
the reaction period cells were centrifuged, washed and suspended in PBS 
containing 0.01% bovine serum albumin (w/v) to an approximate final 
concentration of 106 per mL. - About 0.02 ml was then placed on each spot 
of coated multispot microscope.. slides. Slides were air dried, fixed in cold 
acetone for 10 min, used at-once or stored at -80°C in sealed plastic boxes. 
Samples of the inactivated cells were sonicated to disrupt the cells in a 
sonic bath and titrated in microassay plates. Indirect immunofluorescence 
readings performed on cells 10 days post-inoculation, were compared with 
those one hour post-inoculation. If the number of fluorescent foci after 10 
days was the same as after one hour, the inoculated antigen was judged to 
be inactivated. 
lt was observed (Tables 18 and 19) that complete inactivation of the 
Lassa and Mopeia infected Vero cells with BPL was achieved, the 
antigenicity was retained and that hyperimmune sera reacted well with the 
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slide. No infectivity was demonstrated in any of the combinations used. 
It was noted, however, that, the usable life of the unfixed slides was 
shortened on prolonged storage at -80°C. 
3.3.7. Nucleic acid determination 
Infectivity of all the Mopeia and LGA 391 viruses remained 
unchanged in the presence of BUDR, a deoxyribonucleic acid 
(DNA) 
inhibitor at any of the concentrations used (10-2_10-5). Effects of BUDR 
on the viruses are shown in Table 20. In the presence of BUDR, the 
development of a vaccinia (a DNA-containing virus) CPE was completely 
inhibited. A known RNA-containing virus, _Echo-1 
I. -remained unaffected 
and developed a CPE. 
TABLE 20. EFFECT OF 5-BROMODEOXYURIDINE ON GROWTH OF LGA 391 
AND MOPEIA VIRUS IN VERO CELL CULTUE 
Virus titre 
Virus BUDR (10-5M) No. BUDR 
LGA391 6.8 7.0 
M20410 6.6 6.5 
M 150 6.5 6.8 
M 152 7.1 7.2 
Z478 5.6 5.8 
Vaccinia < 1.0 6.2 
ECHO-1 f 8.2 8.3 
Expressed as Log I OTCID 50/ml 
M. S. Effect of Actinom cin D 
The replication of Lassa and Mopeia viruses was, inhibited by the 
transcription inhibitor, Actinomycin D at levels of greater than lug/ml. 
The degree of inhibition at various dilutions of Actinomycin D is shown in 
Table 21. 
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TABLE 21. GROWTH OF LGA391 OR MOPEIA VIRUS IN THE PRESENCE 
OF VARIOUS CONCENTRATIONS OF ACTINOMYCIN D IN VERO 
CELL CULTURE 
Virus titre 
Actinomycin D 1.0 0.3 0.1 0.03 0.01 0 
Virus 
LGA391 <0.5 1.5 4.5 5.0 6.8 6.8 
M20410 0.5 3.4 4.7 5.0 5.2 
M150 1.0 3.4 4.4 6.0 6.1 
M 152 " 1.0 2.8 5.2 6.0 6.5 
2478 0.5 2.9 4.2 6.0 6.4 
Vero cells infected with Lassa and Mopeia viruses in the presence of 
Actinomycin D and removed after absorbtion showed normal growth of 
virus. Thus, the suppression of Lassa and Mopela virus replication by 
Actinomycin D was found not to be due to the direct effect of the drug 
upon the viruses. 
3.4 ANTIGENIC CROSS-REACTIONS 
3.4.1. Serological reactions using of clonal antisera 
The basic pattern of cross-reactions amongst Mopeia and LGA 391 
viruses by complement-fixation test demonstrated a fair degree of 
uniformity. Low titre CFT cross-reactions with LCM was a consistent 
finding. The extent of cross-reaction between Mopeia and Lassa strains 
was demonstrated with guinea pig sera as shown in Table 22. 
TABLE 22. CROSS-REACTIONS AMONG LGA 391 AND MOPEIA 
VIRUS BY COMPLEMENT FIXATION TEST 
Guinea Pig Serum 1 
Antigen LGA391 M20410 M 150 M152 Z478 LCM 
LGA391 64 32 32 64 32 8 
M20410 64 32 16 32 16 4 
M150 64 16 128 32 32 4 
M152 64 32 16 64 32 4 
Z478 64 32 16 ND 64 8 
LCM2 16 88 8 8 128 
IReciprocal. 
of serum CF titre 
2LCM 
antigen was mouse brain antigen 
ND - Not done 
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Extensive studies using CFT's were avoided in this study because of 
the time-consuming and dangerous aspect of antigenic preparation. During 
the preliminary studies anti-complementary activity was often encountered 
in serum specimens obtained from mice, guinea pigs and monkeys. 
Furthermore, IF antibodies were detected earlier in all the experimental 
studies and proved a more reliable test in diagnosing and monitoring the 
disease process. 
Using the IFA test all Lassa and Mopeia viruses demonstrated a 
similar staining pattern for virus-specific antisera. The main features 
were in the infected cell cytoplasm, where bright yellow-green inclusion 
bodies varied in. shape and Size, from sand-like granules to large odd-shaped 
clumps of antigen. - The brightness of the staining and percentage of 
stained cells usually diminished as the serum was diluted. The serum 
dilution which showed slightly diminished brightness of staining in the 
majority of infected cells was chosen as an endpoint. 
Guinea pig serum, mouse ascitic fluid or serum, and Rhesus monkey 
serum prepared. against the Mopeia strains all cross-reacted with each 
other and with LGA. 39.1 demonstrating little variation. They did not react 
with LCM or Pichinde antigens (Table 23). Cross-reactions using 
convalescent sera from six human cases of Lassa (Table 24) reacted with 
all Mopeia viruses, two reacting with LCM at low titre but not with 
Pichinde. Overall, animal immune sera cross-reacted more extensively 
than human convalescent serum. Normal human and animal sera were 
included in the tests with no staining observed with any of the antigens. 
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TABLE 23. 
........... 
RECIPROCAL FLUORESCENT ANTIBODY TITRES OF ANIMAL 
CONVALESCENT SERA AND ASCITIC FLUIDS FOR 
ARENAVIRUS ANTIGENS 
Antigen 
LGA39I 
M20410 
M 150 
M I52 
Z478 
LCM 
Pichinde 
LGA39 
M20410 
M 150 
M152 
Z478 
LCM 
Pichinde 
LGA39I 
M20410 
M 150 
M152 
2478 
LCM 
Pichinde 
LGA39 I M20410 M150 M 152 
Guinea pig serum 
2048 512 128 1024 
128 1024 512 512 
1024 512 2048 256 
1024 1024 4196 4196 
512 64 128 128 
<4 <4 <4 <4 
<4 <4 <4 <4 
Mouse ascitic fluid 
256 32 128 ND 
32 128 256 ND 
64 64 512 ND 
128 128 256 ND 
32 128 256 ND 
<4 <4 <4 ND 
<4 <4 <4 ND 
Rhe sus Monke y Serum 
2048 1024 2048 4196 
512 4196 1024 2048 
1024 2048 4196 2048 
1024 512 2048 4196 
512 1024 2048 2048 
<4 <4 <4 <4 
<4 <4 <4 <4 
Z478 
128 
512 
512 
512 
512 
<4 
<4 
64 
128 
256 
256 
512 
<4 
<4 
2048 
2048 
2048 
2048 
2048 
<4 
<4 
c_ . 
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TABLE 24. RECIPROCAL FLUORESCENT ANTIBODY TITRES OF HUMAN 
CONVALESCENT SERA AGAINST ARENAVIRUS ANTIGENS 
Serum antibody titre after Lassa v irus infec tion 
Antigen G. A. J. W. P. B. T. E. G. L. A. W. 
LGA391 1024 256 4096 128 128 512 
M20410 256 64 2048 32 16 128 
M150 512 128 2048 16 32 64 
M152 512 128 2048 64 64 128 
Z478 256 64 1024 32 32 512 
LCM 16 <8 16 8 8 <8 
Pichinde <8 <8 <8 <8 <8 <8 
On the basis of the neutralization test used it would appear that 
Lassa convalescent antisera from both experimental animal and human 
infections gave rise to neutralisation antibodies to LGA 391. A range of 
human antiserum used in this exercise did not react with any of the Mopeia 
viruses (Table 25). The reproducibility of Lassa convalescent antiserum 
reacting with Mopeia viruses could not be determined with the Rhesus 
monkey as all monkeys infected with LGA 391 did not survive long enough 
to develop neutralization antibodies. Convalescent sera obtained from 
Mopela infected Rhesus monkeys did not react with LGA 391, although 
they demonstrated varying degrees of cross-reactivity amongst themselves 
(Table 26). Guinea pig anti-Lassa convalescent sera (120 days) 
demonstrated law neutralizing cross-reactivity against all the Mopela 
viruses studied (Table 27). However, guinea pig antisera prepared against 
the Mopeia viruses did not neutralize LGA 391, but showed limited cross- 
reactivity amongst themselves. 
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TABLE 25. CROSS-REACTIVE NEUTRALIZING ANTIBODIES FOUND IN HUMAN 
'ý- CONVALESCENT SERA AGAINST ARENAVIRUS ANTIGENS 
Neutralization Index 
Sera * G. A. 1. W. P. B. T. E. G. L. A. W. 
Antigen 
LGA39 t 
M204 10 
M150 
M152 
Z478 
LCM 
Pichinde 
2.1 1.0 2.3 0.9 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 0 0 
0 0 0 0 . 
0. 0 
* All serum used was 3 months post Lassa infection 
TABLE 26. CROSS-REACTIVE NEUTRALIZING ANTIBODIES FOUND IN 
MONKEY ANTI-MOPEIA CONVALESCENT SERA (60 DAYS) 
Neutralization Index 
Sera Z478 M 150 M 152 M204 10 
Antigen 
LGA391 0 0 ND 0 
M20410 0.8 1.8 2.0 1.6 
M 150 0.7 2.0 2.1 1.8 
M152 1.8 0.9 2.3 1.0 
Z478 1.8 ND 1.6 0.6 
4 
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TABLE 27. CROSS-REACTIVE NEUTRALIZING ANTIBODIES FOUND IN 
GUN A PIG ANTI-MOPEIA/LASSA CONVALESCENT SERA (120 DAYS) 
Neutralization Index 
Sera 
Antigen Z478 M 150 M152 M20410 LGA 391 
LGA391 00002.8 
Z478 1.7 1.5 2.0 1.0 0.9 
M150 1.2 2.5 2.0 2.0 0.8 
M152 0.8 1.8 2.0 1.8 1.3 
M20410 0.8 1.3 2.0 2.2 0.5 
3.4.2. Serological reactions usih& monoclonal antibodies to LGA 391 
. -Seventy-eight 
hybridoma cell lines producing antibody -to LGA 391 
were established. Screening by immuno. fluorescence revealed antibodies 
that reacted in a granular pattern with antigens expressed only in the 
cytoplasm of infected cells and those reacting with determinants expressed 
in the cytoplasm and at the surface of infected cells. Frequency of 
occurrence of virus-specific antibody-producing hybridomas varied from 10 
- 50% of wells showing growth in eight independent fusions. . 
Due to the 
number of hybridomas produced and time involved, details have had to be 
confined to only a few of the hybridomas. 
Analysis of 20 monoclonal antibodies for their immunoglobulin class - 
specificity was determined by immunodiffusion against monospecific 
reagents. This revealed six IgG 1,19 IgG2A and one unknown reactor. 
LGA 391 contains three major polypeptides, a prominent protein of 
molecular 60,000, which corresponds to the nucleocapsid protein N and two 
glycoproteins of molecular weight 45,000 and 38,000 G1 and G2 
respectively (Clegg and Lloyd 1982). It was of interest to determine which 
polypeptides were recognised by the monoclonal antibodies under study. 
This determination was considered useful if the antibodies were to be used 
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as molecular probes to study replication and antigen expression. Immune 
precipitation analysis using radioactive labelled LGA 391 was performed on 
20 of the monoclonal antibodies. All were found to immunoprecipitate 
viral nuclear protein (Table 28). 
Cross-reactivity of LGA 391 virus-specific hybridoma antibodies with 
heterologous arenaviruses of the 'Old World' (Lassa and Mopeia) and 'New 
World' (Tacaribe complex) viruses was assessed by IF on acetone fixed 
infected cells. Seven LGA 391 monoclonal antibodies were studied in 
detail and reacted with Junin (X33), Pichinde (COAN R 6053), Tacaribe 
(TVL-11573), Lymphocytic choriomeningitis (ARM: CA 1371), LGA 391, 
M1501 M1529 M20410 and Z478 viruses (Table 28). Of these seven 
monoclonals four (No. 52,63,72-and 79) were specific for LGA 391 and did 
not react with any of the Mopeia viruses (Table 28). This specificity to 
Lassa viruses as a whole has been extended to include several human and 
Mastom s isolates originating from Liberia, Nigeria and Sierra Leone by 
both immunofluorescence and 'Western blot' analysis (Section 2.6.3. ). None 
of the monoclonals reacted with Junin, Pichinde, Tacaribe or LCM. 
3.4.3. Cross-reactivity between arenaviruses using monoclonal antibodies 
to other arenaviruses 
Cross-reactivity. of Mopela, LCM, Pichinde, Tacaribe and Junin virus- 
specific hybridoma antibodies- with heterologous arenaviruses of the 'Old 
World' and 'New World' groups was assessed by indirect 
immunofluorescence. Four M20410 virus-specific hybridoma antibodies 
tested were either IgG2A and nucleo protein specific. Each reacted with 
the 'Old World' viruses and riot the 'New World' viruses of Junin or Pichinde. 
Neither did they react with LCM. Monoclonal 53-29-1 was specific for the 
Mopeia viruses and did not react with LGA 391. Monoclonal 52-153-2 was 
specific for LGA 391 and reacted very poorly with the Mopela viruses 
(Table 29). 
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TABLE 30. HYBRIDOMA ANTIBODIES TO TACARIBE VIRUS (TVL-11573) 
Immuno-" Tacaribe IFA reactions with other arenaviruses 
Reference globulin Polypeptide Mopeia 
No. Subclass Specificity Junin Pichinde LCM LGA391 strains 
2-100-3 IgG I N + 
2-16-2 IgG2A N ++--- 
2-24-9 IgG2B N ----- 
2-30-10 IgG2A N -- 
2-31-4 IgG2A N -- 
2-69-9 IgG2A N ----- 
2-52-2 IgG2A N +- 
2-74-9 IgG2A N +- 
2-84-11 IgGM N ----- 
2-48-3 IgG2A N ++ 
TABLE 31. HYBRIDOMA ANTIBODIES TO JUNIN VIRUS (XJ3) 
Immuno- Junin IFA reactions with other arenaviruses Reference globulin polypeptide Mopeia 
No. Subclass' Specificity Tacaribe Pichinde LCM LGA39 t strains 
3-88-7 IgG2A N +--- 
3-46-8 it N + 
3-46-1 it N +--- 
3-6-2 to N +---- 
3-70-11 N + 
3-67-7 it N +--- 
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The monoclonal antibodies produced from Junin and Tacaribe 
hybridomas did not react with any of the Lassa or Mopeia strains. Of the 
10 Tacaribe monoclonals only five reacted with Junin and of these two (2- 
16-2 and 2-43-3) reacted with Pichinde. Five nuclear protein reactive 
monoclonals were specific for only Tacaribe virus (Table 30). All six Junin 
monoclonals reacted with Tacaribe but not Pichinde (Table 31). 
The four monoclonal antibodies derived from LCM hybridomas (kindly 
supplied by Dr Buchmeier, Scripps Clinic, California) consisted of three 
nucleoprotein specific antibodies and one glycoprotein-2 directed antibody 
(9-7-5). None of the monoclonals reacted with any of the 'New World' 
viruses tested (Table 32). This confirmed the published work of 
Buchmeier et at., (1981). However, the use of 9-7-5 did not completely 
differentiate between the Lassa and Mopeia viruses as was indicated in the 
same publication. 
Forty-two monoclonal antibodies to Pichinde virus were tested 
against LGA 391 and Mopeia infected cells. Four of these antibodies 
reacted with one or more of the Lassa or Mopeia viruses (Table 33). These 
demonstrate. a reaction with both 'Old' and 'New World' viruses. 
3.5. COMPARISON OF IMMUNOCHEMICAL PROPERTIES OF LASSA 
AND MOPEIA VIRUS STRUCTURAL PROTEINS 
LGA 391 virus had three major proteins of molecular weight 60,000 
(N), 45,000 (G 1) and 38,000 (G2) (Clegg and LLoyd, 1983) and was similar if 
not identical to those corresponding to the Mopeia virus -proteins except 
that all the Mopeia virus strains showed a large N protein of molecular 
weight of 62,000. 
Proteins of LGA 391 and Mopeia viruses separated on SDS- 
polyacrylamide gels, transferred to nitrocellulose were detected by binding 
antibodies of guinea pig and Rhesus monkey sera raised against LGA 391 or 
Mopeia viruses. - When incubated with antisera to LGA 391, antibody bound 
to the N and G2 proteins of Lassa and Mopeia strains tested (Fig. 55a). 
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Fig. 55. Proteins of various strains of Lassa and Mopeia 
viruses. Cell lysates were made 2 days after infection of 
CV-1 cells with strains of Lassa or Mopeia viruses, and the 
proteins separated on 10% polyacrylamide gels and transferred 
to nitrocellulose sheets. The transfers were incubated with 
(a) guinea pig anti-Lassa virus antisera (LGA 391), (b) 
guinea pig anti-Mopeia virus (M148), (c) monoclonal antibody 
52 (raised against LGA 391) and (d) monoclonal antibody 35 
(raised against LGA 391), followed by the appropriate 
peroxidase-conjugated second antibody. 
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Fig. 56 Cross-reaction between SDS gel electrophoresis 
proteins of purified Lassa virus with G. P. anti- 
Mopeia serum. Purified virus was disrupted in 
1% SDS, 1% mercaptoethanol and analysed on 9-15% 
polyacrylamide gradient gels 1.5 mm thick. Tracks 
were strips cut from 3.5 cm slots containing 15 pg 
protein after transfer to nitrocellulose. (a) 
incubated with concanavalin A, (b-i) incubated 
4 hours with guinea pig antiserum to (b) LGA 391, 
(c) M148, (d) M150, (e) `1152, (f) Z478, (g) M20410, 
(h) human anti-Lassa (strain GA) (i) normal guinea 
pig. 
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Alternatively when incubated with antisera to any of the Mopeia viruses, 
antibody bound strongly to the N protein only of Mopeia strains but did not 
react or at most reacted weakly to all the West African Lassa strains (Fig. 
55b). (N. B. All the L designated strains on Fig. 55 are different Lassa 
isolates from West Africa. ) No G2 reaction was noted in Fig. 55b. No 
conclusion can be drawn concerning GI glycoprotein because of its lack of 
antigenicity in the "Western blot" system. 
The LGA 391 nucleoprotein directed monoclonals were also found to 
bind to the nucleoproteins of Lassa and Mopeia viruses in characteristic 
and differentiating patterns (Fig. 55 c and d). - 
This data exactly supports 
the pattern of differentiation observed by imrnunofluorescent staining of 
virus-infected cells (Table 28). 
Finally it should be noted that "Western blots" using purified LGA 391 
confirms that anti-Mopela serum does react with Lassa N protein, 
demonstrating the existence of common antigenic determinants (Fig. 56). 
3.6. TRANSMISSION OF LASSA AND MOPEIA VIRUSES TO MICE 
Tissue culture pools grown in Vero cells and passed three times 
(VCP3) were inoculated into male and female Porton strain mice at 
different ages and by different routes. The volume of each inoculum for 
i. p. was 0.1 ml and for i. c. 0.03 mis. 
3.6.1. Susce tibilit 
The susceptibility of mice at different ages and routes of infection 
are shown in Table 34. No difference was observed between male and 
female mice. 
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TABLE 34. EFFECT OF LGA 391 AND MOPEIA VIRUSES ON PORTON 
STRAIN MICE AT DIFFERENT AGES AND BY DIFFERENT ROUTES OF 
INFECTION 
I. C. 
149 150 152 LGA 391 478 
2-4 days ++--+ 
10 days --++- 
14 days +++++ 
21 days +++++ 
I. P. 
2-4 days ----- ++ 
10 days ----- 
14 days +---- 
21 days ----- 
+ No survivors 
+ Sick, paralysed or stunted growth 
sometimes leading to death 
- No illness 
" Viruses M 152 and LGA391 proved fatal to 2-4 week old mice within 
9-12 days post infection with doses ranging from 102_io8 TCIDSO/0.03 mis 
when introduced i. c. Mopela viruses M 148, M150 and Z478 also proved 
fatal to 2-4 week old mice between 7-9 days post infection. Suckling mice 
were not fatally affected when inoculated by the i. c. route (Table 35). 
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TABLE 35. SUSCEPTIBILITY OF PORTON STRAIN MICE (2-4 WEEKS) 
TO L LG 391 AND MOPEIA VIRUSES WHEN INTRODUCED BY THE I. C. 
ROUTE OF INFECTION 
Dose 
Virus Log 1 OTCID50 Day % died 
LGA391 8 D 13+ 20 
5 D13+ 60 
4 DII 100 
2 DI I 100 
I D 12+ 50 
M20410 7 D9 100 
5 D8 100 
3 D 12 100 
1 D 14+ 40 
M 150 8 D7 100 
6 D7 100 
4 D 12+ 0 
2 D 14+ 40 
M 152 8 D9 100 
6 D9 100 
4 D7 100 
2 Dl1+ 50 
Z478 8 D9 100 
6 D7 100 
4 D l0+ 80 
2 D 14+ 60 
Infection by the i. p. route had no fatal effect on adult or suckling 
mice at any age. Blind passage of brain homogenates derived from 
infected suckling mice did not alter the data. 
3.6.2. Clinical observations 
During the course of a fatal infection following i. c. inoculation, a 
reduced intake of food and water was the first sign of illness. The body 
weight gradually decreased throughout the course of the infection. During 
this phase of the infection the mice became immobile, had an increased 
respiratory rate, and their rear limbs demonstrated extensive tremors 
which finally resulted in paralysis. 
4 
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During the course of a non-fatal illness the suckling and adult mice 
developed milder clinical signs. The main feature appeared to be a 
reduction in body hair and weight during the first 14 days post infection, 
followed by increase in body weight at half the normal rate. 
3.6.3. Virus levels in blood and tissue 
The comparative virus levels in the blood of mice infected with 3 
log 1OTCID50 of virus by i. p. and i. c. routes with Lassa and Mopeia strains 
are shown in Figs. 57 and 58. 
In all cases virus was first detected on day 2 p. i. by the Lc. route and 
on day 4 by the i. p. route. With all the viruses studied, maximum levels of 
virus developed by day 4 p. i. i. c. and days 6-8 p. i. i. p. . After i. c. 
infection, virus levels of between "104=i05/TCID50/ml were observed with 
M152, Z478 and LGA 391 and 102-103TCID50/ml with M 150 and M20410 all 
of which persisted until death. 
Through the non-fatal i. p. route, M150, Z478 and M20410 virus levels 
in the blood reached 2-3 log OTCID50/ml while those of M 152 and LGA 391 
reached 4 log 10TCID50/ml. In all cases virus levels were maintained for 4 
days. By ten days p. i: no virus was detectable in the blood. In the case of 
LGA39 I and M 152 virus was detected in the urine at day 30 although this 
was not a consistent finding. 
In all fatal infections virus was detected in all major organs of the 
body at levels greater than in the blood (Fig. 59). 
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Fi . 59 INFECTIOUS LGA 391 AND MOPEIA VIRUS CONCENTRATIONS 
RECOVERED FROM SERA AND TISSUES OF MORIBUND 2-4 WEEK 
ADULT PORTON STRAIN MICE OBTAINED 7-10 DAYS AFTER I. C. INOCULATION 
WITH 3 LOG 10 TCID50 
Log, OTCID 50/g/ml 
345678 
Serum 0 
Lung 0 
Spleen 0" 
Pancreas 0 
Lymph Node 0" 
Adrenal "0" 
Kidney 0" 
Liver 0". 
Heart 0" 
Brain 00 
LGA 391 " 
M 150 0 
A similar pattern to that shown by Fig. 59 was found with M20410, 
M 152, and Z478 viruses. 
3.6.4. Histopath oio oy 
Mice inoculated by the i. p. route with LGA 391, M 152, M 150, M20410 
and Z478 demonstrated no histological lesions in any organ despite the 
extensive virus recovery. The response to the i. c. route of infection 
demonstrated widespread brain lesions in mice between days 7 and 14 with 
all viral infections, LGA 391 and M 148 viruses causing the most severe 
lesions. M 150 and Z478 were as virulent although the brain was not so 
severely affected. Brain lesions included a variable degree of lymphocytic 
meningitis and perivascular cuffingand in some cases the choroid plexus 
was infiltrated by lymphocytes. Other organs were not affected. 
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3.6.5. Clinical Biochemistr 
To evaluate the significance of altered serum enzymes and substrate 
values during infection, normal values were first established from the 
Porton mouse model. The normal values are tabulated in Table 36. 
0 
TABLE. 36. NORMAL VALUES FOR SOME SERUM ENZYMES AND 
wow 
SUBSTRATES IN PORTON 'MICE* 
Enzyme/Substrate Normal value +SE Units 
GOT 79.8 14.7 IU/I 
GPT 59.8 4.42 if 
LDH 2600 68.2 of 
a-HBDH 1170.1 64.4 It 
CK 100 9.5 
y-GT ND - - 
AP 125 14.4 mg/ 100 ml 
Creatine 0.12 0.03 
Urea 186.8 21.14 
Total protein ND - - 
Triglycerides ND - - 
Cholesterol ND - - 
*Each 
value represents the arithmetic mean of 30 samples. 
Both serum glutamic oxaloacetic transaminase (GOT) and pyruvic 
transaminase (GPT) are elevated during Lassa and Mopeia infections of 
adult mice initiated by the i. c. and 'i. p. routes. Peak GOT levels are 
reached on day 6 p. i. of a fatal i. c. infection falling to normal by day 8 p. i. 
16, x 
(Fig. 60) after which death occurrd. In the case of the non-fatal i. p. 
infection a moderate rise in activity was demonstrated over the first 6 
days p. i. gradually returning to normal by day 14 p. i. GPT activity after 
both Lassa and Mopeia infections showed marked increases, reaching a 
peak by day 5 p. i. and dramatically decreasing to normal on day 6 p. i. 
130 
]s " 
aý p 
" 22 
A 
'o 
so Sv 
2468 
Days post infection 
lb) 
[]-13 
24B8 10 12 14 
Days post iafectlon 
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thereafter giving an irregular pattern before death. A similar initial rise 
in activity was noted with the non-fatal i. p. infections up to day 2 p. i., 
thereafter falling to normal over the following 8 days. 
The isoenzymes LDH and HBDH both decreased from their normal 
levels (Figs. 62 and 63) after the i. c. and i. p. inoculation. In the case of 
LDH the serum value decreased betweeen 80-90% with each virus within 
the first 2 days p. L Thereafter there was a mild recovery before death or, 
in the case of the non-fatal i. p. infection, no recovery was observed until 
21 days p. 1. which was consistent with the gross clinical observation of the 
animals. 
Creatine kinase activity demonstrated a late response in either LGA 
391 or Mopeia= fatal : _i. c.. 
infections. _ 
Normal levels (100 IU/1) were 
maintained during the first 6 days p. i. at, which time they rose sharply (Fig. 
64) to 350-400 IU/l. M150 and M20410 only reached levels of between 
150-200 IU/1. Following this rise they returned to normal by day 8 p. i. In 
the case of the non-fatal i. p. infection all viruses caused an initial rise 
above normal reaching peak levels (200-400 IU/1) by day 2 p. i. returning to 
normal (100 IU/1) by day 12 p. i. 
Alkaline phosphate rose from its normal level and reached maximum 
levels between days 4-6 after i. c. infection and decreased by day 8 p. i. to 
normal levels. This pattern was similar with both LGA 391 and Mopeia 
infections. AP activity with the non-fatal i. p. infections demonstrates 
(Fig. 65) an initial rise in values reaching a peak by day 2-3 p. i. and being 
maintained at that level until day 8 p. i. Normal values were , observed 
from day 9 post infection. Serum creatinine and urea levels remained 
within normal limits. 
3.6.6. Antibody_ levels in blood 
Within the period of fatal i. c. infections - no - 
CF. T or . neutralising 
antibodies were detected. Immunofluorescent antibodies were detected 
during the course of the infection. With M 152 and LGA 391 IFA antibodies 
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Porton strain mice (3 wks) inoculated i. c. (a), i. p. (b) 
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were first detected on day 2 p. i. and reached maximum levels on day 9 p. i. 
of 1: 128 and 1: 512 respectively. Mopeia viruses 20410,150 and 478 
initiated a detectable IFA response on day 4 p. i. reaching between 1: 512- 
1: 4096 (Figs. 57 and 58). 
With the non-fatal i. p. initiated infection IFA antibodies were 
detected between day 2 and 4 p. I. (Figs. 57 and 58) reaching maximum 
levels (1: 2048-1: 4096) between day 10 and 12 p. i. 
Homologous neutralization antibodies were not observed during the 
21-day study with each virus. In response to Mopeia infection, the 
production of anti-Lassa neutralization antibodies was not observed. 
3.7. TRANSMISSION OF LASSA. AND- MOPEIA - VIRUSES TO DUNKIN- 
HARTLEY GUINEA PIGS 
Tissue culture pools of stock virus were inoculated into male and 
female guinea pigs weighing 350-500 g. 
3.7.1. Susce tibilit 
The susceptibility of guinea pigs to different routes of inoculation are 
shown in. Table 37. No difference was observed between males and 
females. 
LGA391 virus killed 7090 of the guinea pigs inoculated by i. p., s. c. and 
i. m. routes with 3 _log 10TCID50. 
By comparison, M 152 was the only 
Mopeia virus that demonstrated any lethal effect on guinea pigs (Table 37) 
when inoculated with >3 log 1OTCID50. All guinea pigs surviving infection 
(Table 37) seroconverted by the IFA tests and resisted further challenge 
with the homologous virus, suggesting that inapparent infections had 
occurred. 
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TABLE 37. INFECTIVITY AND LETHALITY OF LGA391 AND MOPEIA VIRUS 
STRAINS IN GUINEA PIGS (DUNKIN-HARTLEY) INOCULATED 
I. P., S. C. OR I . M. 
Virus Inoculum No dead/No Mean day of Sero Resisted a 
TCID50/0.1 ml treated (%) death (range) converted challenge 
LGA391 >105 22/30(73.3) 15.5(11-17) 30/30 30/30 
103 21/30(70) 17.1(16-19) 30/30 30/30 
lot 0/30 30/30 30/30 
M152 >105 12/30(40) 16(10-16) 30/30 30/30 
103 9/30(30) 18(15-20) 30/30 30/30 
101 0/30 30/30 30/30 
M150 >I05 0/30 - 30/30 30/30 
103 - 0/30 - 30/30 . 30/30 
101 . 0/-30 - 30/30 30/30 
M20410 >105 0/30 - 30/30 .. 
30/30 
103 0/30 - 30/30 30/30 
101 0/30 - 30/30 30/30 
Z478 >l05 0/30 - 30/30 30/30 
103 0/30 - 30/30 30/30 
101 0/30 - 30130 . 30/30 
a.. Lived 45 days or. longer after. i. p. or s. c. inoculation of 
3 log OTCID50 with homologous virus. 
3.7.2. Clinical observations 
Guinea pigs became febrile after infection with LGA 391 or Mopeia 
viruses (Fig. 66a and b). The severity of the pyrexia was dependent . on the 
infective dose and strain of virus. The route of infection, s. c., i. p. or i. m., 
did not alter the outcome of the disease. 
Infecting guinea pigs with LGA39 $ or M152 at a level between 2-6 
logi0TCID50 demonstrated two pyrexial responses (Fig. 66a and b), one 
following a course of infection leading to recovery, the other being lethal. 
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Following a two day incubation period guinea pigs became febrile, 
gradually reaching a peak of of 40.9 -4i. 1°C on day 10 p. i. persisting until 
day 16 p. i. Normal temperature levels (38.2 - 38.9°C) were recorded by 
day 22 p. i. in guinea pigs which recovered. As a result of a lethal 
infection, high temperatures persisted from day 10 to day 15. On day 16 
there was a marked fall in temperature to 39.0°C - 39.2°C which 
consistently signalled the animals' death. A lethal infection did not occur 
with LGA391 or M 152 when the infective dose was <I log I0TCID50 but a 
febrile reaction was observed similar to those produced with higher 
infective doses (Fig. 66a). Peak pyrexia (41.1°C) was observed at day 10, 
remained until day 15 and fell to normal levels by day 20. 
A mild febrile illness also occurred when guinea pigs were inoculated 
with M150, M20410 and Z478 viruses but with no lethal outcome. The 
temperature responses were more dependent upon the dose of infection. 
At infective doses ,6 log I OTCIDS0, there was a similar 2 day incubation 
period. Pyrexia developed after the second day and peaked on day 10 p. i., 
with M 150, Z478 and M20410. No plateau was observed as with LGA391 or 
M 152, and the temperature gradually returned to normal by day 14 in each 
case (Figs. 66a and b). Using an infective dose of 4 log I OTCID50, a similar 
pyrexial pattern was observed (Fig. 66b). Temperature peaks were lower 
but still occurred on day 10 p. i. The fall to normal temperature levels took 
4 days longer. Observations on guinea pigs receiving 2-3 Iog 10TCID50 
demonstrated a marked depression in- febrile response, peak temperatures 
(39.6°C) occurring between day 6 -10 p. i., falling to normal by day 16 p. i. 
A similar picture was observed when guinea pigs were inoculated with I 
log 0TCID50 although there were small alterations in responses. Z478 
infection caused a rapid onset of febrile illness peaking at day 6 at 40.2°C, 
returning to normal by day 10 p. i. Guinea pigs inoculated with M 150 and 
M20410 gave rise to a mild febrile illness peaking at day 6, returning to 
normal by day II -12 p. i. 
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During the course of all the infections the guinea pigs were inactive 
during the febrile phase of illness and reduced their intake of food and 
water, which affected their weight and general condition. 
Noticeably, 
those guinea pigs inoculated with LGA39 l and M152 were the most 
severely affected, even those which survived. The animals did not put on 
any weight during the first 10 days p. i., after which there was a gradual 
weight. reduction to 190-240g until death. Those animals which recovered 
began gaining weight from day 22 p. i. (Fig. 67). The weight of guinea pigs 
inoculated with M150,, M20410 and Z478 did not increase from average 
(300-375g) during the first 14 days p. i. All started to gain weight after 14 
days p. 1. (Fig. 68) but not as rapidly as the controls. 
3.7.3. Virus levels in blood and tissue 
To characterize the LGA 391 and Mopeia virus infections of guinea 
pigs, comparative virus titres were made among groups of 20 guinea pigs 
inoculated with 0.1 ml 3 log 10 TCID50 and bled daily until day 21 or until 
they died (Figs. 69 and 70). 
In the case of LGA391 serum viraemia reached peak levels during the 
first 8-10 days p. 1. both in lethal and surviving guinea pigs. In lethally 
infected guinea pigs, the viraemia reached >4 log10 TCID50/ml and 
persisted above 2.5 loglo TCID50/ml until death. In guinea pigs which 
survived, peak viraemia of 3.5 log 10 TCID50/ml was achieved by day 8 p. i., 
and persisted to day 10 p. i., thereafter declining to undetectable levels by 
day 18 p. 1. (Fig. 69). Similar viraemic patterns were observed in guinea 
pigs infected with M 152, except that the percentage lethalities were 
considerably less than with LGA391 (Table 37). 
Viraemia in guinea pigs infected with the Mopeia viruses 
demonstrated little or no virus (<101 - 101.5 TCID50/ml) by day 4-5 p. i. 
returning to undetectable limits during the remainder of the 21 day study 
(Figs. 69 and 70). The demonstration of serum viraemia proved 
inconsistent in guinea pigs infected with any of the Mopeia viruses. 
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To obtain additional insight into the tissue tropisms and histological 
lesions produced by LGA391 and Mopeia- viruses, various organs were 
removed from the guinea pigs. In the case of LGA39 f. infected animals, 
this was done when the animals were found to be moribund (day 14-18). 
Tissues were removed from M150, M20410 and Z478 guinea pigs sacrificed 
through the course of infection. Infectivity data for the various tissues 
suggested that LGA391 replicated in all of the extraneural tissues 
examined but not in the brain. High titres of LGA391 were found' early 
(day 10-14) in the mesenteric lymph node, spleen and lung. In the 
moribund animals examined 14-13 days after infection, the highest titres of 
virus were. recovered from the lung, liver, mesenteric lymph node and 
spleen, followed by the- adrenals, kidney, heart and salivary gland (Fig. 71). 
Virus recovery from the brain was too low a titre to suggest blood-borne 
virus. 
Mopeia viruses were only recovered at low levels from the liver, 
spleen and mesenteric lymph nodes even in those guinea pigs demonstrating 
low serum viraemia (Fig. 71). Virus recovery was variable and only made 
during the 4-6 day period post infection; thereafter no virus was detected. 
The isolation of Mopeia viruses from some guinea pigs was never achieved 
throughout infection even though IF antibody was detected. This pattern 
was characteristic of M150, M20410 and' Z478. The M152 virus infected 
guinea pigs that survived, demonstrated the same pattern as the other 
Mopeia virus infections. However in those guinea pigs displaying a lethal 
infectiörr, tissue virus levels-mimicked LGA391. Virus was detected 
primarily in the spleen, liver, mesenteric lymph node and adrenals at levels 
between 2-4 log 10 TCID50/ml/g of tissue. Other tissue isolates could be 
attributed to blood-borne virus. 
3.7.4. Antibod levels in blood 
Humoral antibodies to LGA 391 and, Mopeia"viruses were measured in 
guinea pigs inoculated with 3 log ip TCID50 
by the i. p. route. 
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Log10 TCID50/ß 
Serum 
Lung 
Spleen 
Adrenal 
Kidney 
Liver 
Heart 
hies L. N. 
Brain 
Fig-71 Comparative concentrations of LGA 391 ( U) 
virus and Mopeia viruses (® ) recovered from serum 
and tissues of guinea pigs inoculated i. p. with 
3 log 
10 
TCID 
so 
/ml. 
Titres are geometric means (± standard error) 
of (a) 10 moribund guinea pigs of LGA 391 (day 
14-18), and (b) 10 guinea pigs of M150 at the height 
of serum viraemia (day 4-6) as no virus was detected 
before or after this time. 
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Immunofluorescent antibody (I. F. A. ) were first detected between day 6 and 
8. All subsequent development of I. F. antibodies followed a similar 
pattern as demonstrated in Table 38. The IFA -titres reached I: 
64 or 
more by day 10 Lp. and l: 512 to I: 2048 by day 16 p. i. with all the 
strains of Lassa and Mopeia virus. 
TABLE 38. APPEARANCE OF IMMUNOFLUORESCENT ANTIBODIES IN 
GUINEA PIGS 
LG 
INFECTED WITH 3 LOG 
A 391 AND MOP I VI 
TCID50 OF 
E A R 
VIRUSES 
Days p. 1. LGA391 M 152 M 150 M 20410 Z478 
4 8 8 8 8 8 
6 .8 16 8 8 8 
8 64 256 16 16 8 
10 256 ND 64- 64 128 
12 512 512 256 ND 1024 
14 512 ND ND 1024 
16 ND 1024 1024 1024 2048 
18 2048 ND 512 1024 4196 
20 4196 2048 4196 -2048 2048 
22 8392 ND "8392 2048 2048 
24 . ND 4196 8392 2048 2048 
26 ND 4196 8392 2048 2048 
28 4196 4196 8392 2048 2048 
30 4196 4196 8392 2048 2048 
The cross -im muno fluorescent capabilities of, hyperimmune guinea pig 
sera are dealt . with 
in Section 3.4. 
The study of neutralization (N) antibody did not show the same 
consistency of production as with IFA. N-antibody titres were first 
detected around day 60 p. i. in guinea pigs inoculated with 3 log10 TCID50 
(LGA 391) and increased with time for 140 days, the last time tested (Table 
39). N-antibodies were first detected on day 15 p. i. in animals inoculated 
with all the Mopela viruses including M 152. The N-antibody titres began 
to rise between day 25 and 30 p. i. and increased with time for 80-90 days, 
148 
remaining at their peak till 140 days p. i. No anti-Lassa neutralising 
antibodies were found in any Mopela iec& ed guinea pigs during the 140 
days of study. 
TABLE 39. THE APPEARANCE OF HOMOLOGOUS NEUTRALIZING ANTIBODIES IN 
GUINEA PIGS INOCULATED WITH LGA 391 OR MOPEIA VIRUSES 
NEUTRALIZATION INDEX 
Days 
Virus 10 15 20.25 30 35 60 90 120 140 
LGA391 0 0 0 0 0 0 2.1 3.2 3.5 3.5 
M152 0 0 0 0 0 D 1.0 2.8 3.0 3.2 
M 150 0 0 0 0 0.5 ND ND 2.0 3.2 3.2 
M20410 0 0 ND . 0.6 1.0 ND 1.2 2.0 3.2 3.2 
Z478 0 0 . ND 0.8 1.2 ND 1.7 2.7 2.7 2.7 
3.7.5. Clinical Biochemistry 
To evaluate the significance of altered plasma enzymes and substrate 
values as a result of arenavirus infection, normal values for each 
parameter were first calculated for the Dunkin-Hartley Guinea Pig model 
(Table 40). 
TABLE 40. NORMAL VALUES OF SERUM ENZYMES AND SUBSTRATES 
IN DUNKIN-HARTLEY GUINEA PIGS 
Enzyme/Substrate Normal value* +SE Units 
GOT 125.60 40.4 IU/I 
GPT 73.96 12.6 it 
LDH 361.34 33.1 
a-HBDH 140.3 23.1 
CK 448 63.4 
Y-GT 23.32 7.1 " 
AP 248.8 33.4 
Creatine 0.3 0.1 mg/ 100ml 
Urea 55.08 2.2 " 
Total protein 5.30 0.2 of 
Triglycerides 100.75 11.1 it 
Cholesterol 74.76 10.4 
Each value represents analysis of 30 samples. -149'" 
The alterations in enzyme levels in guinea pig serum reflected the 
degree of clinical illness caused by LGA 391 and Mopeia viral infections 
(Figs. 72-80). These can be divided into three categories and can be 
attributed to the various strains arenavirus. 
Degree of change 
Highly significant 
Moderately significant 
Insignificant 
Virus 
LGA391, M 152 
LGA391, M 152 
M 150, M20410, Z478 
The GOT, GPT, LDH, a-HBDH, AP and CK serum enzymes all 
demonstrate significant alterations to LGA391 and M'l52 infections, 
.. resulting 
in a fatal or non-fatal infection and each of the above enzymes 
reflected the ultimate course of the disease (Table 41). 
In both fatal and non-fatal infections enzyme levels start to rise 
between days 2 and 3 p. i. Maximum levels were reached 5 days p. i. in 
fatal infections (Figs. 72,74,76,78,80a). A more gradual course was 
observed with non-lethal infections, peak levels being reached between 
days 6 and 9 (Table 41). As will be noted in. both table and figures, enzyme 
levels. reached, higher levels in lethal infections and were maintained 
throughout the remainder of the infections. Enzyme levels returned to 
normal in surviving guinea pigs between days 10 and 18 p. i. dependent on 
enzyme (see Table 41 and Figs. 72-80). The CK value in fatal cases 
increased 10-fold. . 
The peak value was achieved between 7 and 8 days p. i. 
During the same period in non fatal LGA 391 and M 152 infections the CK 
value doubled, returning to normal by day 10 p. i. The YGT, Creatine, Urea, 
Total Protein, Triglycerides and Cholesterol level did not alter 
significantly from normal. 
Only the CK values demonstrated any noticeable increase with 
M20410, M150 and Z478 viral infections between day 7 and 8 p. i. (Fig. 80b), 
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Fig. 72 GOT activity in the sera of guinea pigs inoculated i. p. 
with 3 log10 TCID50 of LGA 391 and M152 viruses giving a 
lethal () and non-lethal (----) infection. 
Q QM152 f ALGA 391' 
EJ---- EM152 A---- ALGA 391 
------I Normal values 
Each point represents the arithmetic mean of 25 guinea pigs. 
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Fig. 73 GOT activity in the sera of guinea pigs inoculated i. p. 
with 3 log10 TCID50 of Mopeia viruses. 
AM150 RM20410 *Z478 
------I Normal values 
Each point represents the arithmetic mean of 25 guinea pigs. 
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Fig. 74 GPT activity in the sera of guinea pigs inoculated i. p. 
with 3 log TCID of LGA 391 and M152 viruses giving a 
lethal ( 10) and5non-lethal (----) infection. 
QQ M152 A, & LGA 391 
L 1--- Q M152 AL----, & LGA 391 
------I Normal values 
Each point represents the arithmetic mean of 30 guinea pigs. 
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Fig-75, GPT activity in the sera of guinea pigs inoculated i. p. 
with 3 log10 TCID50 of Mopeia viruses. 
fM150 RM20410 *Z478 
------I Normal values 
Each point represents the arithmetic mean of 25 guinea pigs. 
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Fig-76 LDH activity in the sera of guinea pigs inoculated 
i. p. with 3 log10 TCID50 of LGA 391 and M152 viruses 
giving a lethal () and non-lethal (---) infection. 
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Each point represents the arithmetic mean of 30 guinea pigs. 
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Days post infection 
Fig-77 LDH activity in the sera of guinea pigs inoculated 
i. p. with 3 log10 TCID50 of Mopeia virus 
* M150 O M20410 QZ478 
Each point represents the arithmetic mean of 30 guinea 
pigs. 
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Fig. 78 aHBDH activity in the sera of guinea pigs inoculated 
i. p. with 3 log10 TCID50 Lassa and Mopeia viruses. 
(a) A LGA 391 lethal; Q QM152 lethal. 
0 
---. LGA 391 non-lethal; jJ---I1M152 non lethal. 
(b) * M152 QZ478 OM20410 
I Normal values 
Each point represents the arithmetih mean of 30 guinea pigs. 
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Fig. 79 AP activity in sera of guinea pigs infected with 
Lassa and Mopeia viruses. 
(a) Lethal infections: AA LGA 391; Q QM152 
Non-lethal infections: G. ----.. ALGA 391; 
0----911152 
(b) Q QM20410; AA M150; ** Z478 
------I Normal values 
Each point represents the arithmetic mean of 30 guinea pigs. 
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Fig. 80 CK activity in sera of guinea pigs infected with Lassa 
and Mopeia viruses. 
(a) Lethal infections 
Non-lethal 
(b) Q'-OM20410 
ALGA 391; 
D ALGA 391; 
A-AM150 
Q--DM152 
0-- RM152 
*-*Z478 
--------I Normal values (± SE) 
Each point represents the arithmetic mean of 30 guinea pigs 
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TABLE 41. ALTERATION IN ENZYME ACTIVITIES IN SERA 
OF GUINEA PIGS AFTER INFECTION WITH LGA391 OR M 152 
Enzyme Virus Infection Peak value Day Returned to Normal 
Normal/Day value 
" GOT LGA39I Lethal 295 5 No 73.4 
it Non-lethal 120 8 Yes/ 14 If 
GOT M 152 Lethal 255 5 No 73.4 
of it Non-lethal 125 8 Yes/ 18 it 
GPT LGA391 Lethal 108 5 No 46.8 
to " Non-lethal 60 9 Yes/ 12 it 
GPT M 152 Lethal 114 5 No 46.8 
if is Non-lethal 90 8 Yes/ 12 if 
LDH LGA39I Lethal 1450 5 No 361.34 
of Non-lethal 1200 8 Yes/ 10 
LDH M 152 Lethal 1575 5 No 361.34 
of of Non-lethal 1400 6 Yes/ 10 of 
aHBDH LGA391 Lethal 900 5 No 140.3 
if it Non-lethal 675 8 Yes/ 14 
allBDH M 152 Lethal 975 5 No 140.3 
to Non-lethal 700 6 Yes/ 10 
AP LGA391 Lethal 500 4 No 248.8 
Non-lethal 400 4 Yes/ 10 It 
AP M 152 Lethal 475 10 No 248.8 
of if Non-lethal 450 4 Yes/ 10 it 
CK LGA 391 Lethal 1300 7 No 448.0 
to to Non-lethal 650 7 Yes/ 10 
CK M152 Lethal 1500 7 No 448.0 
11 Non-lethal 750 7 Yes/ 10 to 
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returning to normal by day 10 p. i. There was no significant alteration with 
these same viruses in the levels of the remaining serum enzyme and 
substrates studied. 
3.7.6. Histopatholy 
" The distribution and degree of histological damage observed in 
various tissues was less than would have been predicted on the basis of 
LGA 391 infectivity and biochemical data. 
Lung tissue from ten guinea pigs infected with LGA 391 revealed 
lesions. There were large coalescing areas of oedema and fibrin formation 
in alveoli, together with infiltration by macrophages and lymphocytes. 
Some of the zones were also intensely congested and even haemorrhagic 
and there was considerable perivascular oedema. There was no necrosis of 
alveolar walls and no exudate in airway lumina. The alveolar infiltrate 
contained a higher proportion of lymphocytes at day 15 than on the 8th 
day. 
Lesions were present in the liver and consisted of small areas of . 
sinusoidal haemorrhage, having no consistent lobular distribution. There 
were no degenerative changes in hepatic parenchymal cells in the 
haemorrhagic areas. 
Three of the ten s leen sections contained necrotizing lesions of 
varying severity. There were also testicular changes found in two guinea 
pigs. These consisted of active vasculitis of the blood vessels of the tunica 
albuginea, tunica vaginalis and the testis substance. Affected vessels had 
extensive infiltration of the wall and 'adventitia by lymphocytes and 
histiocytes though the intima was undamaged. 
Four kidney sections displayed acute necrotizing nephritis. Although 
LGA 391 clearly replicated in the adrenal and salivary glands no 
remarkable lesions were seen in these tissues. 
Brain tissues from the guinea pigs examined contained no lesions. 
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In the guinea pigs inoculated with M 152 liver and lung changes were 
present and histologically identical to that described for LGA 391. 
Groups of tissues examined from guinea pigs inoculated with M 150, 
M20410 and Z478 between days 5 and 40 had no lesions in any organ. 
ýy 3.7.7. f". hallenge of Mopeia-immunised guinea pigs with LGA 391 
Groups of 10 guinea pigs immunised with either M150, M20410 or 
Z478 (3 log 10 TCID50) were challenged with LGA 391 
(3 log 10 TCID50) at 
various times after immunisation. Studies on their susceptibility to 
challenge with LGA 391 virus were based on the following parameters: 
(a) clinical illness/or mortality 
(b) pyrexia 
(c) serum viraemia 
(d) serum enzymes and substrates 
(e) IF antibody 
(f) neutralization antibody 
(g) histopathology 
It was observed that no matter which combination of inoculation 
routes was used for challenge and/or immunisation, the course of events 
was identical (Table 42). The latter statement also applies to all three 
immunising viruses, M 150, M20410 and Z478. 
TABLE 42. OUTCOME OF IMMUNISATION/CHALLENGE PROTOCOL 
Route of immunisation 
Route of 
challenge i. p. S. C. i. d. -ve control 
i. p. protection protection protection No protection 
S. C. if of if of 
i. d. if it of n 
The detailed comments on the outcome of challenging an immunised 
series of guinea pigs with LGA 391 are based on immunising and 
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challenging s. c. The following data describes the outcome of immunising 
guinea pigs s. c. with 3 log ,0 TCID50 of M 150 and challenging with 
3 log 10 
TCID50 LGA 391 at various times post immunisation. These results can 
equally apply to guinea pigs immunised with M20410 and Z478. 
Simultaneously, a control group of animals not previously inoculated with 
Mopeia virus, received the same dose of LGA 391. All groups were kept 
under observation for 84 days after challenge. Clinical signs and mortality 
rates were recorded (Table 43, Fig. 81) as were estimations of antibody, 
virus and serum biochemistry responses. 
The susceptibility of guinea pigs immunised with M 150 and challenged 
at different times with LGA 391 are shown in Table 43. Partial protection 
was observed up to 21 days post immunisation, after which complete 
resistance was established. 
TABLE 43. NUMBER OF CLINICALLY ILL AND/OR DEAD 
GUINEA PIGS IMMUNISED WITH M 150 AND CHALLENGED WITH 
LGA 391 AT VARIOUS TIMES POST IMMUNISATION 
Days post No. of animals No. of control 
immunisation affected animals affected 
7 10/10 10/10 
14 It to 
21 5/10 
28 0/10 
35 "" 
42 it " 
56 
70 
84 " 
To analyse the origin of protection, guinea pigs at day 48 post M 150 
immunisation were challenged s. c. with LGA 391 (3 log 0 TCID50), since no 
cross-reacting neutralization antibodies were detectable in guinea pigs 
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inoculated only with M 150 (see Section 3.7.4 and Table 39). The level of 
virus found in the blood and tissue of LGA 391 control guinea pigs was high 
(Figs. 69 and 71). In contrast, no Lassa virus could be isolated from 
animals immunised with M 150 virus. With guinea pigs infected with M 150 
alone no virus could be detected. Although viral assays were performed in 
Vero cells, various tissue homogenates from challenged animals were also 
put into adult mice i. c. and guinea pigs i. p., with negative results. 
The results (Fig. 81) also demonstrated the immunological responses 
of M150 immunised guinea pigs when challenged 48 days later with LGA 
391. The IFA levels to Mopeia and LGA 391 before challenge were similar 
(1 / 1028 - 1/2056). Homologous neutralization antibodies to M150 were 
estimated to give an LNI of 2.4 while heterologous antibodies to LGA 391 
were not demonstrated. Normal guinea pigs infected with M 150 did not 
have any demonstrable neutralization antibodies to LGA 391 virus. M 150 
immunised animals challenged at 48 days post infection with LGA 391 gave 
rise to demonstrable anti-neutralizing Lassa antibodies 6-10days post 
challenge, reaching an LNI of 1.4 after 21 days. 
As a result of challenge no febrile illness, no serum viraemia was 
recorded throughout the post challenge period of study. Those serum 
enzymes expected to alter (see Section 3.7.5. ), GOT, GPT, LDH, aHBDH,. 
AP, and CK did not show any alterations from normal. 
The gross pathology and histopathology carried out on liver, spleen, 
heart, lymph nodes, kidney, adrenals, brain and muscle revealed no lesions 
or other abnormalities. Urine removed at autopsy from LGA 391/M 150 
animals contained no Lassa or Mopeia viruses. 
3.8. PRELIMINARY STUDIES ON TRANSMISSION OF LASSA AND 
MOPEIA VIRUSES TO RHESUS MONKEYS 
Although Rhesus (Rh) monkeys have not been implicated in the 
transmission of Lassa infections, it was thought important to infect 
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monkeys experimentally with Lassa and Mopeia viruses to define their 
comparative pathogeneses and determine whether this would provide a 
useful model for evaluating methods of therapy and protection for use 
in 
human Lassa virus infection. 
3.8.1. Transmission of LGA 391 virus 
A male Rhesus monkey at 6.8 Kg was inoculated i. p. with 0. I ml of 
LGA 391 tissue culture fluid containing 3 log l0 TCID50" 
The progress of 
the disease was monitored daily by rectal temperature and a blood sample 
taken. 
3.8.1.1. Clinical observations 
Following a 2-day incubation period the monkey became febrile on 
about the third day post infection with a temperature ranging from 40.2 - 
40.5°C (Fig. 82). The pyrexia persisted until the terminal stages of the 
infection when the temperature became sub-normal (38.6°C) on days 9-10. 
By day 4 the monkey was quiet, it was not eating or drinking and normally 
lay on the floor of the cage only sharply responding in the early stages to 
provocation (days 4-6 p. i. ). By day 6 no amount of provocation stimulated 
any response. No exterior markings or rash became evident throughout 
the duration of the illness. Excessive salivation was evident during days 5- 
7 but contained no virus. Body weight was reduced by 10-15 per cent. 
Slight diarrhoea was evident on days 6 and 7 post infection and death 
occurred on day 9. 
3.8.1.2. Virus levels in the blood 
Virus was detected in the blood on day 4 reaching maximum levels of 
104.6 TCID50/ml on day 6 which was maintained until death. 
3.8.1.3. Virus levels in the tissues 
The concentration of infectious virus recovered from tissues showed 
high concentrations of Lassa in most organs of the body (Table 43a). It 
was not possible to determine whether some of the organs contained Lassa 
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virus because of the high concentrations of virus present in the blood. 
However, virus was recovered in titres higher than those in blood from all 
visceral tissue tested including lung, adrenal glands, spleen, pancreas and 
lymph nodes. Although the faeces never contained any virus, some was 
" isolated in the urine (104.5TCID50/ml) and peritoneal fluid 
(I02.3TCID50/ml). 
TABLE 43a. LEVELS OF VIRUS IN VARIOUS TISSUES FROM 
RHESUS MONKEY EXPERIMENTALLY INFECTED WITH LASSA VIRUS LGA 391 
Organ Viral titre at time of death (day 10) 
Blood 4.6 
Adrenal glands 8.2 
Spleen 7.8 
Liver 8.4 
Thymus 6.4 
Lungs 8.4 
Heart 8.3 
Pancreas 5.6 
Salivary glands 7.7 
Bladder 4.5 
Duodenum 8.4 
Pleural fluid 2.3 
Kidney 8.7 
N. B. Data on log 10 TCID50/ml or log 10 TOD 50/9 
3.8.1.4. Gross necropsy findings 
There were no significant gross pathological lesions or any obvious 
haemorrhagic manifestations. The lungs did show some degree of 
consolidation. Peritonitis was in evidence together with early adhesions 
which involved the liver and spleen. The liver and spleen were slightly 
enlarged and friable. Mesenteric lymph nodes were also enlarged. 
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3.8.1.5. Histo atholo 
In the liver there was evidence of hepatocellular necrosis 
accompanied by slight infiltration of inflammatory cells. The small foci 
of necrosis was randomly distributed throughout the parenchyma. In a 
typical foc%4 hepatocytes demonstrated varying degrees of degeneration 
with some evidence of eosinophilic spherical inclusion bodies. Mitotic 
figures were seen in some hepatocytes together with binucleation and 
nuclear pleomorphism. 
The kidney showed renal tubular necrosis. Tubular lumina contained 
necrotic cells with aggregates of degenerating nuclei. There was limited 
congestion, small inter-tubular haemorrhages in the blood vessels of the 
cortex and outer medulla. Inclusion bodies could not be demonstrated. 
Cellular infiltration was absent. 
The s llenic white pulp contained lymphoblastic re-population of the. 
B-cell region but still contained eosinophilic necrotic material. Lymphoid 
tissue necrosis of the Malpighian corpuscles was present to some degree 
and lymphocytic depletion appeared evident in some follicles together with 
some congestion of the red pulp. 
There was generalised depletion of lymph nodes. The mesenteric 
lymph node contained intracellular inflammation, possibly macrophages or 
reticuloendothelial cells. There was some germinal centre necrosis. 
The lungs demonstrated moderate foci of necrosis of septa with some 
intra-alveolar oedema formation and haemorrhage into the alveoli. There 
was evidence of interstitial pneumonia. It was characterized by alveolar 
wall thickening, the result of deposition within septa of eosinophilic 
material and mononuclear cell infiltrations. The septa also contained 
cellular debris, which was suggestive of endothelial cell necrosis, mixed 
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with infiltrate. The epithelium of bronchi and bronchioli remained 
unaffected. There was thrombosis and fibrin deposition in pulmonary 
vesicles. There was no damage found to the walls of affected. 
The adrenal glands contained multifocal adenocortical necrosis 
principally in the zona reticulinus and zona fasciculata. Within and 
adjacent to foci of necrosis were adenocortical cells with eosinophilic 
cytoplasmic inclusions. There was little congestion of the blood vessels of 
the cortex and medulla. 
The small intestine had erythrocytes and macrophages in the lamina 
propria. Minimal perivascular mononuclear cell infiltration was observed 
in the sub-mucosa. 
Within the gastrointestinal tract there was no congestion observed in 
the ileum or large intestine. There was no necrosis of the surface 
epithelium, crypt tissue or lamina propria. There was a little necrosis 
found in the mucosa which involved in some instances the Pey' er's patches. 
No irregularity was found in the villi. 
The myocardium showed acute myocarditis with vacuolar 
degeneration and necrosis of myocardial fibres. There was moderate 
inflammatory infiltration primarily composed of polymorphonuclear 
leukocytes and mononuclear cells. 
No changes were found in other tissues, namely the pancreas, salivary 
glands or skeletal muscle. 
3.8.1.6. Clinical Biochemistry 
Normal values of plasma enzymes and substrates were first 
calculated in a series of samples obtained from normal Rhesus monkeys 
(Table 44). 
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TABLE 44. NORMAL VALUES OF SERUM ENZYMES AND SUBSTRATES 
IN RHESUS MONKEYS 
Enzyme/Substrates Normal values* tSE Units 
GOT 50.2 12.50 IU/I 
GPT 28.2 2.50 of 
LDH 850.0 28.70 of 
a-HBDH 585 54.74 it 
CK 287.65 41.02 It 
Y-GT 36.70 5.30 if 
AP 458.37 26.25 of 
Creatine 0.68 0.12 mg/100ml 
Urea 38.39 4.82 If 
Total protein 8.4 1.2 it 
Triglycerides 63 5.3 to 
Cholesterol 95.5 5.2 if 
*Each 
value represents analysis of 30 samples. 
Both GOT and GPT were elevated during LGA 391 infection. 
Elevation of GOT began to rise on day I p. i. reaching a peak level of 348 
IU/I on day 8 and 9. GPT levels rose on day 4 p. i., reaching 212 IU/I on day 
8 (Fig. 33a). Normal value in Rh monkeys of GOT and GPT are shown in 
Table 44). 
The isoenzymes LDH and aHBDH both decreased from their normal 
levels. In the case of LDH the serum value decreased from 1378 to 547 
IU/I by day 4 p. i. and by day 9 the level had risen to 3528 IU/1 (Fig. 84a). 
A similar pattern was observed with allBDH which remained stable at 836 
IU/1 for the first 2 days, falling to 368 IU/1 by day 4. The level of aHBDH 
rose to 2980 IU/1 by day 9 p. i. In Rh monkeys the normal values for LDH 
are 850 IU/1 +/- SE 28.7, and for aHBDH 585 +/- SE 300. 
Creatine kinase (CK) activity had a biphasic response. During the 
first phase its value rose from a normal value of 230 +/- SE 41 to 778 IU/l 
by day 2 p. i. Between day 2 and day 4 it returned to normal. The CK 
value reached its peak of 1400 IU/I by day 9 (Fig. 85a). 
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Alkaline hos hatase (AP), Glutam 1 trans e tidase (GT) and Leucine 
amino eeptidase (LAP) (Fig. 86) activities all rose above their normal 
values as the course of infection progressed. 
Of the substrates investigated there was an initial rise in Cholesterol 
level from 99 mg/100 ml to 132 mg/100 ml in the first 4 days of infection 
followed by a decrease to 47 mg/100 ml by day 8-9 (Fig. 87). Normal 
values for Rhesus monkeys are 95.5 SE+/- 5.2 mg/100 ml. 
Triglyceride serum levels decreased throughout the infection from 65 
mg/ 100 ml to 15.7 mg/ 100 day 8 p. i. (Fig. 87). Normal values range from 
63 +/- SE 5.3 mg/ 100 ml. 
Total serum protein levels increased marginally from 8.4 to I5.2 
mg/ 100 ml at death of the monkey . 
Serum urea and creatine levels did not significantly alter from 
normal values throughout the infection. 
3.8.1.7. Antibody levels in the blood 
No CFT or neutralizing antibodies were detected within the 9 day 
period of infection. An immunofluorescent IgG reciprocal antibody titre 
of 1 /8 was noted on day 8 and 1/ 16 on day 9. No immunofluorescent IgM 
antibody was found. 
3.8.2. Transmission of Mopeiawl 50w wvirus ww. ý  w   w owwý 
A male Rhesus monkey weighing 6.6 Kg was inoculated i. p. with 0.1 
ml stock tissue culture fluid containing 3 log OTCID50 M 150 virus. The 
course of the infection was monitored in detail over the first 26 days p. i. 
and the results recorded. 
3.8.2.1. Clinical observations 
A mild febrile illness became apparent during the first 8 days of 
infection. Pyrexia reached a peak of 40.4°C on day 8 but returned to 
39.7°C by day 10 and 34.3°C by day 16. Thereafter it fluctuated between 
39.3 and 39.9°C till day 26 (Fig. 88). At no time was any distress noted, 
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water and food intake remained consistent throughout. Responses to 
provocation never faltered throughout the study period. No salivation, or 
diarrhoea was evident. Body weight continued to increase normally. 
3.8.2.2. Virus levels in the blood 
" Virus was not detected throughout the 26-day study period. 
3.8.2.3. Clinical biochemistry 
The serum GOT and GPT were only slightly altered during Mopeia 
infection. Both transaminase levels began to rise on day 2 p. i. The GOT 
reached 110 IU/I on day 4 and GPT increased to 78 IU/I also on day 4 (Fig. 
83b). 
The isoenzymes LDH and HBDH fluctuated about their normal values 
throughout the 26 day study period (Fig. 84b). 
Creatine kinase did show a high degree of activity between days 4 
and 16p. i. (Fig. 85b). The CK level also increased from 240 IU/I on day 0 
to 1121 IU/I on day 4, decreasing to 580 IU/l on day 6 and returning to 1283 
IU/I on day 8 where it remained to day 14 p. i. Normal values were 
observed from day 16 p. i. onwards. 
The other enzymes AP, GT and LAH activity remained within normal 
values throughout the course of infection. 
None of the substrates studied significantly altered from normal 
values. 
3.8.2.4. Antibody levels in the blood ww wýý      w w w 
The serologic responses, as measured by IFA anti-IgG were first 
detectable on day 6 (1 : 16) and reached their peak on day 14 p. i. at 
I: 4096. 
Complement fixation antibodies against Mopeia and LGA 391 strains 
were not detected by day 26, but further studies demonstrated a reciprocal 
CF antibody of I: 16 at day 32 which remained unaltered at day 56 p. i. 
Neutralizing antibodies against M150 appeared on day 46 p. i. at an 
LNI of 1.0. Before this date no neutralizing antibodies could be detected 
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against either Mopeia or Lassa virus strains. No anti-Lassa neutralization 
antibodies could be detected at day 46. 
3.8.2.5. Challenge with M 150 
The Rhesus monkey first inoculated with M 150 was challenged 
" in traperitoneally a second time with 0.1 ml of stock M 150 virus (3 
log 10TCID50) on day 56. At the time of challenge the clinical, 
immunological and biochemical status of the animal is outlined in Table 
45). 
TABLE 45 . DETAILS CONCERNING THE RHESUS MONKEY GIVEN M 150 AFTER 56 DAYS 
IFA (IgG) against M 150 
against LGA 391 
Neut. Ab. against M 150 
against LGA 391 
Serum enzyme/substrate 
(reference Section 3.8.1.6. ) 
Serum viraemia 
Temperature 
Weight 
Reciprocal titre 1: 4096 
" it 1: 2048 
LNI 1.8 
None found 
Normal 
Negative 
38.1°C 
7.2 Kg 
During the 24 day period of study following the second inoculation, 
the monkey did not develop a fever neither was virus detected in the blood. 
The serum enzymes and substrates studied (Section 3.8.1.6. ) remained 
normal. The weight of the animal remained stable and there was no 
detectable pyrexia. The IFA against M150 and LGA 391 remained the 
same, while the neutralization antibodies continued to rise against M 150 to 
an LNI of 2.8 by day 80. By day 80 LGA 391 neutralizing antibodies could 
not be demonstrated. Therefore the immunological, biochemical and 
clinical status of the monkey after a second challenge with M150 is 
tabulated in Table 46. 
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TABLE 46. DETAILS CONCERNING THE RHESUS MONKEY GIVEN M 150 
(DAY 0, DAY 56) AT 80 DAYS POST INFECTION) 
IFA (IgG) against M 150 
against LGA 391 
Neut. Ab. against M 150 
against LGA 391 
Serum enzyme/substrate 
reference Section 3.8.1.6. ) 
Reciprocal titre I: 2048 
If 11 1: 1024 
LNI 2.8 
None found 
Normal throughout study 
Serum viraemia 
Temperature 
Weight 
Negative 
38.2° C 
7.4 Kg 
3.8.2.6. Re-challenge with LGA 391 
The Rhesus monkey which had been given 2 doses of M 150 was 
challenged s. c. after 80 days with 3 log 10 
TCID 50 LGA 391 and monitored 
for 45 days at which time the experiment had to be terminated. The 
biological status of the animal pre-LGA 391 challenge is outlined in Table 
46. A non-immune (M 150) Rhesus monkey was used as a positive control. 
There was no indication of a febrile illness in the M150 immunised 
monkey or alteration in IFA values. The serum enzymes and substrate 
normally affected by Lassa infection (Section 3.8.1.6. ) remained normal . 
No virus was detected in the serum throughout the LGA 391 challenge 
period . The neutralizing antibody level to M150 remained the same, but 
low level neutralizing antibody was detected against LGA 391 at day 10 p. i. 
(LNI 0.3) and increased to an LNI of 1.0 by day 45 post infection. No virus 
was detected in heart muscle, adrenals, kidneys, liver, spleen, pancreas, 
small intestine, or lymph nodes after autopsy on day 45 post LGA 391 
challenge. Histological examination yielded no obvious lesions or 
abnormalities which are normally associated with Lassa infection . 
Therefore the biological status of the monkey after M 150 immunisation and 
LGA 391 challenge is summarised in Table 47). 
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TABLE 47. DETAILS CONCERNING M 150 IMMUNE RHESUS MONKEY 
CHALLENGED WITH LGA 391 AFTER 45 DAYS 
IFA (IgG) against M 150 Reciprocal titre I: 2048 
against LGA 391 Of 1: 2048 
Neut. Ab. against M 150 LNI 2.8 
against LGA 391 LNI 1.0 
Serum enzymes/substrate Normal throughout study 
GOT levels increased on day 6 and 
returned to normal on day 12 
viraemia Negative 
Tissue " Negative 
Histology Normal 
3.8.3. Transmission of other Mopeia viruses to Rhesus monkeys 
A series of Rhesus monkeys were given 0.1 ml of tissue culture virus 
i. p., at either of two dosages, 3 log 10 TCID50 or 6 log 10 TCID50. The 
experimental design is tabulated below in Table 48. The monkeys were 
monitored over a 28-day period for signs of clinical illness, viraemia, 
alterations in serum biochemistry, IF and neutralizing antibodies. Samples 
of blood were taken every two days. Temperatures were taken daily. 
TABLE 48 . EXPERIMENTAL INFECTION OF RHESUS MONKEYS WITH MOPEIA VIRUS 
Rh. monkey Weight Sex Mooeia Route of Virus dose 
No. (Kg) 
3 4.2 Male 
4 3.8 Female 
5 4.2 Female 
6 3.9 Female 
7 4.0 Female 
8 4.5 Male 
9 4.6 Male 
10 4.8 Female 
Virus Infection 0.1 ml 
strain TCID50 
M 148 i. p. 2 
M148 of 6 
M150 if 6 
M152 2 
M152 it 6 
Z478 2 
Z478 to 6 
None None None 
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3.8.3.1. Clinical observations 
None of the monkeys (3-9) became febrile throughout the 28 days and 
all their temperatures remained within normal limits of 38.6 to 39.8°C. 
The monkeys remained alert, active and demonstrated no loss of apetite. 
All animals survived infection with each Mopeia virus at both infective 
doses. 
3.8.3.2. Virus levels in the blood 
Virus was not detected in the blood at any time during the study in 
any of the monkeys. 
3.8.3.3. Antibody levels in the blood 
The serological responses as measured by IF anti IgG were first 
detectable between days 10-12 in all monkeys. Peak levels of homologous 
IF antibody were reached by day 21 in all monkeys (Table 49). 
TABLE 49. DEVELOPMENT OF HOMOLOGOUS IMMUNOFLUORESCENT ANTIBODIES 
OVER 28 DAYS IN RHESUS MONKEYS INFECTED WITH STRAINS OF 
MOPEIA VIRUS 
Rhesus Mopeia Dose Days p. i. 
Monkey Virus log I OTCID50 No. Strain 9 12 14 19 21 28 
3 M148 2 <8 <8 32 1024 4096 4096 
4 M148 6 <8 <8 128 1024 4096 4096 
5 M150 6 <8 32 4096 4096 8192 8192 
6 M152 2 <8 16 512 2048 4096 8192 
7 M152 6 <8 32 2048 2048 8192 8192 
8 Z478 2 <8 32 4096 4096 8192 8192 
9 Z478 6 <8 64 4096 8192 8192 8192 
No complement fixing or neutralizing antibodies were detected 
against homologous Mopeia or heterologous LGA 391 viruses. 
3.8.3.4. Clinical biochemistry 
There was no alteration in the GOT, GPT, LDH, aHBDH, YGT, CK2 
LAH, urea, total protein, triglycerides, creatinine or cholesterol leve ls in 
any of the monkeys throughout the 28 days. 
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3.8.4. Challenge of Moeia-immunised Rhesus monkeys with LGA 391 
The Rhesus monkeys (3-9) that had been infected with various strains 
of Mopeia virus were challenged on day 60 post Mopeia infection, with LGA 
391. They were challenged s. c. with 0.1 ml virus tissue culture fluid, the 
" final dose being 3 log10 TCID50. A control non-immunised Rhesus monkey 
(10) was included and acted as a positive LGA 391 control. The monkeys 
were monitored over a 28-day post Lassa challenge period. Samples of 
blood were taken every two days for virological, immunological and 
biochemical analysis. Temperatures were taken daily. Baseline details on 
each Rhesus monkey are outlined in Table 50. 
TABLE 50. DETAILS CONCERNING RHESUS MONKEYS 60 DAYS 
AFTER MOPEIA IMMUNISATION AND PRIOR TO CHALLENGE WITH LGA 391 
RH monkey No. 3456 7- 89 10 
Immunising 
Virus M 148 M 148 M150 M 152 M 152 Z478 Z478 None 
Homologous 
IFA 4096 4096 4096 2048 2048 1012 2048 <8 
Hetgrologous 
IFA against 2048 1024 1024 1024 1024 1024 1012 <8 
LGA 391 
Homologoyj 
Neut. Ab. ND 1.0 1.8 1.0 ND 1.6 1.8 ve 
Heterologous 
Neut. Ab. -ve -ve -ve -ve -ve -ve -ve ve 
against 
LGA 391 
Serum enzyme 
& substrates NNNNNNNN 
Viraemia -ve- -ve -ve -ve -ve -ve -ve ve 
Temperature 
(°C) 39.2 39.2 39.3 39.5 39.6 39.3 39.1 38.7 
Weight (Kg) 4.8 4.0 4.3 4.2 4.0 4.6 4.7 3.8 
* 
reciprocal antibody titres 
expressed as LNI 
N- Normal N. D. not done 
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3.8.4.1. Clinical observations 
None of the immunised Rhesus monkeys became febrile throughout 
the 28 days p. i. and all the temperatures remained within normal limits, 
38.6 - 39.8°C. The control monkey demonstrated a febrile illness which 
started to rise above normal on day 6 (40°C) and reached a peak on day 9 
(41°C). Between days 10-12 the temperature of the control monkey 
gradually decreased to sub-optimal levels (36.7°C) at which time it became 
moribund. A summary of the clinical observations is made in Table 51). 
TABLE 51. COMPARATIVE SUMMARY OF CLINICAL OBSERVATIONS 
FROM MOPEIA IMMUNE RHESUS MONKEYS AFTER CHALLENGE WITH 
LGA 391 
Rhesus 
monkey 
No. 3 4 5 6 7 8 9 t0 
Immunising 
Virus M 148 M 148 M 150 M152 M 152 Z478 Z478 None 
Dose 
Log1OTCID50 2 6 6 2 6 2 6 - 
Febrile 
illness No No No No No No No Yes 
Food and 
H2O intake N N N N N N N Reduced 
to nil 
Activity of Reduced 
from day 3 
Weight 
reduction None None None None None None None 240g 
Outcome of 
challenge ** S S S S S S S Moribund 
day 12 
*N 
- Normal 
** 
- Survived 
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3.8.4.2. Virus levels in blood 
No LGA 391 was found in any of the blood samples taken from any of 
the Mopeia Rhesus monkeys, throughout the 28 days post Lassa challenge. 
In comparison, LGA 391 was isolated from the control Lassa Rhesus 
- monkey from day 6 and remained in evidence until the animal became 
moribund on day 12 (Table 52 and Fig. 89). 
TABLE 52. COMPARATIVE VIRAEMIA OBTAINED FROM RHESUS MONKEYS 
IMMUNISED WITH STRAINS OF MOPEIA AND CHALLENGED WITH LGA 391 
Serum virus titre (Log 10TCID50/ml) at various 
days 
2468 10 12 14 16 18 21 28 
Rhesus monkey 
Nos. (3-9) -ve -ve -ve -ve -ve -ve -ve -ve -ve -ve ve 
Control LGA391 -ve -ve 2.7 6.3 6.3 5.8 
Rhesus monkey Died 
0 0) 
3.8.4.3. Clinical biochemistry 
In the case of the control Rhesus monkey challenged with LGA 39 t, 
the serum enzymes GOT, GPT, LDH, aHBDH. CK and AP gradually 
increased above normal to their maximum by day 12 when the animal 
became moribund (Fig. 90). 
The serum biochemistry of the immunised monkeys after challenge 
demonstrated slight alterations in the GOT levels. The GOT values rose 
above normal levels on day 6 in those monkeys immunised with only 2 
log 1 0TCID50 Mopeia viruses (M 148, M 152p Z478) and challenged with LGA 
391 (Figs. 91 and 92). The levels varied between 3-4 times normal and 
were consistent with each monkey immunised with the Mopeia strains. The 
GOT levels in each case returned to normal by day 12. The rise in the 
GOT level was not evident in those monkeys immunised with 6 
log 
10TCID50 Mopeia strains (M 148, M 150, M 152 and Z478). The other 
serum enzymes studied (LDH, allBDH, yGT, CK, SD and AP) all remained 
normal throughout the 28 days. The serum substrates (triglycerides, total 
proteins and urine) also remained within normal limits throughout the 28 
days. 
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3.8.4.4. Antibod levels in the blood 
The reciprocal IF homologous antibody levels of Mopeia immunised 
Rhesus monkeys after LGA 391 challenge are shown in Table 53. IF values 
are reduced between days 2-8 post challenge, thereafter rising to slightly 
higher levels by day 28. The anti-LGA 391 IF antibodies demonstrated the 
same fluctuations. 
TABLE 53. RECIPROCAL IgG IF HOMOLOGOUS ANTIBODY LEVELS IN MOPEIA 
IMMUNISED MONKEYS OVER 28 DAYS POST LGA 391 CHALLENGE 
Day post LGA 391 challenge 
Rhesus Immunising 
Monkey virus(Dose 
No. TCID50) 0 2 4 6 8 
3 M148(2) 1024 512 128 512 256 
4 M 148(6) 2048 1024 512 2048 ND 
5 M 150(6) 2048 1024 2048 2048 ND 
6 M 152(2) 2048 2048 512 512 512 
7 M 152(6) 1024 512 1024 1024 512 
8 Z478(2) 1024 1024 1024 1024 512 
9 Z478(6) 2048 1024 512 256 256 
10 -ve <8 <8 <8 8 16 
10 12 14 21 28 
512 1024 1024 2048 4096 
ND 4096 4096 4096 4096 
ND 4096 4096 4096 4096 
ND 2048 ND 2048 2048 
ND 2048 ND 2048 2048 
ND 1024 4096 ND 4096 
ND 1024 2048 4096 4096 
256 512 Died 
The appearance of neutralizing antibodies in all the monkey sera 
demonstrated varying levels. The anti-LGA 391 activity as measured by 
LNI did not rise above 0.5 in any of the Mopeia challenged monkeys 28 days 
post Lassa challenge. The LNI levels are shown in Table 54. 
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TABLE 54. HOMOLOGOUS AND HETERLOGOUS NEUTRALIZING ANTIBODIES 
IN THE SERA OF MOPEIA IMMUNISED RHESUS MONKEYS 
28 DAYS POST LGA 391 CHALLENGE 
Rh. Monkey Immunizing LNI 
No. Virus and 
(Dose) Homologous Heterologous 
(anti-LGA 391) 
3M 148(2) 1.5 -ve 
4M 148(6) 2.0 0.3 
5M 150(6) 2.0 0.5 
6M 152(2) 1.5 0.3 
7M 152(6) 2.1 0.5 
8 Z478(2) 1.8 0.5 
9 Z478(6) 2.0 0.5 
3.9. STUDIES ON A HUMAN CASE OF LASSA FEVER 
In the light of studying the effects of LGA 391 and Mopeia virus 
strains in Rhesus monkeys, an ideal opportunity arose during the course of 
the work to study a human case in the acute and convalescent stages of the 
disease and to directly compare the results with those found in the Rhesus 
monkey. 
3.9.1. Case history 
An 18-year-old Nigerian woman visitor (P. B. )to London fell ill on 28 
December 1981 with fever, headache, myalgia, nausea and vomiting (Fig. 
93). By 4 January 1982, she was so unwell that she was referred to St 
Thomas' Hospital. By 8 January, her condition was serious and a diagnosis 
of Lassa fever seemed to be a very strong possibility. In view of this and 
the possible risk of infection in the event of haemorrhage, she was 
transferred to the high security infectious disease unit at Coppetts Wood 
Hospital, where she was admitted into a Trexler negative pressure patient 
isolator. 
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3.9.2. Virological and Serological studies 
The first specimen of blood collected for virological studies on 8 
January 1982,12 days after the patient became feverish, was examined by 
electron microscopy and arenavirus particles were seen. Tissue culture 
which had been inoculated with the blood proved positive by IFA 2-3' days 
later. 
Virus isolation and serological studies were made on specimens of 
blood, urine and throat washings collected during the acute and 
convalescent phases of the illness. The, highest level of virus in the blood 
(105'2TCID50/ml) was found in the sample taken on 8 January 1982; virus 
declined to undetectable levels by day 32 (21 January 1982) after onset of 
illness (Fig. 93). 
No virus was isolated from urine samples collected before day 22 (18 
January 1982). Thereafter virus was evident until day 67. The peak level 
of virus (104.0TCID50/ml) was found. in the urine on day 36 but levels 
.ý 2 ranged from 10'0-104'O TCID50/ml between days 22 to 53. Undetectable 
virus was observed by day 7 I. 
All throat washings taken throughout the patient's isolation yielded 
no virus. 
Circulating antibody levels as determined by IFA demonstrated an 
anti-Lassa IgG antibody of I: 64 present on day 22 and peak levels of 
I: 24,000 and I: 32,000 being reached on days 44-55. These antibody 
levels were sustained throughout her convalescence. Circulating anti- 
Lassa IgM antibody of I: 16 -I: 32 were detectable between day 19 and 
day 21 only. 
Convalescent sera given on day 12 and day 17 had an IFA level of 
"I: 1024 and l 2048 respectively but no CF or' neutralizing antibodies 
were detectable. 
A CF antibody level of I: 16 was observed on day 50 which rose to 
64 on day 76. Anti-Lassa GA 391 neutralization antibodies of I: 256 
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were observed on day 56 and I: 64 on day 76. No neutralising antibodies 
were evident before day 56. 
3.9.3. Clinical Biochemistry 
Normal values of human serum enzymes and substrates were 
determined using random human serum on the LKB Analyser. A 
comparison was made using this data with the results obtained from the 
serum obtained from P. B. 
TABLE 55. NORMAL VALUES OF SERUM ENZYMES AND SUBSTRATES IN 
MAN 
Enzymes/Substrates Normal Values Units 
Men Women 
GOT 40 35 IU/I 
GPT 45 35 
LDH 450 
a -HBDH 125 
CK 24 - 170 24 -150 
yGT I1- 50 7- 30 
AP 270 
Creatine 3- 97 44 - 80 mg/ 100 ml 
Urea 1.7 -8.3 
Total protein 6.6 - 8.7 of 
Triglycerides 70 - 170 
Cholesterol 7.5-6.7 it 
In the acute phase of her disease, various enzyme levels rose 
progressively. By day 7 after onset the GOT rose to a peak level of 4440 
IU/I (normal 7-20 IU/1) and GPT 850 IU/I (normal 8-30 IU/1) (Fig. 94). Both 
these enzymes in the serum were reduced to normal levels by day 18 after 
onset of illness. 
Lactate dehydrogenase (L DH) and hydroxybutyrate dehydrogenase 
(HBDH) (Fig. 94) were also at the highest levels at day 7 after onset of 
illness at 4003 IU/1 and 4015 IU/I respectively. The LDH and HBDH were 
reduced to normal levels by day 32. 
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Fig. 94 ' Demonstration of serum enzyme levels from a Lassa patient 
(P. B. ) during the course of the illness 
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Creatine kinase (CK) (Fig. 95) levels 7 days after onset were raised to 
123 IU/I (normal <65 IU/1), and decreased to normal levels by day 14. The 
CK activity increased to its peak level of 312 IU/I on day 19 and decreased 
to normal levels by day 21. The levels remained at approximately twice 
0 their normal values during convalescence. 
LAH (Fig. 95) was also at its peak level during the acute phase of the 
disease. On day 7 the value of 250 IU/I was observed which decreased to 
normal by day 19 and remained normal throughout the course of the 
disease. 
AP (Fig. 95) reduced from its peak level of 225 IU/l on day to 120 
IU/1 on day 76. 
yGT (Fig. 96) remained high during the acute phase of the disease at 
60-80 IU/l (day 7-22) falling to normal levels during the convalescent 
phase. 
Urea levels remained above normal throughout the course of the 
infection even in the convalescent phase (Fig. 96). 
Creatine and Total Proteins were already high on admission to 
hospital (day 7) but returned to normal throughout the course of the 
infection. Cholesterol and triglyceride values fluctuated throughout the 
illness. 
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4. DISCUSSION 
The International Committee on Taxonomy of Viruses (ICTV), having 
accepted the recommendation of a Study Group (Pfau et at., 1974), 
proposed that the name 'Arenaviridae' be given to a set of viruses 
previously designated arenaviruses. Their most striking characteristic is 
a unique morphology and additionally all the component viruses are 
antigenically related to a greater or lesser extent, depending on the 
serological assay employed and the potency of the antigens and antisera. 
The implications of molecular biological comparisons, the use of 
monoclonal probes, of shared antigens on specific diagnosis, protection 
against cross-challenges and im munopathological developments resulting 
from sequential exposures to different viruses are also to be borne in mind. 
LCM virus has been chosen as the prototype virus for the family in 
which there are at present 12 members (Pedersen, 1979; Wulff et al., 
1978). The group is divided into the LCM complex ('Old World') and the 
Tacaribe complex New World') on the basis of serological cross-reactivity 
demonstrated by CF or IF assays. Besides LCM, the other members of the 
'Old World' group are Lassa and Mopeia viruses. Lassa virus, like most 
other arenaviruses, appears to be a single-host rodent parasite, and because 
M. natalensis is widely distributed over the African continent (Isaacson, 
1975), the presence of a virus (Mopeia) closely related to Lassa does not 
represent a biological surprise, especially when one compares it with the 
distribution of arenaviruses in South America. Mopeia viruses, in contrast, 
while isolated from the same rodent species, are found in Mozambique 
(Wulff et al., 1977), and Zimbabwe (Johnson et al., 1981), where a disease 
like Lassa fever has not been reported. In addition, a Lassa related virus 
has been isolated from Praom s sp. found in the Central African Republic 
(CAR) which is considered to be distinct from the other African 
arenaviruses (Gonzalez, et al. 1983). The Mopela and CAR isolates raise 
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several questions of more than academic interest. Are the viruses a minor 
antigenic variant of Lassa virus or are they new arenavirus immunotypes? 
It is important to determine if the new strains are pathogenic for man and 
whether M. natalensis from West Africa and south-east Africa are truly 
identical. The question of pathogenicity will only be answered on the 
chance recognition of Lassa fever outside West Africa or the elucidation of 
pathogenic properties and their comparative biology of Lassa and Mopeia 
viruses in animals such as a non-human primate. Therefore, within the 
context of the stated hypothesis of this thesis (Section 1, page 14) the 
characteristics of the Mopeia viruses (Tables 56,57 and 58) will be 
examined and compared with the established view of the arenavirus family. 
Isolation of arenaviruses in vitro does not readily distinguish various 
strains. Lassa and Mopela viruses grow readily in Vero and CV-1 cell lines 
producing an obvious cytopathic effect. In the present studies a 
cytopathic effect developed within 3-4 days post inoculation and was very 
obvious by day 5 in the case of Lassa and by day 7 with all Mopeia viruses. 
Lassa was the most productive virus in Vero or CV-1 cells reaching levels 
10-100 fold higher than that produced by the Mopela viruses. In stock 
pools of Lassa and Mopeia viruses with titres >10 
6 
no cell destruction was 
observed in assay systems until the 10-3 dilution. This phenomenon of 
auto interference has been previously reported for LCM and other 
arenaviruses (Welsh et al., 1975; Dutko et al., 1976). This interference 
was observed shortly before maximal infectious virus synthesis and 
increased as the age of the culture increased. Welsh and Pfau (1972) 
demonstrated with LCM infection of BHK-21 cells, an interfering 
component which inhibited LCM synthesis. Dilution of the inoculum 
before infection reduced the interference and resulted in 100-fold more 
infectious virus, a similar increase being observed with both Lassa and all 
the Mopeia viruses in the studies carried out in this Thesis. On the basis of 
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several physicochemical studies, Welsh and Pfau (1972) suggested that the 
interfering component was a defective interfering (DI) virus. A number of 
studies indicated that LCM produces DI virus (reviewed by Huang, 1973) 
and that these may play a role in persistent infections. DI virus was first 
separated from infectious LCM in the culture fluid from BHK-21/13s cells 
persistently infected with LCM (Welsh et al., 1972; Staneck et al., 1972). 
It is now clear that LCM DI (i) sediments to a lower density in sucrose than 
LCMV (Oldstone et al., 1977; Welsh and Buchmeier, 1979), (ii) contains 
infectious LCM structural proteins (Welsh and Buchmeier, 1979), (iii) does 
not reproduce itself in culture unless infectious LCMV is also present, 
(iv) 
interferes specifically with LCMV but not heterologous viruses (Welsh and 
Pfau, 1972), and (v) has a target size for UV inactivation significantly less 
than infectious LCMV suggesting a reduced genome size (Welsh et al., 
1972; Popescu et al., 1976). Attempts to isolate or prove the existence of 
DI particles with Lassa or Mopeia cultures proved unsuccessful even though 
the interference phenomenon in those cultures was observed. 
In addition it has been shown that some tissue culture types infected 
with LCM, show no CPE over extended periods but still retain infective 
virus (Hotchin and Cinits, 1956). Similar observations were made with 
cultures of Tamiami (Calisher et al., 1970), Junin (Coto et al., 1974), 
Parana (Staneck et al., 1972), Pichinde (Dutko and Pfau, 1978), and Lassa 
viruses (Buckley and Casals, 1970). The studies with Lassa and all the 
Mopeia strains in infected L cells show the same arenavirus 
characteristics. 
4. I. Ph Biochemical ro erties (Table 56) 
The similarities in morphology and morphogenesis of Lassa and 
Mopeia viruses are so marked and distinctive that they all conform to the 
basic electron microscopical pattern attributed to the arenaviridae (Figs. 
23-42). Thin section electron microscopy of Vero, CV-1 or L cells infected 
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TABLE 56. SUMMARY OF THE PHYSICOCHEMICAL AND BIOLOGICAL 
PÖ ERTIES COMMON TO LASSA LGA 391 AND MOPEIA VIRUSES 
Properties Virus 
LGA 391 Mopeia viruses 
Origin Nigeria Mozambique Zimbabwe 
RNA genome + + + 
Infectious nucleic acid - - - 
Overall shape spherical 
to pleomorphic + + + 
Diameter nm 80-250 80-240 120-130 
Surface projections 
club shaped, 10 nm long + + + 
Contains host ribosomes + + + 
Replicating potential + + + 
BUDR sensitivity - - - 
Rapidly inactivated between 
pH 5.5 and above 8.5 + + + 
UV sensitive + + + 
Heat sensitive 56°C, + + + 
60° C 
Lipid solvent sensitive + + + 
BPL, formalin, glutaraldehyde 
sensitive + + + 
Immunizing antigen (+) 
. + + 
Interference potential + + + 
Cytoplasmic effect + + + 
Cytoplasmic antigen + + + 
Cell surface antigen + + + 
observed in experimental animals that survived LGA 391 infec tion. 
+= present -= absent += eq uivocal 
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with LGA 391 or Mopeia viruses show them to be indistinguishable from 
each other. The particles are round, oval or pleomorphic, 60-280 nm in 
diameter, having a membraneous envelope with surface projections or spike 
approximately 6-10 nm long, and contain a variable number of internal 
electron-dense granules about 20 nm in diameter which strongly resemble 
ribosomes. Comparison between LGA 391 and Mopeia viruses show that 
there is a striking morphological similarity with LCM, Machupo and 
Tacaribe (Murphy et al., 1969), Latino, Parana and Tamiami (Calisher t 
al., 1970). The envelope of the LGA 391 and Mopeia virus is consistent 
with the other arenaviruses in that it consists of two electron-dense layers 
supported by a broader electron-lucent intermediary zone (Murphy and 
Whitfield, 1975). The virus particles are formed by a process of budding at 
the cell surface. During this process there is continuity of the unit 
membrane of the cell surface and the viral envelope. As with all 
arenaviruses, development of the viral envelope is denser and more distinct 
than that of the host membrane from which it is derived, a feature shown 
with LGA 391 and Mopeia viruses. Late in infection large areas of plasma 
membrane become dense, seem to have virus surface projections and may 
accumulate a layer of amorphous material in patches. 
Negative-contrast electron microscopy of virus particles sedimented 
from infected cell cultures demonstrates uniformity of the viruses, with 
pleomorphic particles slightly larger than in thin sections, 90-350 nm, 
pronounced surface projections, and no resolution of internal structure 
(Murphy et al., 1970). 
Electron microscopy of animal tissue proved unproductive in the case 
of Lassa and Mopeia viruses. In general, only occasional virus particles 
were observed in the brain tissue of mice infected with LGA 391 and 
Mopeia strains, which with parallel studies using CFT and IF indicated the 
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presence of specific antigen. No particles were found in tissues of guinea 
pigs or monkeys infected with Mopeia viruses, a situation not uncommon 
with that found with Tacaribe and Junin viruses (Casals 1975). 
The common characteristics of viral morphology and development 
link Mopeia viruses to members of the arenaviridae. In addition, the 
physicochemical characteristics studied and outlined in Table 56 
demonstrate further compatibility with the arenavirus family. All 
arenaviruses so far studied including Mopeia and LGA 391 viruses are 
sensitive to lipid solvents such as sodium desoxycholate (Buckley and 
Casals, 1970; Calisher et al., 1970; Downs et al., 1963; Mettler et al., 
1961; Trapido and Sanmartin 1971), chloroform (Johnson et al., 1965; Webb 
et al., 1970) and ether (Mifune et al., 1971). Similarly a rapid loss in 
infectivity below pH 5.5 and above pH 8.5 was a consistent finding in the 
present study and with other arenaviruses like Pichinde (Mifune et al., 
1971), Junin (Parodi eet al., 1966) and Parana (Webb et al., 1970). They are 
relatively heat-sensitive, infectivity half-lives being a matter of minutes 
at 60°C and 56°C, hours at 37°C and days at 25°C and 4°C (Calisher et al., 
1970; Lloyd et al., 1982; Mifune et al., 1971; Parodi et al., 1966; Webb et 
al., 1967). It is impossible to make exact comparisons here because no 
experiments have been done with purified virus and/or under identical 
conditions. Although no direct inactivation data are available, human sera 
containing Lassa virus remained infectious after 4 days at crushed ice 
temperature while in transit from West Africa to New York (Buckley and 
Casals, 1970). It is important to note the temperature sensitivity of the 
arenaviruses especially with Lassa and to a certain extent Mopeia, since 
treatment of purified or tissue culture extracts at 60°C under high 
containment should provide a means of safely removing the samples for 
analytical study in less restrained conditions, i. e. molecular biological 
analysis, providing they do not interfere with the analysis being carried out 
or the final results. 
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No DNA synthesis-inhibiting compound has been found to inhibit 
arenavirus replication. LCM synthesis was unaffected by concentrations 
of halogenated deoxyuridines (BUDR, FUDR, IUDR) that inhibits DNA 
containing viruses (Hotchin, 1971; Lehmann-Grube, 1971). The Nlopeia 
and LGA 391 viruses in the present study plus Lassa (Buckley and Casals, 
1970), Junin (Martinez Segovia and Grazioli, 1969), Machupo (Webb et at., 
1967) and Parana (Webb et al., 1970) were all resistant to BUDR. 
Definitive proof of the RNA content of arenaviruses was obtained after 
chemical analysis of purified LCM and Pichinde viruses (Pedersen 1970; 
Coto, 1973). The arenaviruses contain a single-stranded RNA genome of 
total molecular weight of about 4x 106 (Ramsingh, 1980) in two segments 
of negative polarity. 
The protein structure of purified Lassa virus (Clegg and Lloyd, 1982; 
Kiley et al., 1981) is very similar to that of other arenaviruses which have 
been analysed. The major component of the virus particle is the 
nucleocapsid protein with a molecular weight of 60,000 compared with 
54,000-68,000 reported for other arenaviruses (Pedersen, 1979; Howard 
and Simpson, 1980). Lassa and Mopeia viruses (Kiley et al., 1981; Clegg 
and Lloyd, in preparation) also have two envelope glycoproteins with 
molecular weights similar to those found with other members of the 
family, although Tacaribe and Tamiami viruses are reported to have only a 
single envelope glycoprotein (Gard 1977; Boersma et al., 1982). There are 
also some similarities between the minor virion components of Lassa and 
Mopeia viruses (Clegg unpublished) and those found in other arenaviruses. 
In addition an RNA polymerase activity, which would be expected in a 
negative strand RNA virus has been found in purified preparations of 
Pichinde virus (Carter et al., 1974; Leung et al., 1979) as well as a protein 
kinase activity in purified LCM (Howard and Buchmeier, 1983). These 
enzyme activities have not yet been identified with polypeptides 
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observable by polyacrylamide gel electrophoresis. A further virus-specific 
protein (GPC) has been found in immunoprecipitates from cells infected 
with LCM, Tacaribe or Pichinde viruses (Buchmeier et al., 1978; Buchmeier 
and Oldstone, 1979; Buchmeier et al. 1980b; Harnish et al., 1981; Saleh et 
al., 1979). This is a glycoprotein with a molecular weight of 70,000-79,000 
which appears to be processed by proteolytic cleavage and carbohydrate 
modification to give the mature envelope glycoproteins. Analysis of 
purified LGA 391 has shown a major protein component very similar to that 
of other arenaviruses (Clegg and Lloyd 1982). 
The N protein of arenaviruses is similar in size and proportion to the 
other structural proteins. This homogeneity does not extend to 
glycoproteins. The common major glycoprotein species is the GP-2 
protein (33-44,000 m. w. ) found in all examined arenaviruses including 
Mopeia virus (Clegg and Lloyd, unpublished). The other glycoprotein (GP-1 
(52-65,000 m. w. ) is more variable in size. The GP-I and GP-2 
glycoproteins are thought to be located at the surface of the virus. This 
conclusion is based on work treating Pichinde and LCM viruses with 
pronase and bromelain (Vezza et al., 1977; Buchmeier et al., 1978) or 
Tacaribe and Tamiami viruses with chymotrypsin (Gard et al., 1977) which 
specifically remove the spikes from the virus surface, as seen by the 
electron microscope or by a change in the virus density. Polyacrylamide 
gel electrophoresis (PAGE) analysis of these spikeless virus particles has 
shown a great reduction of the glycoprotein. A 84,000 m. w. glycoprotein 
found in preparations of Mopeia 20410 may be a precursor of the GP-1 
and/or GP-2 proteins (Kiley 1981). Kiley further suggested that the 
uncleaved glycoprotein of M20410 may play a role in the differential 
pathogenicity of the Lassa or Mopeia viruses in experimental animals. 
4.2. Serological and Immunochernical Pro erties (Table 57) 
Although the nature of arenavirus surface antigens has yet to be 
defined it has been suggested by Howard and Simpson (1980) that the 
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TABLE 57. SUMMARY OF THE SEROLOGICAL AND IMMUNOCHEMICAL 
PROPERTIES COMMON (a) TO LASSA (LGA 391) AND MOPEIA 
VIRUSES AND (b) TO LCM AND 'NEW WORLD' ARENAVIRUSES 
(a) (b) 
Common antigens 
CF 
IF 
Neutralizing 
Common reactive structural proteins 
N 
GI 
G2 
Common reactive nucleoprotein 
determinants with hybridoma 
antibodies to LGA 391 
35 
41 
47 
52 
65 
72 
79 
Common reactive nucleoprotein 
determinants as indicated with 
hybridoma antibodies to M20410 
53-29-1 
52-153-3 
52-54-6 
53-237-5 
Common reactive nucleoprotein 
determinants as indicated 
with hybridoma antibodies to 
Pichinde 
75-7 
75-19 
75-23 
75-25 
ND - not done 
+= present absent ?= unknown 
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++ 
++ 
- ND 
+ ND 
? ND 
- ND 
+_ 
+_ 
+_ 
+_ 
+- 
+ + 
+ + 
+ + 
+ + 
surface glycoproteins play an important role in eliciting a protective 
antibody response. It remains to be established if each protein is present 
in all the outer projections or whether they are composed of two or more 
chemically different types. The role of minor structural components in 
the formation of antigenically reactive surface components is at present 
unclear. Biological activities such as haemolysis, haemagglutination etc. 
which are associated with the envelope protein of other RNA viruses, have 
not been discovered with arenavirus preparations. Relating the structural 
aspect of the virus to biological function is the next stage in our 
understanding of arenavirus infections. 
Studies of the immunologic properties of arenaviruses and the varied 
disease states associated with infection must consider the virus as a 
complex, replicating mosaic of antigens. Viral antigens are found in many 
forms during the infection: (a) as free virions, (b) as antigens expressed on 
the surfaces of infected cells, and (c) as products liberated by degradation 
of virions or by immunologically mediated destruction. 
The most extensive studies on the antigenic properties of the 
arenaviruses have been primarily investigated with LCM virus (Pederson, 
1973) and Pichinde (Rawls and Leung, 1979). Early studies with LCM 
established that there was a complement-fixing (CF) antigen distinct and 
separable from the infective particle by centrifugation and designated the 
soluble antigen (Smadel et al., 1942; Lehmann-Grube, 1971,1975; Rawls 
and Leung, 1979). Virus specific CF antigen has further been 
demonstrated in Junin infected animals (Coto, 1974), from LCM virus- 
infected tissue cells (Bro-Jorgensen, 1971; Geschwender et al., 1976) and 
Lassa-infected animals and cells (Buckley, 1973). 
Studies presented by Geschwender et al. (1976) on LCM virus and 
Buchmeier et al. (1977) on Pichinde virus demonstrated that the CF 
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antigens of these viruses are antigenically identical to an 
internal 
structural component of the virion. This component is released by 
solubilization of virions, and in the solubilized form is resistant to heat 
denaturation and to proteolysis (Buchmeier et al., 1977). Antisera prepared 
against purified cell-associated CF antigen of Pichinde specifically 
immunoprecipitates with the viral nucleoprotein. Immunization with 
purified nucleocapsid protein of LCM produces a high CF antibody titre, 
but will not neutralize virus and reacts only with antigens expressed in the 
cytoplasm of infected cells (Buchmeier and Oldstone, 1978). The 
mechanism by which excess CF (i. e. nucleocapsid) antigen is released from 
the infected cell to become 'soluble' antigen is unknown. However, there is 
no reason to believe that the other cell-associated viral antigens should not 
have CF activity, this being attributed to the sensitivity of the assay. This 
view is emphasised by the fact that purified LCM virus could not be lysed 
by antibody and complement (Welsh et al., 1976). The CF antigens from 
LCM virus infected tissue and tissue culture cells are immunologically 
identical (Bro-Jorgensen, 1971; Geschwender et al., 1976). Occasionally 
two viral antigens related to CF antigen have been found by 
immunodiffusion. One of these antigens is heat stable and pronase 
resistant, and has a molecular weight of 20,000-30,000 (Buchmeier and 
Oldstone, 1979); the other is thermolabile, and has a molecular weight of 
about 48,000 (Bro-Jorgensen, 1971). Since the arenavirus N protein has a 
molecular weight of about 66,000 the low molecular weight antigens with 
CF antivity probably represent degraded N protein. Immunofluorescent 
studies have shown that the CF antigens in LCM virus-infected cells gives 
rise to a coarse fluorescence in the cytoplasm of infected cells (Rutter and 
Geschwender, 1973; Geschwender et al., 1976). Pulse-labelling 
experiments (Buchmeier egal., 1978) showed that N antigen was 
synthesised in the cells six hours after the infection, corresponding to the 
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beginning of the log phase of viral replication. It was not evident on the 
cell surface. 
Neutralizing antibody to LCM is almost certainly directed against 
one or both of the virus surface glycoproteins. Sera containing high 
neutralizing antibody titres immunoprecipitate GP-1 ' and GP-2 
glycoproteins. Whether these surface antigens are identical to those 
recognized by cytotoxic T lymphocytes is a subject of ongoing studies. 
Evidence from studies in which cytotoxic T cell-mediated lysis of infected 
cells was blocked by antisera containing GP-1 and GP-2 antibodies but not 
by monospecific anti-nucleoprotein suggesting that the surface 
glycoproteins are important in T cell cytolysis (Welsh and Oldstone, 1977; 
Buchmeier et al., 1978). Monoclonal antibodies generated to all the viral 
polypeptides can be used as molecular probes to examine this and other 
questions of specific polypeptide participation in LCM induced disease. 
Examination of the serological and immunochemical characteristics 
common to Mopeia and Lassa viruses are examined and the results 
summarised in Table 57. 
The arenaviruses are serologically related among themselves but not 
to the viruses outside the family; the present study and those directed to 
other Lassa viruses (Buckley at al., 1970; Wulff et al., 1978), have clearly 
established this point. The serological relationships among arenaviruses 
were observed before morphological and biochemical studies were initiated 
(Mettler, 1963) and resulted in the creation of the Tacaribe antigenic 
group, to which additional viruses were subsequently added. The degree of 
cross-reactivity depends upon the serological test employed. The 
complement fixation tests exhibits the broadest relationships. LCM, 
Mopela and Lassa are distantly related in the CF test to Amapari, Junin, 
Parana, Latino, Machupo and Tacaribe viruses. Pichinde and Tamiami are 
not so closely related to each other or to other members of the Tacaribe 
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complex viruses, whereas Lassa virus seems to be distantly related (Casals 
et al., 1975; Casals, 1975). Mopeia strains studied in this thesis showed a 
close relationship to each other and to Lassa (LGA 391) and also 
demonstrated a distant relationship to LCM (Table 57). 
The indirect immunofluorescence test shows a closer' relationship 
among the arenaviruses although the assay system is less specific than the 
neutralization assay. The assay stains cytoplasmic antigens and 
demonstrates that Mopeia and Lassa virus are clearly related to each other 
and more distantly related to LCM and to viruses of the Tacaribe complex 
(Rowe et al., 1970a; Casals, 1975; Wulff, 1978). Staining the surface of 
infected cells by IF demonstrated no cross-reactivity among members of 
the Tacaribe complex or between those viruses and LCM (Buchmeier and 
Oldstone, 1979). A relationship has been shown by this method between 
Lassa and isolates from Mozambique (Wulff et al., 1977). These workers 
also established that both Lassa and the Mozambique isolate (Mopeia 
20410) cross react only to a low titre with other members of the arenavirus 
group. In this study all Mopeia strains react in the same way. Surface 
staining of Mopeia and Lassa infected cells with anti-Mopeia sera 
demonstrates a limited IF response, indicating a limited reaction to anti- 
GP-1 and/or GP-2 antibodies in the antisera so far used. Anti Lassa serum 
demonstrates some surface staining of both Mopeia- and Lassa-infected 
cells. 
In neutralization assays, arenaviruses form distinct serotypes (Casals, 
1975). In those plaque-reduction assays using human serum no cross- 
neutralization has been observed between viruses of the Tacaribe complex 
which are closely related by CF, an example being Junin and Machupo 
viruses, which are quite distinct. A similar marked specificity has been 
demonstrated between LCM and Lassa viruses, both viruses being readily 
distinguishable from one another by this technique. However, in 
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neutralizing assays involving guinea pigs immunized with five doses of 
Tacaribe virus, anti-Junin neutralization antibodies were shown to develop 
20 days after Tacaribe infection demonstrating a high degree of cross- 
reactivity after 120 days (Weissenbacher et al., 1975/6). Further studies 
with Tacaribe infection of non-human primates (Callithrix 'acchas) 
demonstrated no anti-Junin antibodies after 45 days, but homologous anti- 
Tacaribe after 21 days. This type of cross-neutralization relationship 
between non-infectious Tacaribe and infectious Junin can now be extended 
to non-infectious Mopeia and infectious Lassa, where present studies show 
a lack of anti-Lassa neutralization antibodies after Mopeia infection in 
guinea pigs and Rhesus monkeys. Limited studies of the molecular basis 
for serological cross-reactivity among Tacaribe complex viruses have been 
carried out by Buchmeier and Oldstone (1978). Antisera directed against 
Amapari, Tacaribe and Junin viruses specifically immunoprecipitated only 
the nucleocapsid protein of Pichinde virus, while antisera directed against 
Pichinde virus immunoprecipitated the two virion glycoproteins in addition 
to the nucleocapsid protein. Neutralizing antibody to LCM is almost 
certainly directed against one or both of the virus surface glycoproteins. 
LCM sera containing high neutralizing antibody titres immunoprecipitates 
GP-I and GP-2 glycoproteins. Present studies have indicated that guinea 
pig and Rhesus monkey sera raised against LGA 391 reacted strongly with 
N and G2 structural proteins of all the Lassa and Mopeia strains tested by 
the "Western blot" assay system (Table 57). This suggests that there are 
antigenic determinants common to LGA 391 on both the internal 
nucleocapsid proteins and on at least one of the envelope glycoproteins 
(G2). No conclusion can be drawn concerning the GI glycoprotein because 
of its lack of antigenicity in the "Western blot" assay system. 
Alternatively, the use of Mopeia antisera demonstrated that the N protein 
of the Mopeia viruses reacted strongly with antibody, but the N protein of 
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LGA 391 virus reacted extremely weakly. There was no reaction with the 
glycoproteins of any virus. Both these characteristics have been endorsed 
with other Lassa strains (Fig. 55). It is clear that the viruses can be 
differentiated into two groups: those from West Africa which may be 
considered Lassa virus strains, and those from Mozambique or Zimbabwe 
which may be considered strains of Mopeia virus. The reason for the lack 
of G2 reactivity which is characteristic of all the Mopeia antisera tested so 
far is unclear. Further work is necessary to determine if antibody 
reactivity in other systems is present or whether the results reflect an 
absence of specific glycoprotein antibody. The latter proposal is unlikely 
since neutralizating antibody has been demonstrated. 
Monoclonal antibodies have proved to be useful tools in analyzing 
virus-specific antigens. The present study demonstrates that antibodies 
raised in vitro against LCM, Mopeia and Pichinde can be used to analyse 
the cross-reactive make-up of viruses included in the Arenaviridae. This 
ability to raise useful cross-reactive monoclonal antibodies may make it 
possible to circumvent the need to grow dangerous pathogens such as Lassa 
virus, yet still produce useful and precise clinical reagents. Functional 
activity of the various anti-glycoprotein hybridomas are as yet not known. 
Conventional human or animal antisera used in CFT or IF have not been 
able to differentiate between the Mopeia viruses from Mozambique and 
Zimbabwe, the Lassa related virus from the Central African Republic or 
the various West African Lassa isolates. Prior to this Thesis, a limited 
number of monoclonal antibodies produced by Buchmeier et al. (I 980a, 
1981) indicated differences between the arenavirus isolates from Africa. 
However, a cautionary note should be sounded in that it is important to 
generate a diverse panel of hybridoma antibodies, since one can easily be 
misled by the results of a small and biased panel of such antibodies which 
are specific for only limited aspects of the total antigenicity of the viral 
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protein under examination. Therefore, observations made with 
individual 
monoclonals (Buchmeier et al., 1980a) should always be evaluated in the 
context of the overall antigenicity as delineated by conventional antisera. 
Nevertheless, a clear differentiation between Lassa and Mopeia viruses can 
be achieved using nucleocapsid protein-specific monoclonal antibodies 
raised against Lassa (LGA 391) or Mopeia (M20410) the results of which are 
summarised in Table 57. When the monoclonal antibodies are tested 
against Mopeia and LGA 391 viruses, some of the antibodies reacted more 
or less well with either group of viruses. This pattern was observed using 
IF or "Western blot" assay systems and and is exactly complementary to 
that seen by conventional anti-Mopeia antiserum. Taking all the 
serological and immunological results together, these viruses appear to be 
serologically related by common antigenic determinants located on the N 
and G2 proteins, but also possess unique determinants which divide them 
into two groups. This supports the original hypothesis of antigenic 
variability between Lassa and Mopeia viruses. Studies using Pichinde 
monoclonal antibodies also indicate common antigenic determinants 
between Lassa, Mopeia and Pichinde viruses, and support the inclusion of 
Mopeia virus within the arenavirus family. The division of Lassa and 
Mopeia into two groups also coincides with their geographical separation 
and this is further demonstrated by the host susceptibility studies 
summarised in Table 58. 
4.3. Ex erimental infection (Table 58) 
Almost all the arenaviruses cause a fatal illness in suckling mice 
following intracerebral inoculation. The exceptions are Latino virus, 
which does not infect mice, Parana, Lassa and Mopeia viruses which cause 
illness but few deaths and LCM which has no effect on suckling mice, but 
produces a fatal infection in young adult mice (Casals 1975). Infection of 
adult mice with Mopela and Lassa viruses also proves fatal by the i. c. route 
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TABLE 5S. SUMMARY OF HOST SUSCEPTIBILITY FOLLOWING INFECTION WITH 
LASSA LGA 391 AND MOPEIA VIRUSES 
Host responses 
Natural host 
M. natalensis 
Human susceptibility 
Acute haemorrhagic disease 
Pyrexia 
Lethality % 
Altered serum biochemistry 
Ab. response 
Ex erimental (in vivo) 
Monkey susceptibility 
Acute haemorrhagic disease 
Pyrexia 
Lethality % 
Altered serum biochemistry 
Ab. response 
Guinea pig susceptibility 
Acute haemorrhagic disease 
Pyrexia 
Lethality % 
Altered serum biochemistry 
Ab. response 
Adult mouse susceptibility (IC) 
Acute haemorrhagic disease 
Lethality % 
Altered serum biochemistry 
Ab. response 
Adult mouse susceptibility (IP) 
Acute haemorrhagic disease 
Lethality % 
Altered serum biochemistry 
Ab. response 
Suckling mouse (2-4 day) IC 
Suckling mouse (2-4 day) IP 
Tissue tropism 
Ex erimental (in vitro) 
Site of maturation 
Mechanism of maturation 
Cytopathology 
LGA391 
Incidental 
30-60 
100 
60-70 
100 
0 
+ 
+ 
** 
Pantropic 
Mopeia viruses 
Unknown 
0 
+ 
0 
100 
m153 
(+) 
(+) 
(+) (30) 
(+) 
0 
** 
Occasionally detected 
in spleen, liver 
Both groups of viruses infect a variety 
of mammalian cell lines 
Cytoplasm Cytoplasm 
Budding through Budding through 
plasma membrane plasma membrane 
Total cell Partial cell 
destruction destruction 
M 152 did demonstrate mild Lassa-like characteristics in Dunkin-Hartley guinea pigs. 
Mice became sick with paralysis or stunted growth sometimes leading to death. 
+= present -= absent += equivocal 
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but not the i. p. route. The histopathological response observed from i. c. 
route of infection demonstrated widespread brain lesions but other organs 
appeared unaffected despite the recovery of high levels of virus. Junin, 
Latino, Machupo, Parana and Pichinde viruses will kill new born hamsters 
(Casals, 1975) while guinea pigs are susceptible to Junin (Weissenbacher et 
al., 1975), Lassa infection (Jahrling et al., 1982) and Mopeia 152 in the 
present study. Finally Junin (Weissenbacher et al., I982), and Lassa (Callis 
1982; Kiley 1982) have demonstrated the susceptibility of non-human 
primates. Studies using marmosets challenged with Tacaribe virus 
(Weissenbacher et al., 1982) and Rhesus monkeys infected with Mopeia 
strains have shown the non-human primate to be resistant to infection. 
The studies reported here suggest that mice, guinea pigs and Rhesus 
monkeys are potentially useful models for identifying differential aspects 
of the pathogenesis between Lassa and Mopeia virus infections. They 
would allow the development of studies into prophylaxis and protection, 
providing a comparative understanding of the disease process in each model 
(especially with man). 
The disease produced in man, after infection with Lassa, Junin or 
Machupo follow a similar pattern. The onset of illness is insidious, with 
chills, malaise, headache, nausea, pain behind the eyes and in muscles 
followed by fever, conjunctival injection, exanthema and oedema of the 
face and neck and upper thorax. After a few days the patient becomes 
appreciably worse with the development of hypotension, oliguria, 
haemorrhages from gums and nose, haematemesis, haematuria and 
melaena. Death may result from anaemia, coma, or hypovolaemic shock 
caused by plasma leakage. In Lassa infections, a pronounced pharyngitis 
with ulcerative lesions on the tonsils is a frequent finding (P. A. Webb, 
personal communication). Junin or Machupo are rarely transmitted from 
person to person like Lassa which has the reputation for frequent man-to- 
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man transmission. This may correlate with the low titre of circulating 
virus in patients with AHF and BHF in contrast to the high titre found in 
some cases of Lassa infection (Emond et al. 1982). Inapparent and sub- 
clinical infections with Lassa are now believed to be quite common but 
inapparent infections with Junin and Machupo viruses are extremely rare. 
J. B. McCormick and P. A. Webb and others (unpublished information) 
assessed the factors influencing the prognosis of Lassa fever and found that 
17 patients died out of 18 patients with serum aspartate transaminase 
activity in excess of 150 IU/1 and a viraemia greater than 104 median 
tissue culture infectious dose/ml. In my investigations, the patient (P. B. ) 
studied in comparison with experimental monkeys survived a transaminase 
activity of 4440 IU/I and a viraemia greater than 105 median tissue culture 
infectious dose/ml. During the acute stages of Lassa illness, the presence 
of virus has to date severely restricted haematological and biochemical 
investigations to guide management. The kidneys of the few Lassa 
patients studied are variably affected and they show an initial rise in blood 
urea concentration followed by prolonged haematuria and proteinuria. The 
lack of evidence of disseminated intravascular coagulation (Copper et at., 
1982) suggests that the disturbance of clotting and tendency to bleed were 
probably related to impaired liver function and vascular endothelial 
damage, in particular grossly raised serum aspartate transaminase activity 
and hydroxybutyrate concentrations. In view of lower serum GPT activity, 
that cannot be the whole explanation. It is more likely that a variety of 
tissues such as the kidney, muscle and blood also suffer cellular damage 
and contribute to the high enzyme activities. The prolonged recovery 
period of the patient under study can be monitored by the enzyme 
chemistry. 
The classical histopathology studies involving Lassa fever, although 
small in number represent a select and well documented group. A review 
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(Winn et at.., 1975) demonstrates a major site of tissue damage in the liver 
and outlines several other areas that deserve further study. There are also 
interesting parallels with susceptible non-human primates (Rhesus 
monkeys, Jahrling at al., 1980 and squirrel monkeys, Walker et al., 1982). 
The findings of the present study are in general agreement with the 
results reported by Jahrling et al. (1980) on experimental infection of 
Rhesus monkeys with the Josiah strain of Lassa virus, the difference being 
that the Rhesus monkeys studied by Jahrling recovered, a situation not 
repeated in the present work with LGA 391 infection. There was 
widespread infection which involved nearly all viscera and caused a 
prolonged viraemia. The panorganotropism is also comparable to the 
results of studies of Lassa fever in humans in which adrenotropism, 
hepatotropism and lymphoreticulotropism have been found (Walker et al., 
1982). Moreover as in the disease of humans the development of serum 
antibody in Rhesus monkeys does not result in rapid clearing of viraemia or 
assume imminent clinical recovery. The studies of the Rhesus monkey 
with unmodified Lassa virus infection suggested that damage to certain 
tissues was variable and that cellular necrosis, host reaction and 
regeneration occurred in temporal succession. The present studies on 
clinical biochemistry reflect the degree of pantropic activity with rising 
levels of enzymes suggesting renal, liver and muscular damage. It is noted 
by Walker et al. (1982) that pulmonary vasculitis, systemic arteritis and 
skeletal myositis are more prominent in monkeys than in humans. 
Experimental infection of the Rhesus monkey with any of the Mopeia 
viruses resulted in no adverse clinical or pathological changes. No Mopeia 
virus could be recovered from the blood at any time post-infection. Anti- 
Mopeia neutralizing antibodies were evident at 60 days. 
Immunofluorescent antibodies appeared 12-14 days post infection. A 
similar situation was noted with Tacaribe infected marmosets except that 
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anti-Tacaribe neutralizing antibodies appeared 3 weeks post infection 
(Weissenbacher, 1982). The significance of these two studies stems from 
the fact that Tacaribe immunised non-human primates are protected 
against Junin challenge and Rhesus monkeys immunised with any Mopeia 
virus proved to be protected against Lassa infection. 
A similar situation occurs with guinea pig models. Although outbred 
guinea pigs develop an illness characterised by respiratory insufficiency the 
mortality rate varies according to the strain of Lassa used (3ahrling et al., 
1982; Walker et al., 1975). Organ infectivity titrations showed high titres 
of Lassa virus in virtually all the organs tested between days 16 and 24 
after inoculation. This pattern of organ infection did not suggest any 
specific tropism, but resembled the 'pantropism' seen in the squirrel and 
rhesus monkeys. 
There was a marked disparity between lesions found in guinea pigs 
infected with Lassa virus and those found in humans with Lassa fever or in 
non-human primates experimentally infected with Lassa virus. This was 
the case in spite of apparently similar patterns of viral tropisms in guinea 
pigs and primates. Walker et al. (1975) pointed out that disparity in the 
pathology was seen in the liver and heart. Lassa virus is particularly 
hepatotropic; however, whereas man develops hepatocellular necrosis, the 
monkey shows increased regenerative activity and the guinea pig only foci 
of calcified hepatocytes. Mopeia infection of guinea pigs demonstrates 
low levels of viral activity in both serum and organs. The main target 
appeared to be the mesenteric lymph node especially after i. p. inoculation. 
However, guinea pigs do survive, despite a mild febrile illness after 
challenge with most Mopeia viruses with the exception of M 152. Infection 
of guinea pigs with M152 resulted in a moderate degree of clinical 
symptoms similar to Lassa resulting in a 30% death rate. All the 
symptoms exhibited by Lassa infection are reproduced with lethal M152 
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infection. Jahrling et al. (1982) have suggested that Strain 13 guinea pigs 
were more sensitive and were uniformly killed by Lassa, whereas the 
Hartley strain proved to be relatively resistant. Because of this they 
suggested that Strain 13 guinea pigs are preferable to outbred animals 
for 
studying the pathogenesis of acutely lethal Lassa virus infections and 
for 
assessing vaccine and treatment regimes. However, outbred guinea pigs 
offer an opportunity to generate convalescent antisera and examine the 
natural basis for fatal versus non-fatal disease, and to study late sequelae 
(if any) of these infections. These observations are similar to those 
reported for Pichinde virus which, like Lassa, uniformly killed inbred Strain 
13 guinea pigs but killed less than half of outbred animals regardless of the 
dose (Jahrling at al., 1981). 
Lassa virus infections of outbred guinea pigs results in neutralizing 
antibodies not being detected until eight weeks after the viraemia had 
subsided. Although antigen concentrations in tissue are high and could 
conceivably remove neutralizing antibody from the circulation, passively 
administered antibody was not cleared from the circulation of infected 
guinea pigs any more quickly than it was from uninfected controls 
(Jahrling, personal communication). Mopeia neutralizing antibody 
appeared between 21 and 35 days but no anti-Lassa activity was evident up 
to 120 days post infection. Differences in susceptibility of guinea pigs, 
mice and monkeys to Mopeia or Lassa virus are probably also unrelated to 
the early IFA response, since they were similar in both timing and 
magnitude. Furthermore early Lassa convalescent sera containing high 
concentrations of antibody as measured by IFA conferred no demonstrable 
protection to Lassa infected guinea pigs (Jahrling, personal communication) 
suggesting that the IFA response is of little consequence in resolving acute 
Lassa virus infections. 
The replication of Lassa virus in tissues showing little or no 
histological damage or inflammation is a recurrent theme (Jahrling et al., 
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1980; Jahrling et al., 1982; Walker et al., 1975). Disease may result as a 
consequence of functional impairment of infected cells, which appear 
histologically normal but are inhibited from performing the specialty 
functions of differentiated cells (Oldstone et al., 1977). Insight critical to 
the understanding of Lassa and Mopeia virus infections may be obtained by 
studying the biochemical and haematological changes in blood, hepatic and 
cardiovascular functions and capillary permeability changes in various 
animal models. To this end serum biochemistry in all models was studied 
for both Lassa and Mopeia virus and used as markers in following the 
progress of viral disease and determining the effectiveness of protection 
experiments. Numerous experiments with animals including those reported 
here, together with clinical observations, have demonstrated that the 
levels of enzyme activity reached in plasma are directly related to the 
amount of tissue damage, but not necessarily to the severity of the clinical 
condition. Although little is known at present about the means by which 
enzymes are cleared from the plasma, enzymes differ in their plasma half- 
lives and these differences contribute to the observed variations in rates of 
rise and fall of individual enzymes. It is generally agreed that leakage of 
enzymes from dying cells is the main cause of the observed rise in serum 
enzyme activity in such conditions as myocardial infarction and viral 
hepatitis. Alternate views also suggest that failure to maintain the semi- 
permeable cell membrane in its normal state is also a cause of enzyme 
leakage in conditions that stop short of cell death (Kachmer and Ross, 1976 
review). The serum enzymes chosen in this study are those considered to 
be of clinical and diagnostic value. In all experimental models used there 
is a consistent response to infection in that the enzymes normally 
associated with cytoplasm (GPT, GOT, LDH) leak into the plasma, 
progressively increasing until the animal dies or recovers. The enzymes 
also indicate the target organs affected in that the GOT and GPT are 
223 
predominantly an indication of liver damage; LDH and aHBDH activity 
would indicate the degree of possible damage to liver, heart, kidney, 
skeletal muscle; YGT activity indicates cardiovascular problems and 
pancreas malfunction; the CK indicates the degree of muscle damage and 
normally can be associated with various forms of shock. Therefore the 
serum enzymes studied verify the 'pantropism' indicated by histopathology 
and virology, in that Lassa infection as measured by serum biochemical 
analysis reflects the progress and severity of the disease and are useful 
markers of the disease process, comparative pathogenesis and assessing the 
protective ability of a possible vaccine. The degree of damage caused by 
the Mopeia viruses in the mouse model demonstrated an alteration in serum 
enzyme activity. This reflected the outcome of the disease and was 
similar to that found with a Lassa infection. In the case of guinea pigs the 
levels of serum enzymes remain unaffected upon challenge of these models 
with all the non-lethal strains of Mopeia virus. The only Mopeia strain not 
to conform to this non-activity was M 152 which caused an increase in GPT, 
GOT, LDH, YHBDH, AP and CK levels whether there was a lethal or non- 
lethal outcome, a pattern very similar to Lassa. No Rhesus monkey 
infected with either a high (6 log I OTCID50) or low 
(2 log 
I OTCIDS0) dose of 
any strain of Mopeia virus showed any significant alteration in their serum 
biochemistry. 
The Rhesus monkey known to be highly susceptible to Lassa virus 
(lahrling et at., 1981; Walker, 1975; and Walker, 1981) failed to exhibit 
any clinical symptoms, viraemia or serum biochemical alterations when 
infected with 102 - 105 TCID50 of Mopeia virus derived from Mozambique 
or Zimbabwe. A similar situation was also demonstrated with Dunkin- 
Hartley guinea pigs. It was possible to demonstrate that Mopeia immunised 
Rhesus monkeys or guinea pigs were fully protected against lethal doses of 
a pathogenic strain of Lassa LGA 391. Furthermore, in the protected 
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Rhesus monkey and guinea pig, viraemia was absent together with an 
inhibition of spread and replication of the challenge virus . This situation is 
reminiscent of that reported with Tacaribe and Junin, where Tacaribe 
immunised guinea pigs (Coto et al., 1980; Weissenbacher et al., 1975/76) 
and marmosets (Weissenbacher et al., 1982) were protected against lethal 
challenge with Junin. However the systems differ in the humoral antibody 
studies. It is evident that Tacaribe infected marmosets or Mopeia 
infected animals were protected by mechanisms that inhibited detectable 
viral replication, viraemia and spread of challenge virus. Passive 
immunization studies performed in guinea pigs and humans infected with 
Junin virus have demonstrated the important role of neutralizing antibodies 
in the protection against the disease and death induced by Junin (Maiztegui 
et al., 1979; Weissenbacher et al., 1968). However similar studies carried 
out in Sierra Leone (P. A. Webb, personal communication) have not proved 
the efficacy of anti-Lassa convalescent serum in the treatment of Lassa 
patients. However since neutralizing antibodies develop late in infection 
the quality of serum used in serotherapy is open to doubt since a true 
assessment of neutralization antibody content was suspect. P. Jahrling 
(personal communication) has indicated in guinea pig passive antibody 
studies that for any serum (human, monkey or guinea pig) to be of any 
effect the neutralizing index must be at least 2. 
The absence of anti-Lassa neutralizing antibodies in Mopeia infected 
monkeys and guinea pigs up to the time of challenge contrasts with the 
results obtained in guinea pigs infected with Tacaribe virus, where late 
anti-Junin antibodies (45 days p. i. ) were found. However, in both systems 
with either guinea pigs or Rhesus monkeys, the protective effect against 
Lassa was demonstrated before the detection of any humoral neutralizing 
antibodies. A similar situation was recorded by Weissenbacher et al. 
(1982) with the Tacaribe-Junin system. It has been generally accepted 
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that members of the Tacaribe complex are separated by nearly complete 
absence of antigenic overlap with respect to antigens which determine 
neutralization (Jahrling et al., 1973). However some findings by Anderson 
and Downs (1965) and Mackenzie (1965) demonstrated that Junin virus is 
weakly neutralized by Tacaribe immune serum and that this is a one-way 
cross-reaction. Weissenbacher et al. (1968 and 1982) demonstrated a two- 
way cross-reaction using guinea pig and marmoset immune serum. The 
present study indicates that Mopeia immune sera derived from Rhesus 
monkeys or guinea pigs did not neutralize Lassa while anti-Lassa serum 
weakly neutralized Mopeia viruses. Upon challenge of Mopeia immunised 
animals anti-Lassa neutralizing activity was eventually demonstrated 
although the level did vary from animal to animal, and was not as dramatic 
as was found with Tacaribe immune marmosets. Junin challenged anti- 
Tacaribe animal sera demonstrated levels of LNI >2. 
It has been postulated that viral interference or cell mediated 
immunity (or both) play a part in the protection against both Junin and 
Lassa in guinea pigs or non-human primates (Coto et al., 1980; Damonte et 
al., 1978). It is also suggested that cell mediated immunity (CMI) plays a 
major role in heterologous protection among Togaviruses (Crissman and 
Hammon, 1974; Jacoby et al., 1980; Latif et al., 1979). This cross- 
protection occurs in the absenced of detectable cross-neutralizing antibody 
(Brown and Officer, 1975; Casals, 1965; Chamberlain, 1968; Hearne and 
Rainey, 1963; Porterfield, 1962; Smith-Owirodu et al., 1980). The 
suppression of a humoral response to the challenge of Lassa in non-human 
primates immunised with Mopeia viruses is a significant finding but not 
unique within the arenavirus group. Weissenbacher et al., (1975/6) 
reported that infection with viruses of the Tacaribe complex bestowed 
partial immunity to guinea pigs and modified the course of infection with 
Junin virus, i. e. 30% of Machupo immunised guinea pigs survived; 3 doses of 
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Ampari protected 58%. In the present study, the delayed response 
in 
neutralizing antibody production to Lassa is coincident with protection 
similar to that reported between Semliki Forest virus and Sindbis 
(Smith- 
Owirodu et al., 1980; Peck et al., 1975). In the Togavirus studies, T-cell 
mediated immunity plays a major role in cross-protection since recipient 
animals receiving adoptive T-cell rich populations of spleen cells from an 
immunized donor resisted fatal challenge (Peck et al. 1979a and b). 
Pathologic lesions of human and non-human primates infected with 
other arenaviruses (Walker et al., 1975) suggest a possible role for 
immunopathologic mechanisms for the vascular lesions in these Rhesus 
monkeys. The lymphoreticulotropism of Lassa virus as indicated by lymph 
node and spleen infectivity titres and necrosis of B-cell regions, may 
correlate for the delayed neutralizing antibody response which is 
characteristic of several arenavirus infections of man and experimental 
animals including those of this present study (Carey et al., 1972; Fraser et 
a!., 1974; Hotchin et al., 1969; Johnson 1973; Jahrling et al., 1982; 
1Veissenbacher 1980). Complement fixing antibody develops slowly in 
human Lassa fever patients and in the present study none was found, 
although the monkey did die early. However, Jahrling et al., (1980) and 
Walker (1975) did not find any neutralizing antibodies 28 days post 
infection. It has been suggested by Walker et al., (1975) that the delay in 
anti-Lassa antibody responses could be due to viral infection and 
destruction of responding lymphoid cells. Another feature of non-human 
primate lymphoreticulum histopathology was hyperplasia of the T-cell- 
dependent paracortical regions of the lymph nodes and varying degrees of 
severity in sinus histocytosis. The precise role of cell-mediated 
immunopathology in man and hon-human primates is not known. 
Laboratory models of rodent infections with LCM (Nathanson, 1975) and 
Tacaribe viruses (Doherty and Zinkernagel, 1974) have demonstrated T-cell 
mediated immunopathology. 
227 
Thus the role of the cell mediated immune system needs to be studied 
more extensively not only in the area of protection but in studying the 
differences between fatal and non-fatal arenavirus infections. Studies :n 
determining the differences in cellular immune responses, including 
quantitative differences in reticuloendothelial cell function may explain 
variations in susceptibility. The availability of models using inbred 
animals facilitates adoptive cell transfer studies to approach these C. '. II 
problems. The susceptibility of various animal models may also depend on 
genetically determined differences in cellular susceptibility to produce 
viral infection or defective interfering particles. 
4.4. Conclusion 
These studies have shown that Mopeia viruses have physicochemical, 
morphological and structural characteristics similar to the Lassa virus and 
those viruses characterised within the arenaviridae. The serological and 
immunochemical data indicate the presence of both common and unique 
antigenic determinants on Mopeia and Lassa viruses, suggesting two 
possible groups within the 'Old World' arenavirus classification. Th: s 
aspect is endorsed by the geographical separation of these viruses and by 
the differences in host susceptibility, showing Lassa to be pathogenic and 
Mopeia non-pathogenic. It is therefore concluded that the Mopeia viruses 
can be incorporated within the arenavirus family and are minor antigenic 
variants of Lassa. 
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